{
  "timestamp": "2025-12-01T23:28:32.820231",
  "config": {
    "data_dir": "persistent_data/benchmark_articles_md",
    "model": "gpt-4o-mini",
    "concurrency": 3
  },
  "output_directory": "outputs/pipeline_run_20251201_231608",
  "combined_file": "outputs/pipeline_run_20251201_231608/combined_20251201_231608.json",
  "summary": {
    "total_pmcids": 32,
    "benchmarked_pmcids": 32,
    "scores": {
      "var-pheno": 0.47892378768080596,
      "study-parameters": 0.5121870157563614,
      "var-drug": 0.45305623046719773,
      "var-fa": 0.3359687411209993
    },
    "overall": 0.48249626382884486,
    "timestamp": "2025-12-01T23:28:32.820310"
  },
  "pmcid_results": {
    "PMC6435416": {
      "var-pheno": {
        "overall_score": 0.05965105659431882,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.06666666666666667,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.06666666666666667,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.06666666666666667,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.06666666666666667,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.06041032870610555,
            "scores": [
              0.9061549305915833,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.06666666666666667,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.06666666666666667,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.0647618571917216,
            "scores": [
              0.971427857875824,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.058013610045115155,
            "scores": [
              0.8702041506767273,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 15,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9061549305915833,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.971427857875824,
              "When treated with/exposed to/when assayed with": 0.8702041506767273,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2D6*4",
                "prediction": "CYP2D6*4"
              },
              "Gene": {
                "ground_truth": "CYP2D6",
                "prediction": "CYP2D6"
              },
              "Drug(s)": {
                "ground_truth": "risperidone",
                "prediction": "risperidone"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
                "prediction": "*4"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:adverse events",
                "prediction": "adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "due to",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "cyp2d6*4"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*1",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*1xN",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*2",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*2xN",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*3",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*4xN",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*5",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*6",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*9",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*10",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*17",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*29",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*35",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1450932846,
            "Variant/Haplotypes": "CYP2D6*41",
            "Gene": "CYP2D6",
            "Drug(s)": "risperidone",
            "PMID": 30661084,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Normal metabolizer also included: *35/*35 + *2/*9 + *2/*3 + *2/*29 + *2/*10 + *1xN/*4 + *10/*46 + *10/*35 + *1/*6 + *1/*33 + *1/*10 + *4/*35. Most common AEs were weight change (9%), sedation (6%), and extrapyramidal symptoms (6%). Of the 224 normal/ultrarapid metabolizers, 20 (9%) were taking one or more concomitant drugs that are known strong inhibitors of CYP2D6. The frequency of AEs was not different among those with a strong concomitant CYP2D6 inhibitor (6/20, 30%) vs. those without (55/204, 27%, P= 0.8). CYP2D6 phenoconversion not considered in the PM+IM vs NM+UM analysis.",
            "Sentence": "CYP2D6 *4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17 (assigned as intermediate metabolizer and poor metabolizer phenotype) are associated with increased likelihood of adverse events due to risperidone in children as compared to CYP2D6 *1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1 (assigned as normal metabolizer and ultrarapid metabolizer phenotype) .",
            "Alleles": "*4/*4 + *3/*4 + *3/*5 + *4/*4xN + *4/*6 + *5/*41 + *4/*29 + *4/*17 + *5/*10 + *3/*41 + *4/*9 + *4/*41 + *4/*10 + *5/*17",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "due to",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/ *2xN + *1/*1xN + *1xN/ *2 + *1/ *2 + *1/*4 + *2/*4 + *1/*41 + *1/*35 + *2/*41 + *1/*9 + *1/*17 + *1/*5 + *3/*35 + *2/*5 + *2/*35 + *2/*17 + *35/*41 + *2/*6 + *1/*29 + *2/*2 + *1/*3 + *1/*1",
            "Comparison Metabolizer types": "normal metabolizer and ultrarapid metabolizer",
            "PMID_norm": "30661084",
            "Variant Annotation ID_norm": "1450932846",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "risperidone",
              "drug_id": "PA451257",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.8608476042747497,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.9127140641212463,
            "scores": [
              0.9127140641212463
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "P Value": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          }
        },
        "total_samples": 1,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9127140641212463,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1450932850,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1450932846,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 257.0,
                "prediction": 257.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "multivariate analysis adjusted for age, sex, race, and initial risperidone dose",
                "prediction": "Children \u226418 years with at least four weeks of risperidone exposure"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.03",
                "prediction": "= 0.03"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.4,
                "prediction": 2.4
              },
              "Confidence Interval Start": {
                "ground_truth": 1.1,
                "prediction": 1.1
              },
              "Confidence Interval Stop": {
                "ground_truth": 5.1,
                "prediction": 5.1
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, White Hispanic, White non-Hispanic, African American, Asian/Pacific Islander, Native American or 'Unknown' ethnicities",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cohort, retrospective:multivariate analysi"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 257.0,
            "Study Controls": null,
            "Characteristics": "Children \u226418 years with at least four weeks of risperidone exposure",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.46,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": 0.27,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.04",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.4,
            "Confidence Interval Start": 1.1,
            "Confidence Interval Stop": 5.1,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC12038368": {
      "var-drug": {
        "overall_score": 0.39250113148438304,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "PMID": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.48797425627708435,
            "scores": [
              0.9759485125541687,
              0.0
            ]
          },
          "Specialty Population": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "isPlural": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Population types": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.46954724192619324,
            "scores": [
              0.9390944838523865,
              0.0
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9759485125541687,
              "Specialty Population": 1.0,
              "Metabolizer types": 0.0,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 1.0,
              "Population Phenotypes or diseases": 0.9390944838523865,
              "Multiple phenotypes or diseases And/or": 0.0,
              "Comparison Allele(s) or Genotype(s)": 1.0,
              "Comparison Metabolizer types": 0.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4149056",
                "prediction": "rs4149056"
              },
              "Gene": {
                "ground_truth": "SLCO1B1",
                "prediction": "SLCO1B1"
              },
              "PMID": {
                "ground_truth": 40297930,
                "prediction": 40297930
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "CC + CT",
                "prediction": "TC + CC"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": "decreased function"
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Are"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "PD/PK terms": {
                "ground_truth": "concentrations of",
                "prediction": "concentrations of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in people with",
                "prediction": "in people with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Cardiovascular Disease, Other:Dyslipidaemia",
                "prediction": "Disease:Dyslipidemia, Disease:Coronary Artery Disease"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": "or",
                "prediction": "and"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "TT",
                "prediction": "TT"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": "normal function"
              },
              "Drug(s)": {
                "ground_truth": "simvastatin acid",
                "prediction": "simvastatin acid"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "PA166154579"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1454052282,
            "Variant/Haplotypes": "rs2306283",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin acid",
            "PMID": 40297930,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"Additionally, SLCO1B1 rs2306283 was associated with significantly higher SVA levels in patients carrying the G allele (AG+GG genotype) at the same dose (3.63 vs. 1.59\u2009ng/mL, p\u2009=\u20090.04). \"",
            "Sentence": "Genotypes AG + GG is associated with increased concentrations of simvastatin acid in people with Cardiovascular Disease or Dyslipidaemia as compared to genotype AA.",
            "Alleles": "AG + GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Cardiovascular Disease, Other:Dyslipidaemia",
            "Multiple phenotypes or diseases And/or": "or",
            "Comparison Allele(s) or Genotype(s)": "AA",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40297930",
            "Variant Annotation ID_norm": "1454052282",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs2306283",
              "variant_id": "PA166154547",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "simvastatin",
              "drug_id": "PA451363",
              "confidence": 0.8148148148148148
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "SLCO1B1*1b/*15",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin acid",
            "PMID": 40297930,
            "Phenotype Category": "metabolism/PK",
            "Significance": "yes",
            "Notes": "0.58 vs. 0.16 ng/mL, p < 0.001",
            "Sentence": "Genotypes *1b/*15 is associated with increased concentrations of simvastatin acid in people with Dyslipidemia or Coronary Artery Disease as compared to genotype *1a/*1a.",
            "Alleles": "*1b/*15",
            "Specialty Population": null,
            "Metabolizer types": "decreased function",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:Dyslipidemia, Disease:Coronary Artery Disease",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "*1a/*1a",
            "Comparison Metabolizer types": "normal function",
            "Citations": [
              "\"Similarly, the SLCO1B1*1b/*15 genotype was associated with higher simvastatin acid levels than SLCO1B1*1a/*1a (0.58 vs. 0.16 ng/mL, p < 0.001).\"",
              "\"These findings suggest that SLCO1B1 c.521T>C, alone or with c.388A>G (SLCO1B1*1b/*15), reduces OATP1B1 function, leading to elevated simvastatin acid levels and increased myotoxicity risk.\"",
              "\"The *SLCO1B1* c.521T>C variant, either alone or in combination with c.388A>G (*1b/*15*), was significantly associated with elevated simvastatin acid levels, potentially increasing the risk of myotoxicity.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "SLCO1B1*1b/*15",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "simvastatin",
              "drug_id": "PA451363",
              "confidence": 0.8148148148148148
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.6429789781570434,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.8946846723556519,
            "scores": [
              0.8946846723556519,
              0.8946846723556519
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8946846723556519,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454052280,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454052260,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 89.0,
                "prediction": 89.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "12h simvastatin acid concentrations",
                "prediction": "Thai patients with dyslipidemia or coronary artery disease on simvastatin treatment"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": 0.19
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": "C"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.03",
                "prediction": "= 0.03"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8946846723556519,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454052320,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454052282,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 89.0,
                "prediction": 89.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "12h simvastatin acid concentrations",
                "prediction": "Thai patients with dyslipidemia or coronary artery disease on simvastatin treatment"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": 0.53
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": "C"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.04",
                "prediction": "= 0.07"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:12h simvastatin acid",
          "None:12h simvastatin acid"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 89.0,
            "Study Controls": null,
            "Characteristics": "Thai patients with dyslipidemia or coronary artery disease on simvastatin treatment",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.16,
            "Allele Of Frequency In Cases": "C",
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.001",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 89.0,
            "Study Controls": null,
            "Characteristics": "Thai patients with dyslipidemia or coronary artery disease on simvastatin treatment",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.58,
            "Allele Of Frequency In Cases": "C",
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.001",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC5508045": {
      "var-drug": {
        "overall_score": 0.40067473289213684,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "PMID": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 0.25,
            "scores": [
              0.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.45644472539424896,
            "scores": [
              0.9337546229362488,
              0.8920242786407471,
              0.0,
              0.0
            ]
          },
          "Specialty Population": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "isPlural": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.25,
            "scores": [
              0.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.25,
            "scores": [
              0.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 0.45376867055892944,
            "scores": [
              0.9075373411178589,
              0.9075373411178589,
              0.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Population types": {
            "mean_score": 0.47338634729385376,
            "scores": [
              0.9467726945877075,
              0.9467726945877075,
              0.0,
              0.0
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.4792201817035675,
            "scores": [
              1.0,
              0.91688072681427,
              0.0,
              0.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 4,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 0.0,
              "Alleles": 0.9337546229362488,
              "Specialty Population": 1.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 0.0,
              "PD/PK terms": 0.9075373411178589,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.9467726945877075,
              "Population Phenotypes or diseases": 0.0,
              "Multiple phenotypes or diseases And/or": 0.0,
              "Comparison Allele(s) or Genotype(s)": 1.0,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs2108622",
                "prediction": "rs2108622"
              },
              "Gene": {
                "ground_truth": "CYP4F2",
                "prediction": "CYP4F2"
              },
              "PMID": {
                "ground_truth": 28550460,
                "prediction": 28550460
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "dosage"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "no"
              },
              "Alleles": {
                "ground_truth": "TT",
                "prediction": "CC, CT, TT"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Not associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": null
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": "stable weekly doses of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in people with",
                "prediction": "in Thai patients"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Disease:Atrial Fibrillation, Disease:Heart valve replacement, Disease:Pulmonary Hypertension, Disease:Pulmonary Embolism, Disease:Venous Thrombosis",
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": "and",
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": "CC"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "warfarin",
                "prediction": "warfarin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8920242786407471,
              "Specialty Population": 1.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 0.9075373411178589,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.9467726945877075,
              "Population Phenotypes or diseases": 0.0,
              "Multiple phenotypes or diseases And/or": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.91688072681427,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs887829",
                "prediction": "rs887829"
              },
              "Gene": {
                "ground_truth": "UGT1A1",
                "prediction": "UGT1A1"
              },
              "PMID": {
                "ground_truth": 28550460,
                "prediction": 28550460
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "dosage"
              },
              "Significance": {
                "ground_truth": "no",
                "prediction": "no"
              },
              "Alleles": {
                "ground_truth": "C",
                "prediction": "CC, CT, TT"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Not associated with"
              },
              "Direction of effect": {
                "ground_truth": null,
                "prediction": null
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": "stable weekly doses of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in people with",
                "prediction": "in Thai patients"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Disease:Atrial Fibrillation, Disease:Heart valve replacement, Disease:Pulmonary Hypertension, Disease:Pulmonary Embolism, Disease:Venous Thrombosis",
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": "and",
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "T",
                "prediction": "CC"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "warfarin",
                "prediction": "warfarin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "PA166155381",
          "PA166155607"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1448624157,
            "Variant/Haplotypes": "rs9923231",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "Please note: alleles have been complemented to the + strand.",
            "Sentence": "Genotypes CT + TT are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism or Venous Thrombosis as compared to genotype CC.",
            "Alleles": "CT + TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:Atrial Fibrillation, Disease:Heart valve replacement, Disease:Pulmonary Hypertension, Disease:Pulmonary Embolism, Disease:Venous Thrombosis",
            "Multiple phenotypes or diseases And/or": "or",
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "PMID_norm": "28550460",
            "Variant Annotation ID_norm": "1448624157",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs9923231",
              "variant_id": "PA166155091",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448624168,
            "Variant/Haplotypes": "rs1057910",
            "Gene": "CYP2C9",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": null,
            "Sentence": "Genotypes AC + CC are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype AA.",
            "Alleles": "AC + CC",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:Atrial Fibrillation, Disease:Heart valve replacement, Disease:Pulmonary Hypertension, Disease:Pulmonary Embolism, Disease:Venous Thrombosis",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "AA",
            "Comparison Metabolizer types": null,
            "PMID_norm": "28550460",
            "Variant Annotation ID_norm": "1448624168",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1057910",
              "variant_id": "PA166153959",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "VKORC1",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "p < 0.001",
            "Sentence": "Genotypes AA and GA is associated with decreased stable weekly doses of warfarin in Thai patients as compared to genotype GG.",
            "Alleles": "AA, GA, GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "Citations": [
              "The patients with variant genotypes of VKORC1 \u2212 1639G > A required significantly lower warfarin stable weekly doses (SWDs) than those with wild-type genotype (p < 0.001).",
              "Patients with AA and GA genotypes of VKORC1 \u2212 1639G > A required 49.7% and 27.7% significantly lower averages of SWDS of warfarin as compared with those with wild-type GG genotype (p < 0.001).",
              "The warfarin SWDs were decreased by 9.7 mg and 18.1 mg in the patients with GA and AA genotypes of VKORC1 \u2212 1639G > A as compared with those with wild-type GG genotype (p < 0.001)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "VKORC1 \u2212 1639G > A",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "\u2212",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "p < 0.001",
            "Sentence": "Genotypes AA and GA is associated with decreased stable weekly doses of warfarin in Thai patients as compared to genotype GG.",
            "Alleles": "AA, GA, GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "Citations": [
              "The patients with variant genotypes of VKORC1 \u2212 1639G > A required significantly lower warfarin stable weekly doses (SWDs) than those with wild-type genotype (p < 0.001).",
              "Patients with AA and GA genotypes of VKORC1 \u2212 1639G > A required 49.7% and 27.7% significantly lower averages of SWDS of warfarin as compared with those with wild-type GG genotype (p < 0.001).",
              "The warfarin SWDs were decreased by 9.7 mg and 18.1 mg in the patients with GA and AA genotypes of VKORC1 \u2212 1639G > A as compared with those with wild-type GG genotype (p < 0.001)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "VKORC1 \u2212 1639G > A",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "1639G",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "p < 0.001",
            "Sentence": "Genotypes AA and GA is associated with decreased stable weekly doses of warfarin in Thai patients as compared to genotype GG.",
            "Alleles": "AA, GA, GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "Citations": [
              "The patients with variant genotypes of VKORC1 \u2212 1639G > A required significantly lower warfarin stable weekly doses (SWDs) than those with wild-type genotype (p < 0.001).",
              "Patients with AA and GA genotypes of VKORC1 \u2212 1639G > A required 49.7% and 27.7% significantly lower averages of SWDS of warfarin as compared with those with wild-type GG genotype (p < 0.001).",
              "The warfarin SWDs were decreased by 9.7 mg and 18.1 mg in the patients with GA and AA genotypes of VKORC1 \u2212 1639G > A as compared with those with wild-type GG genotype (p < 0.001)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "VKORC1 \u2212 1639G > A",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": ">",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "p < 0.001",
            "Sentence": "Genotypes AA and GA is associated with decreased stable weekly doses of warfarin in Thai patients as compared to genotype GG.",
            "Alleles": "AA, GA, GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "Citations": [
              "The patients with variant genotypes of VKORC1 \u2212 1639G > A required significantly lower warfarin stable weekly doses (SWDs) than those with wild-type genotype (p < 0.001).",
              "Patients with AA and GA genotypes of VKORC1 \u2212 1639G > A required 49.7% and 27.7% significantly lower averages of SWDS of warfarin as compared with those with wild-type GG genotype (p < 0.001).",
              "The warfarin SWDs were decreased by 9.7 mg and 18.1 mg in the patients with GA and AA genotypes of VKORC1 \u2212 1639G > A as compared with those with wild-type GG genotype (p < 0.001)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "VKORC1 \u2212 1639G > A",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "A",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "p < 0.001",
            "Sentence": "Genotypes AA and GA is associated with decreased stable weekly doses of warfarin in Thai patients as compared to genotype GG.",
            "Alleles": "AA, GA, GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "Citations": [
              "The patients with variant genotypes of VKORC1 \u2212 1639G > A required significantly lower warfarin stable weekly doses (SWDs) than those with wild-type genotype (p < 0.001).",
              "Patients with AA and GA genotypes of VKORC1 \u2212 1639G > A required 49.7% and 27.7% significantly lower averages of SWDS of warfarin as compared with those with wild-type GG genotype (p < 0.001).",
              "The warfarin SWDs were decreased by 9.7 mg and 18.1 mg in the patients with GA and AA genotypes of VKORC1 \u2212 1639G > A as compared with those with wild-type GG genotype (p < 0.001)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "VKORC1 \u2212 1639G > A",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "CYP2C9*3",
            "Gene": "CYP2C9",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "p = 0.006",
            "Sentence": "Genotypes *1/*3 and *3/*3 is associated with decreased stable weekly doses of warfarin in Thai patients as compared to genotype *1/*1.",
            "Alleles": "*1/*1, *1/*3, *3/*3",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "Citations": [
              "The averages of warfarin SWDs were 64.6% and 34.1% lower in *CYP2C9* *3/*3* and *1/*3* patients than in *1/*1* patients (*p* = 0.006).",
              "Similarly, the patients with *CYP2C9*3* variant allele required significantly lower warfarin SWDs than those with homozygous wild-type (*p* = 0.006).",
              "Multiple linear regression analyses for variables responsible for stable weekly warfarin doses showed that *CYP2C9* *1/*3* and *CYP2C9* *3/*3* genotypes were negatively associated with warfarin dose requirements; while increased BMI, current smoker status, and the TT variant genotype of *CYP4F2* rs2108622 showed positive correlations."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C9*3",
              "variant_id": "PA165816544",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "CYP4F2",
            "Gene": "CYP4F2",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "no",
            "Notes": null,
            "Sentence": "Genotypes TT is not associated with stable weekly doses of warfarin in Thai patients as compared to genotype CC.",
            "Alleles": "CC, CT, TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "Citations": [
              "In contrast, there were no significant differences in the SWDs between the patients who carried variant alleles of CYP4F2 rs2108622 and UGT1A1 rs887829 as compared to wild-type allele carriers.",
              "Multivariate analysis, however, showed that CYP4F2 rs2108622 TT genotype accounted for a modest part of warfarin dose variability (1.2%).",
              "The present study showed that the CYP4F2 rs2108622 polymorphism accounted for a modest part of warfarin dose variability (1.2%)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP4F2 rs2108622",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 4,
            "Variant/Haplotypes": "UGT1A1",
            "Gene": "UGT1A1",
            "Drug(s)": "warfarin",
            "PMID": 28550460,
            "Phenotype Category": "dosage",
            "Significance": "no",
            "Notes": null,
            "Sentence": "Genotypes TT is not associated with stable weekly doses of warfarin in Thai patients as compared to genotype CC.",
            "Alleles": "CC, CT, TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": "stable weekly doses of",
            "Multiple drugs And/or": null,
            "Population types": "in Thai patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "Citations": [
              "In contrast, there were no significant differences in the SWDs between the patients who carried variant alleles of CYP4F2 rs2108622 and UGT1A1 rs887829 as compared to wild-type allele carriers.",
              "In contrast, the UGT1A1 rs887829 polymorphism did not contribute to dose variability.",
              "The present results showed that UGT1A1 rs887829 did not significantly contribute to the variability of the stable warfarin doses."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1 rs887829",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.5007135401169459,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.8857031017541885,
            "scores": [
              0.9025686383247375,
              0.8422160148620605,
              0.8979310989379883,
              0.9000966548919678
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.875,
            "scores": [
              1.0,
              1.0,
              0.5,
              1.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 4,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9025686383247375,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.0,
              "Allele Of Frequency In Controls": 0.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448624167,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448624157,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 250.0,
                "prediction": 250.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "warfarin; CT genotype assoc. w/avg decrease of 9.7 mg, and TT of 18.1 mg vs CC",
                "prediction": "VKORC1 \u2212 1639G > A genotype"
              },
              "Characteristics Type": {
                "ground_truth": "Drug",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": 0.832,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "T",
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": 0.168,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": "C",
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.001",
                "prediction": "< 0.001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8422160148620605,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.0,
              "Allele Of Frequency In Controls": 0.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448624190,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448624188,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 250.0,
                "prediction": 250.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "warfarin",
                "prediction": "UGT1A1 rs887829 genotype"
              },
              "Characteristics Type": {
                "ground_truth": "Drug",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": 0.88,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "C",
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": 0.12,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": "T",
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.921",
                "prediction": "= 0.921"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8979310989379883,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.0,
              "Allele Of Frequency In Controls": 0.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448624180,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448624178,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 250.0,
                "prediction": 250.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "warfarin; TT genotype assoc. w/avg increase of 4.1 mg vs CC",
                "prediction": "CYP2C9*3 genotype"
              },
              "Characteristics Type": {
                "ground_truth": "Drug",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": 0.774,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "C",
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": 0.226,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": "T",
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.016",
                "prediction": "= 0.006"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9000966548919678,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.0,
              "Allele Of Frequency In Controls": 0.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448624170,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448624168,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 250.0,
                "prediction": 250.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "warfarin; CC genotype assoc. w/avg decrease of 25.9 mg, and AC of 7.9 mg vs AA",
                "prediction": "Thai patients with stable warfarin doses"
              },
              "Characteristics Type": {
                "ground_truth": "Drug",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": 0.976,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "A",
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": 0.024,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": "C",
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.001",
                "prediction": "< 0.001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cohort, retrospective:warfarin; CT genotyp",
          "cohort, retrospective:warfarin",
          "cohort, retrospective:warfarin; TT genotyp",
          "cohort, retrospective:warfarin; CC genotyp"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 250.0,
            "Study Controls": null,
            "Characteristics": "CYP4F2 rs2108622 genotype",
            "Characteristics Type": "drug",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.172",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 250.0,
            "Study Controls": null,
            "Characteristics": "Age > 60 years",
            "Characteristics Type": "age group",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.021",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 250.0,
            "Study Controls": null,
            "Characteristics": "BMI > 30 kg/m^2",
            "Characteristics Type": "age group",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.008",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC3113609": {
      "var-pheno": {
        "overall_score": 0.2958123857776324,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.2964734037717183,
            "scores": [
              0.889420211315155,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.3025192618370056,
            "scores": [
              0.9075577855110168,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.889420211315155,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9075577855110168,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-A*31:01",
                "prediction": "HLA-A*3101"
              },
              "Gene": {
                "ground_truth": "HLA-A",
                "prediction": "HLA-A"
              },
              "Drug(s)": {
                "ground_truth": "carbamazepine",
                "prediction": "carbamazepine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*31:01",
                "prediction": "HLA-A*3101"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Disease:Severe Cutaneous Adverse Reactions",
                "prediction": "hypersensitivity reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "hla-a+carbamazepine"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1184466916,
            "Variant/Haplotypes": "HLA-A*31:01",
            "Gene": "HLA-A",
            "Drug(s)": "carbamazepine",
            "PMID": 21428769,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Patients with carbamazepine-induced maculopapular exanthema had an increased frequency of *31:01, as compared to carbamazepine-tolerant controls.",
            "Sentence": "HLA-A *31:01 is associated with increased risk of Maculopapular Exanthema when treated with carbamazepine.",
            "Alleles": "*31:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Maculopapular Exanthema",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "21428769",
            "Variant Annotation ID_norm": "1184466916",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-A*31:01",
              "variant_id": "PA165954030",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "carbamazepine",
              "drug_id": "PA448785",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1184466909,
            "Variant/Haplotypes": "HLA-A*31:01",
            "Gene": "HLA-A",
            "Drug(s)": "carbamazepine",
            "PMID": 21428769,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Hypersensitivity syndrome defined as the presence of a rash or liver involvement within 3 months after initiation of carbamazepine treatment, along with a minimum of two of the following manifestations: prolonged recovery phase despite drug withdrawal, fever, involvement of other internal organs, or presence of hematologic abnormalities. Patients who experienced carbamazepine-induced hypersensitivity syndrome had an increased frequency of *31:01, as compared to carbamazepine-tolerant controls.",
            "Sentence": "HLA-A *31:01 is associated with increased risk of Drug Hypersensitivity when treated with carbamazepine.",
            "Alleles": "*31:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Drug Hypersensitivity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "21428769",
            "Variant Annotation ID_norm": "1184466909",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-A*31:01",
              "variant_id": "PA165954030",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "carbamazepine",
              "drug_id": "PA448785",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.5577777777777778,
        "field_scores": {
          "Study Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.3333333333333333,
            "scores": [
              0.0,
              1.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.5,
            "scores": [
              0.5,
              0.5,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.9333333333333332,
            "scores": [
              0.8,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.6666666666666666,
            "scores": [
              0.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.9333333333333332,
            "scores": [
              0.8,
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.8,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.8,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1184466918,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1184466916,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 106.0,
                "prediction": 145.0
              },
              "Study Controls": {
                "ground_truth": 257.0,
                "prediction": 257.0
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Carbamazepine-induced hypersensitivity reactions"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 8.0E-7",
                "prediction": "= 1.0\u00d710\u22127"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 8.33,
                "prediction": 9.12
              },
              "Confidence Interval Start": {
                "ground_truth": 3.59,
                "prediction": 4.03
              },
              "Confidence Interval Stop": {
                "ground_truth": 19.36,
                "prediction": 20.65
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.0,
              "Allele Of Frequency In Controls": 0.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1184466924,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1184466922,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 12.0,
                "prediction": 12.0
              },
              "Study Controls": {
                "ground_truth": 257.0,
                "prediction": 257.0
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Carbamazepine-induced SJS\u2013TEN"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": 0.42
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": "HLA-A\u26053101"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": 0.04
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": "HLA-A\u26053101"
              },
              "P Value": {
                "ground_truth": "= 8.0E-5",
                "prediction": "= 8.0\u00d710\u22125"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 25.93,
                "prediction": 25.93
              },
              "Confidence Interval Start": {
                "ground_truth": 4.93,
                "prediction": 4.93
              },
              "Confidence Interval Stop": {
                "ground_truth": 116.18,
                "prediction": 116.18
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.0,
              "Allele Of Frequency In Controls": 0.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1184466915,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1184466909,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 27.0,
                "prediction": 22.0
              },
              "Study Controls": {
                "ground_truth": 257.0,
                "prediction": 3987.0
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Carbamazepine-induced hypersensitivity syndrome"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": 0.4
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": "HLA-A\u26053101"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": 0.049
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": "HLA-A\u26053101"
              },
              "P Value": {
                "ground_truth": "= 0.03",
                "prediction": "= 3.5\u00d710\u22128"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 12.41,
                "prediction": 12.41
              },
              "Confidence Interval Start": {
                "ground_truth": 1.27,
                "prediction": 1.27
              },
              "Confidence Interval Stop": {
                "ground_truth": 121.03,
                "prediction": 121.03
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "case/control",
          "case/control",
          "case/control"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 43.0,
            "Study Controls": 1296.0,
            "Characteristics": "Carbamazepine-induced maculopapular exanthema",
            "Characteristics Type": "disease",
            "Frequency In Cases": 0.27,
            "Allele Of Frequency In Cases": "HLA-A\u26053101",
            "Frequency In Controls": 0.04,
            "Allele Of Frequency In Controls": "HLA-A\u26053101",
            "P Value": "= 1.1\u00d710\u22126",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 8.33,
            "Confidence Interval Start": 3.59,
            "Confidence Interval Stop": 19.36,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC3548984": {
      "var-pheno": {
        "overall_score": 0.18940384586652118,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.17212631702423095,
            "scores": [
              0.8606315851211548,
              0.8606315851211548,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.16970393657684327,
            "scores": [
              0.8485196828842163,
              0.8485196828842163,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.17524880170822144,
            "scores": [
              0.8762440085411072,
              0.8762440085411072,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 10,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8606315851211548,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8485196828842163,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8762440085411072
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2D6*1",
                "prediction": "CYP2D6"
              },
              "Gene": {
                "ground_truth": "CYP2D6",
                "prediction": "CYP2D6"
              },
              "Drug(s)": {
                "ground_truth": "tamoxifen",
                "prediction": "tamoxifen"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Alleles": {
                "ground_truth": "*3/*3 + *4/*4",
                "prediction": "PM/PM"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Recurrence",
                "prediction": "disease event"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "EM/EM"
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8606315851211548,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8485196828842163,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8762440085411072
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2D6*4",
                "prediction": "*4"
              },
              "Gene": {
                "ground_truth": "CYP2D6",
                "prediction": "CYP2D6"
              },
              "Drug(s)": {
                "ground_truth": "tamoxifen",
                "prediction": "tamoxifen"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Alleles": {
                "ground_truth": "*3/*3 + *4/*4",
                "prediction": "PM/PM"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Recurrence",
                "prediction": "disease event"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "EM/EM"
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "cyp2d6*1",
          "cyp2d6*4"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1444933926,
            "Variant/Haplotypes": "CYP2D6*3",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "Note: article did not report all genotypes; only *1/variant allele and homozygous variant allele but no combinations of variant alleles e.g. PM/IM even if phenotype grouping exist. Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *3/*3 + *4/*4 are associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*3/*3 + *4/*4",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933926",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444933959,
            "Variant/Haplotypes": "CYP2D6*1",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Note: PM/IM genotypes are missing; article did not report all genotypes; only *1/variant allele and homozygous variant allele but no combinations of variant alleles e.g. PM/IM even if phenotype grouping exist.Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *1/*3 + *1/*4 + *1/*6 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*1/*3 + *1/*4 + *1/*6",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933959",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444933959,
            "Variant/Haplotypes": "CYP2D6*3",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Note: PM/IM genotypes are missing; article did not report all genotypes; only *1/variant allele and homozygous variant allele but no combinations of variant alleles e.g. PM/IM even if phenotype grouping exist.Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *1/*3 + *1/*4 + *1/*6 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*1/*3 + *1/*4 + *1/*6",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933959",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444933959,
            "Variant/Haplotypes": "CYP2D6*4",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Note: PM/IM genotypes are missing; article did not report all genotypes; only *1/variant allele and homozygous variant allele but no combinations of variant alleles e.g. PM/IM even if phenotype grouping exist.Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *1/*3 + *1/*4 + *1/*6 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*1/*3 + *1/*4 + *1/*6",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933959",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444933959,
            "Variant/Haplotypes": "CYP2D6*6",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Note: PM/IM genotypes are missing; article did not report all genotypes; only *1/variant allele and homozygous variant allele but no combinations of variant alleles e.g. PM/IM even if phenotype grouping exist.Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *1/*3 + *1/*4 + *1/*6 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*1/*3 + *1/*4 + *1/*6",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933959",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444933987,
            "Variant/Haplotypes": "CYP2D6*1",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *1/*10 + *1/*41 + *10/*10 + *41/*41 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*1/*10 + *1/*41 + *10/*10 + *41/*41",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933987",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444933987,
            "Variant/Haplotypes": "CYP2D6*10",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *1/*10 + *1/*41 + *10/*10 + *41/*41 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*1/*10 + *1/*41 + *10/*10 + *41/*41",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933987",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444933987,
            "Variant/Haplotypes": "CYP2D6*41",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23213055,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Genotyped for null alleles [*3 (2549 del A),*4(1846G>A), and *6(1707T>del)] reduced alleles [*10 (100 C>T and 1846 G>A) and *41 (2988 G>A)] with Applied Biosystems Taqman assay; duplicated alleles could not be assayed. \u201cextensive\u201d metabolizers do not carry a null or reduced allele (EM/EM); those with 1 to 2 reduced alleles without a null allele (EM/IM, IM/IM); one null allele (PM/IM, PM/EM), and \u201cpoor\u201d metabolizers, those with 2 null alleles (PM/PM). Post-menopausal women with estrogen receptor positive breast cancer were treated 5 years with tamoxifen only. The study grouped cases (cancer recurrence) and controls (no recurrence). In a second study arm (tamoxifen+ anastrozole) the higher risk did not persist after switching to anastrozole. [postmenopausal] [adjuvant] [DNA source: paraffin-embedded tissue] [HWE: yes for *4, *6, *10; no for *3, *41]",
            "Sentence": "CYP2D6 *1/*10 + *1/*41 + *10/*10 + *41/*41 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.",
            "Alleles": "*1/*10 + *1/*41 + *10/*10 + *41/*41",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Recurrence",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23213055",
            "Variant Annotation ID_norm": "1444933987",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.7335156623522441,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.9027349352836609,
            "scores": [
              0.9060787558555603,
              0.9047384262084961,
              0.8973876237869263
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.9333333333333332,
            "scores": [
              1.0,
              1.0,
              0.8
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.9060787558555603,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1444933951,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1444933926,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "prospective",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 166.0,
                "prediction": 319.0
              },
              "Study Controls": {
                "ground_truth": 287.0,
                "prediction": 557.0
              },
              "Characteristics": {
                "ground_truth": "endpoint: event (disease recurrence, contralateral breast cancer, second non-breast cancer, or death); PM/PM vs EM/EM",
                "prediction": "Post-menopausal women with ER positive breast cancer receiving tamoxifen"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.04",
                "prediction": "= 0.04"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.45,
                "prediction": 2.45
              },
              "Confidence Interval Start": {
                "ground_truth": 1.05,
                "prediction": 1.05
              },
              "Confidence Interval Stop": {
                "ground_truth": 5.73,
                "prediction": 5.73
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.9047384262084961,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1444933961,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1444933959,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "prospective",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 166.0,
                "prediction": 319.0
              },
              "Study Controls": {
                "ground_truth": 287.0,
                "prediction": 557.0
              },
              "Characteristics": {
                "ground_truth": "endpoint: event (disease recurrence, contralateral breast cancer, second non-breast cancer, or death); PM/IM and EM/PM vs EM/EM",
                "prediction": "Post-menopausal women with ER positive breast cancer receiving tamoxifen"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.07",
                "prediction": "= 0.07"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.67,
                "prediction": 1.67
              },
              "Confidence Interval Start": {
                "ground_truth": 0.95,
                "prediction": 0.95
              },
              "Confidence Interval Stop": {
                "ground_truth": 2.93,
                "prediction": 2.93
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8973876237869263,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.8,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1444933989,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1444933987,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "prospective",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 166.0,
                "prediction": 319.0
              },
              "Study Controls": {
                "ground_truth": 287.0,
                "prediction": 557.0
              },
              "Characteristics": {
                "ground_truth": "endpoint: event (disease recurrence, contralateral breast cancer, second non-breast cancer, or death); IM/IM and EM/IM vs EM/EM",
                "prediction": "Post-menopausal women with ER positive breast cancer receiving anastrozole after tamoxifen"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.6",
                "prediction": "= 0.47"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.23,
                "prediction": 0.6
              },
              "Confidence Interval Start": {
                "ground_truth": 0.58,
                "prediction": 0.15
              },
              "Confidence Interval Stop": {
                "ground_truth": 2.61,
                "prediction": 2.37
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "prospective:endpoint: event (dis",
          "prospective:endpoint: event (dis",
          "prospective:endpoint: event (dis"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 319.0,
            "Study Controls": 557.0,
            "Characteristics": "Post-menopausal women with ER positive breast cancer receiving tamoxifen",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.09",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.4,
            "Confidence Interval Start": 0.86,
            "Confidence Interval Stop": 6.66,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 319.0,
            "Study Controls": 557.0,
            "Characteristics": "Post-menopausal women with ER positive breast cancer receiving anastrozole after tamoxifen",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.32",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.76,
            "Confidence Interval Start": 0.43,
            "Confidence Interval Stop": 1.31,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC6714829": {
      "var-drug": {
        "overall_score": 0.8451803750113437,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "PMID": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Significance": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.8530258536338806,
            "scores": [
              0.8352553248405457,
              0.8707963824272156
            ]
          },
          "Specialty Population": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "isPlural": {
            "mean_score": 0.5,
            "scores": [
              0.0,
              1.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 0.8977150321006775,
            "scores": [
              0.8977150321006775,
              0.8977150321006775
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Population types": {
            "mean_score": 0.9612473249435425,
            "scores": [
              0.9612473249435425,
              0.9612473249435425
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.8464389145374298,
            "scores": [
              0.8477108478546143,
              0.8451669812202454
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8352553248405457,
              "Specialty Population": 1.0,
              "Metabolizer types": 1.0,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 0.8977150321006775,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.9612473249435425,
              "Population Phenotypes or diseases": 0.0,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8477108478546143,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4149056",
                "prediction": "rs4149056"
              },
              "Gene": {
                "ground_truth": "SLCO1B1",
                "prediction": "SLCO1B1"
              },
              "PMID": {
                "ground_truth": 30336686,
                "prediction": 30336686
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "TT",
                "prediction": "388AA, 521TT, 388G, 521C"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Are"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "PD/PK terms": {
                "ground_truth": "response to",
                "prediction": "concentrations of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in people with",
                "prediction": "in patients with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Hypercholesterolemia",
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC + CT",
                "prediction": "388G and 521C"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "simvastatin",
                "prediction": "simvastatin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 0.0,
              "Alleles": 0.8707963824272156,
              "Specialty Population": 1.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 0.8977150321006775,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.9612473249435425,
              "Population Phenotypes or diseases": 0.0,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8451669812202454,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs2306283",
                "prediction": "rs2306283"
              },
              "Gene": {
                "ground_truth": "SLCO1B1",
                "prediction": "SLCO1B1"
              },
              "PMID": {
                "ground_truth": 30336686,
                "prediction": 30336686
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Significance": {
                "ground_truth": "no",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "AG + GG",
                "prediction": "388AA, 388AG, 388GG"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Are",
                "prediction": "Are"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "PD/PK terms": {
                "ground_truth": "response to",
                "prediction": "concentrations of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in people with",
                "prediction": "in patients with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Hypercholesterolemia",
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "AA",
                "prediction": "388AG or 388GG"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "simvastatin",
                "prediction": "simvastatin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "PA166154579",
          "PA166154547"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "CYP2C19*2",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin",
            "PMID": 30336686,
            "Phenotype Category": "efficacy",
            "Significance": "yes",
            "Notes": "P < .05 for lipid-lowering response to simvastatin in 388G allele and 521TT genotype carriers.",
            "Sentence": "Genotypes 388G and 521TT is associated with increased lipid-lowering response to simvastatin in patients with hyperlipidemia as compared to genotype 388G and 521C.",
            "Alleles": "388G, 521TT, 521C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "response to",
            "Multiple drugs And/or": null,
            "Population types": "in patients with",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "388G and 521C",
            "Comparison Metabolizer types": null,
            "Citations": [
              "\"In addition, compared to 388G allele and 521C allele carriers, individuals with the 388G allele and 521TT genotype carriers had greater TC and LDL-C reduction in response to simvastatin after 4 weeks of treatment.\"",
              "\"Moreover, we found that, compared with the 388G and 521C allele carriers, the patients with the 388AA and 521TT genotypes had significantly higher concentrations of ALT and AST.\"",
              "\"Our conclusion suggests that the interaction between the SLCO1B1 388A>G and 521T>C polymorphisms could be an important genetic determinant of hepatic function and the therapeutic efficiency of simvastatin in Chinese patients with hyperlipidemia.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*2",
              "variant_id": "PA165980635",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "simvastatin",
              "drug_id": "PA451363",
              "confidence": 1.0
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.7,
        "field_scores": {
          "Study Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Study Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.5,
            "scores": [
              0.5,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451226980,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451226960,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 542.0,
                "prediction": 542
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Patients with hyperlipidemia, including 166 men and 376 women"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.016",
                "prediction": "= 0.002"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Chinese"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451227040,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451227020,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 542.0,
                "prediction": 542
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Patients with hyperlipidemia, including 166 men and 376 women"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.52",
                "prediction": "= 0.001"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Chinese"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cohort",
          "cohort"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 542,
            "Study Controls": null,
            "Characteristics": "Patients with hyperlipidemia, including 166 men and 376 women",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.28,
            "Allele Of Frequency In Cases": "A",
            "Frequency In Controls": 0.11,
            "Allele Of Frequency In Controls": "T",
            "P Value": "= 0.037",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Chinese",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 542,
            "Study Controls": null,
            "Characteristics": "Patients with hyperlipidemia, including 166 men and 376 women",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.4",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.4,
            "Confidence Interval Start": 0.2,
            "Confidence Interval Stop": 0.9,
            "Biogeographical Groups": "Chinese",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 542,
            "Study Controls": null,
            "Characteristics": "Patients with hyperlipidemia, including 166 men and 376 women",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.5",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.5,
            "Confidence Interval Start": 0.2,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": "Chinese",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC8973308": {
      "var-pheno": {
        "overall_score": 0.6313574885328611,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Alleles": {
            "mean_score": 0.8403716683387756,
            "scores": [
              0.8403716683387756
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.9078661799430847,
            "scores": [
              0.9078661799430847
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          }
        },
        "total_samples": 1,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8403716683387756,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.9078661799430847,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs1800462",
                "prediction": "rs1800462"
              },
              "Gene": {
                "ground_truth": "TPMT",
                "prediction": "TPMT"
              },
              "Drug(s)": {
                "ground_truth": "mercaptopurine",
                "prediction": "mercaptopurine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CG",
                "prediction": "*2, *3A"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Not associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": null
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Febrile neutropenia, Side Effect:Discontinuation",
                "prediction": "myelotoxicity, liver toxicity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA166156993"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "rs1800460",
            "Gene": "TPMT",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "toxicity",
            "Significance": "no",
            "Notes": "No statistically significant association identified between genetic variants and outcomes of interest.",
            "Sentence": "TPMT variants are not associated with likelihood of myelotoxicity or liver toxicity when treated with mercaptopurine in pediatric patients with acute lymphoblastic leukemia.",
            "Alleles": "*2, *3A",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "myelotoxicity, liver toxicity",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "acute lymphoblastic leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "35431360",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "No statistically significant association was identified between the genetic variants and the outcomes of interest.",
              "Although no statistically significant associations were identified, two of the four patients heterozygous for NUDT15 required a decrease in 6-MP during the follow-up period. Concerning the genetic variants of TPMT, for rs1800462, two of the four heterozygous patients presented febrile neutropenia, and the same patients also required discontinuation 6-MP during the first six months of maintenance therapy.",
              "Our study did not find any association between the allelic frequencies of each polymorphism or in those 42 cases in which we had the complete typing of TPMT."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1800462, rs1800460, rs1142345",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "mercaptopurine",
              "drug_id": "PA450379",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "rs1142345",
            "Gene": "TPMT",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "toxicity",
            "Significance": "no",
            "Notes": "No statistically significant association identified between genetic variants and outcomes of interest.",
            "Sentence": "TPMT variants are not associated with likelihood of myelotoxicity or liver toxicity when treated with mercaptopurine in pediatric patients with acute lymphoblastic leukemia.",
            "Alleles": "*2, *3A",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "myelotoxicity, liver toxicity",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "acute lymphoblastic leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "35431360",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "No statistically significant association was identified between the genetic variants and the outcomes of interest.",
              "Although no statistically significant associations were identified, two of the four patients heterozygous for NUDT15 required a decrease in 6-MP during the follow-up period. Concerning the genetic variants of TPMT, for rs1800462, two of the four heterozygous patients presented febrile neutropenia, and the same patients also required discontinuation 6-MP during the first six months of maintenance therapy.",
              "Our study did not find any association between the allelic frequencies of each polymorphism or in those 42 cases in which we had the complete typing of TPMT."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1800462, rs1800460, rs1142345",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "mercaptopurine",
              "drug_id": "PA450379",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "rs116855232",
            "Gene": "NUDT15",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "toxicity",
            "Significance": "no",
            "Notes": "No statistically significant association identified between genetic variants and outcomes of interest.",
            "Sentence": "NUDT15 variants are not associated with likelihood of myelotoxicity or liver toxicity when treated with mercaptopurine in pediatric patients with acute lymphoblastic leukemia.",
            "Alleles": "T",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "myelotoxicity, liver toxicity",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "acute lymphoblastic leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "35431360",
            "Variant Annotation ID_norm": "2",
            "Citations": [
              "No statistically significant association was identified between the genetic variants and the outcomes of interest.",
              "Although no statistically significant associations were identified, two of the four patients heterozygous for NUDT15 required a decrease in 6-MP during the follow-up period.",
              "Our study did not find any association between the allelic frequencies of each polymorphism or in those 42 cases in which we had the complete typing of TPMT."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs116855232",
              "variant_id": "PA166154759",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "mercaptopurine",
              "drug_id": "PA450379",
              "confidence": 1.0
            }
          }
        ]
      },
      "var-drug": {
        "overall_score": 0.7239423049123663,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "PMID": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Alleles": {
            "mean_score": 0.8821223378181458,
            "scores": [
              0.8821223378181458,
              0.8821223378181458
            ]
          },
          "Specialty Population": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "isPlural": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Population types": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.9677683115005493,
            "scores": [
              0.9677683115005493,
              0.9677683115005493
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.9050131440162659,
            "scores": [
              0.9050131440162659,
              0.9050131440162659
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 0.0,
              "Significance": 1.0,
              "Alleles": 0.8821223378181458,
              "Specialty Population": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 0.0,
              "PD/PK terms": 0.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 1.0,
              "Population Phenotypes or diseases": 0.9677683115005493,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9050131440162659,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs116855232",
                "prediction": "rs116855232"
              },
              "Gene": {
                "ground_truth": "NUDT15",
                "prediction": "NUDT15"
              },
              "PMID": {
                "ground_truth": 35431360,
                "prediction": 35431360
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "toxicity"
              },
              "Significance": {
                "ground_truth": "no",
                "prediction": "no"
              },
              "Alleles": {
                "ground_truth": "CT",
                "prediction": "C/C, C/T"
              },
              "Specialty Population": {
                "ground_truth": "Pediatric",
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Not associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": null
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": null
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in children with",
                "prediction": "in children with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Acute lymphoblastic leukemia",
                "prediction": "Disease:Acute Lymphoblastic Leukemia"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": "C/C"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "mercaptopurine",
                "prediction": "mercaptopurine"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 0.0,
              "Significance": 1.0,
              "Alleles": 0.8821223378181458,
              "Specialty Population": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 0.0,
              "PD/PK terms": 0.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 1.0,
              "Population Phenotypes or diseases": 0.9677683115005493,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9050131440162659,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs1800460",
                "prediction": "rs1800460"
              },
              "Gene": {
                "ground_truth": "TPMT",
                "prediction": "TPMT"
              },
              "PMID": {
                "ground_truth": 35431360,
                "prediction": 35431360
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "toxicity"
              },
              "Significance": {
                "ground_truth": "no",
                "prediction": "no"
              },
              "Alleles": {
                "ground_truth": "CT",
                "prediction": "C/C, C/T"
              },
              "Specialty Population": {
                "ground_truth": "Pediatric",
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Not associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": null
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": null
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in children with",
                "prediction": "in children with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Acute lymphoblastic leukemia",
                "prediction": "Disease:Acute Lymphoblastic Leukemia"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": "C/C"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "mercaptopurine",
                "prediction": "mercaptopurine"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "PA166154759",
          "PA166156992"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "rs1800462",
            "Gene": "TPMT",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "toxicity",
            "Significance": "no",
            "Notes": "No statistically significant association identified between the genetic variants and the outcomes of interest.",
            "Sentence": "Genotype C/T is not associated with increased toxicity of mercaptopurine in children with Acute Lymphoblastic Leukemia as compared to genotype C/C.",
            "Alleles": "C/C, C/T",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": null,
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Disease:Acute Lymphoblastic Leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "C/C",
            "Comparison Metabolizer types": null,
            "Citations": [
              "No statistically significant association was identified between the genetic variants and the outcomes of interest.",
              "Although no statistically significant associations were identified, two of the four patients heterozygous for NUDT15 required a decrease in 6-MP during the follow-up period. Concerning the genetic variants of TPMT, for rs1800462, two of the four heterozygous patients presented febrile neutropenia, and the same patients also required discontinuation 6-MP during the first six months of maintenance therapy.",
              "Our study did not find any association between the allelic frequencies of each polymorphism or in those 42 cases in which we had the complete typing of TPMT."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1800462",
              "variant_id": "PA166156993",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "mercaptopurine",
              "drug_id": "PA450379",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "rs1142345",
            "Gene": "TPMT",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "toxicity",
            "Significance": "no",
            "Notes": "No statistically significant association identified between the genetic variants and the outcomes of interest.",
            "Sentence": "Genotype C/T is not associated with increased toxicity of mercaptopurine in children with Acute Lymphoblastic Leukemia as compared to genotype C/C.",
            "Alleles": "C/C, C/T",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": null,
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Disease:Acute Lymphoblastic Leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "C/C",
            "Comparison Metabolizer types": null,
            "Citations": [
              "No statistically significant association was identified between the genetic variants and the outcomes of interest.",
              "Although we are considered as a Latino population, different degrees of Caucasian, Amerindian and African ancestry are found in different regions of Colombia. Although, our findings vary significantly from previous reports regarding the association between variants and outcomes, those studies were carried out in non-Latino population.",
              "Our study did not find any association between the allelic frequencies of each polymorphism or in those 42 cases in which we had the complete typing of TPMT."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1142345",
              "variant_id": "PA166156978",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "mercaptopurine",
              "drug_id": "PA450379",
              "confidence": 1.0
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.2418502926826477,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.29442105690638226,
            "scores": [
              0.8832631707191467,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8832631707191467,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451769007,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451769000,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "observational, longitudinal"
              },
              "Study Cases": {
                "ground_truth": 68.0,
                "prediction": 68
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Pediatric ALL",
                "prediction": "Pediatric patients with acute lymphoblastic leukemia undergoing maintenance therapy"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": "> 0.05"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cohort:Pediatric ALL"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1451768400,
            "Variant Annotation ID": 1451768380,
            "Study Type": "cohort",
            "Study Cases": 68.0,
            "Study Controls": null,
            "Characteristics": "Pediatric ALL",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1451768380"
          },
          {
            "Study Parameters ID": 1451769045,
            "Variant Annotation ID": 1451769040,
            "Study Type": "cohort",
            "Study Cases": 68.0,
            "Study Controls": null,
            "Characteristics": "Pediatric ALL",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1451769040"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC10275785": {
      "var-drug": {
        "overall_score": 0.8886296780485856,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "PMID": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Significance": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Alleles": {
            "mean_score": 0.941135585308075,
            "scores": [
              0.9518988728523254,
              0.9303722977638245
            ]
          },
          "Specialty Population": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "isPlural": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Direction of effect": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Population types": {
            "mean_score": 0.9612473249435425,
            "scores": [
              0.9612473249435425,
              0.9612473249435425
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.9815809726715088,
            "scores": [
              0.9815809726715088,
              0.9815809726715088
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9518988728523254,
              "Specialty Population": 1.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 0.0,
              "Population types": 0.9612473249435425,
              "Population Phenotypes or diseases": 0.9815809726715088,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs2043211",
                "prediction": "rs2043211"
              },
              "Gene": {
                "ground_truth": "CARD8",
                "prediction": "CARD8"
              },
              "PMID": {
                "ground_truth": 37332933,
                "prediction": 37332933
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "TT",
                "prediction": "AA + AT, TT"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "PD/PK terms": {
                "ground_truth": "response to",
                "prediction": "response to"
              },
              "Multiple drugs And/or": {
                "ground_truth": "or",
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in people with",
                "prediction": "in patients with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Rheumatoid arthritis",
                "prediction": "Disease:Rheumatoid Arthritis"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "AA + AT",
                "prediction": "AA + AT"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "etanercept, infliximab",
                "prediction": "anti-TNF-\u03b1 drugs"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9303722977638245,
              "Specialty Population": 1.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 0.0,
              "Population types": 0.9612473249435425,
              "Population Phenotypes or diseases": 0.9815809726715088,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4612666",
                "prediction": "rs4612666"
              },
              "Gene": {
                "ground_truth": "NLRP3",
                "prediction": "NLRP3"
              },
              "PMID": {
                "ground_truth": 37332933,
                "prediction": 37332933
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "TT",
                "prediction": "CC + CT, TT"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "PD/PK terms": {
                "ground_truth": "response to",
                "prediction": "response to"
              },
              "Multiple drugs And/or": {
                "ground_truth": "or",
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in people with",
                "prediction": "in patients with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Rheumatoid arthritis",
                "prediction": "Disease:Rheumatoid Arthritis"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC + CT",
                "prediction": "CC + CT"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "etanercept, infliximab",
                "prediction": "anti-TNF-\u03b1 drugs"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "PA166305763",
          "PA166305782"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.0,
        "field_scores": {},
        "total_samples": 0,
        "detailed_results": [],
        "aligned_variants": [],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1452143368,
            "Variant Annotation ID": 1452143360,
            "Study Type": null,
            "Study Cases": 66.0,
            "Study Controls": 33.0,
            "Characteristics": "Cases = responders, controls = non-responders",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.265,
            "Allele Of Frequency In Cases": "T",
            "Frequency In Controls": 0.647,
            "Allele Of Frequency In Controls": "T",
            "P Value": "< 0.0001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.183,
            "Confidence Interval Start": 0.063,
            "Confidence Interval Stop": 0.531,
            "Biogeographical Groups": "Near Eastern",
            "Variant Annotation ID_norm": "1452143360"
          },
          {
            "Study Parameters ID": 1452143420,
            "Variant Annotation ID": 1452143400,
            "Study Type": null,
            "Study Cases": 66.0,
            "Study Controls": 33.0,
            "Characteristics": "Cases = responders, controls = non-responders",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.197,
            "Allele Of Frequency In Cases": "T",
            "Frequency In Controls": 0.559,
            "Allele Of Frequency In Controls": "T",
            "P Value": "< 0.0001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.131,
            "Confidence Interval Start": 0.047,
            "Confidence Interval Stop": 0.36,
            "Biogeographical Groups": "Near Eastern",
            "Variant Annotation ID_norm": "1452143400"
          }
        ],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 100.0,
            "Study Controls": 100.0,
            "Characteristics": "Rheumatoid arthritis patients",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.17",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 100.0,
            "Study Controls": 100.0,
            "Characteristics": "Rheumatoid arthritis patients",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.08",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 100.0,
            "Study Controls": null,
            "Characteristics": "Patients with higher DAS-28",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "HR",
            "Ratio Stat": 1.88,
            "Confidence Interval Start": 1.08,
            "Confidence Interval Stop": 3.25,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 100.0,
            "Study Controls": null,
            "Characteristics": "Patients with higher TNF-\u03b1 and IL-1\u03b2 serum levels",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "HR",
            "Ratio Stat": 5.44,
            "Confidence Interval Start": 1.49,
            "Confidence Interval Stop": 19.9,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control",
            "Study Cases": 100.0,
            "Study Controls": null,
            "Characteristics": "Non-responders to anti-TNF-\u03b1 therapy",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC4706412": {
      "var-drug": {
        "overall_score": 0.4221960149313274,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "PMID": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 0.375,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.45083602517843246,
            "scores": [
              0.8921316266059875,
              0.8973216414451599,
              0.902420163154602,
              0.9148147702217102,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Specialty Population": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 0.125,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "isPlural": {
            "mean_score": 0.125,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Population types": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.4458882585167885,
            "scores": [
              0.8838853240013123,
              0.8944069147109985,
              0.8944069147109985,
              0.8944069147109985,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 8,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8921316266059875,
              "Specialty Population": 1.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.0,
              "Population Phenotypes or diseases": 1.0,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8838853240013123,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP4F2*3",
                "prediction": "CYP4F2*3"
              },
              "Gene": {
                "ground_truth": "CYP4F2",
                "prediction": "CYP4F2"
              },
              "PMID": {
                "ground_truth": 26745506,
                "prediction": 26745506
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "dosage"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*3",
                "prediction": "CYP4F2*1/*3"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": "dose of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": null,
                "prediction": "in Caribbean Hispanics"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": null,
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP4F2*1/*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "warfarin",
                "prediction": "warfarin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8973216414451599,
              "Specialty Population": 1.0,
              "Metabolizer types": 0.0,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.0,
              "Population Phenotypes or diseases": 1.0,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8944069147109985,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C9*2",
                "prediction": "CYP2C9*2"
              },
              "Gene": {
                "ground_truth": "CYP2C9",
                "prediction": "CYP2C9"
              },
              "PMID": {
                "ground_truth": 26745506,
                "prediction": 26745506
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "dosage"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *8",
                "prediction": "CYP2C9*1/*2"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": "intermediate metabolizer"
              },
              "isPlural": {
                "ground_truth": "Are",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": "dose of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": null,
                "prediction": "in Caribbean Hispanics"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": null,
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP2C9*1/*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "warfarin",
                "prediction": "warfarin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.902420163154602,
              "Specialty Population": 1.0,
              "Metabolizer types": 0.0,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.0,
              "Population Phenotypes or diseases": 1.0,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8944069147109985,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C9*3",
                "prediction": "CYP2C9*3"
              },
              "Gene": {
                "ground_truth": "CYP2C9",
                "prediction": "CYP2C9"
              },
              "PMID": {
                "ground_truth": 26745506,
                "prediction": 26745506
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "dosage"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *8",
                "prediction": "CYP2C9*1/*3"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": "poor metabolizer"
              },
              "isPlural": {
                "ground_truth": "Are",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": "dose of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": null,
                "prediction": "in Caribbean Hispanics"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": null,
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP2C9*1/*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "warfarin",
                "prediction": "warfarin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 0.0,
              "Alleles": 0.9148147702217102,
              "Specialty Population": 1.0,
              "Metabolizer types": 0.0,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.0,
              "Population Phenotypes or diseases": 1.0,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8944069147109985,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C9*8",
                "prediction": "CYP2C9*8"
              },
              "Gene": {
                "ground_truth": "CYP2C9",
                "prediction": "CYP2C9"
              },
              "PMID": {
                "ground_truth": 26745506,
                "prediction": 26745506
              },
              "Phenotype Category": {
                "ground_truth": "Dosage",
                "prediction": "dosage"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "not stated"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *8",
                "prediction": "CYP2C9*1/*8"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": "poor metabolizer"
              },
              "isPlural": {
                "ground_truth": "Are",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "PD/PK terms": {
                "ground_truth": "dose of",
                "prediction": "dose of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": null,
                "prediction": "in Caribbean Hispanics"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": null,
                "prediction": null
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP2C9*1/*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "Drug(s)": {
                "ground_truth": "warfarin",
                "prediction": "warfarin"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cyp4f2*3",
          "cyp2c9*2",
          "cyp2c9*3",
          "cyp2c9*8"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1447682700,
            "Variant/Haplotypes": "CYP4F2*1",
            "Gene": "CYP4F2",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: the derivation cohort was 99% male.",
            "Sentence": "CYP4F2 *3 is associated with increased dose of warfarin as compared to CYP4F2 *1.",
            "Alleles": "*3",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682700",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP4F2*1, CYP4F2*3",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1447682605,
            "Variant/Haplotypes": "CYP2C9*1",
            "Gene": "CYP2C9",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: the derivation cohort was 99% male and  \"variables were included in final lin. reg model if p<0.05 or if association with daily warfarin dose was marginally significant 0.05 = p = 0.20 with strong biological plausibility\".",
            "Sentence": "CYP2C9 *2 + *3 + *8 are associated with decreased dose of warfarin as compared to CYP2C9 *1.",
            "Alleles": "*2 + *3 + *8",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682605",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1447682688,
            "Variant/Haplotypes": "rs9923231",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: the derivation cohort was 99% male.",
            "Sentence": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
            "Alleles": "CT + TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682688",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs9923231",
              "variant_id": "PA166155091",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1447682722,
            "Variant/Haplotypes": "rs1800566",
            "Gene": "NQO1",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: 1) the derivation cohort was 99% male 2) alleles have been complemented to the + chromosomal strand and 3) \"variables were included in final lin. reg model if p<0.05 or if association with daily warfarin dose was marginally significant 0.05 = p = 0.20 with strong biological plausability\".",
            "Sentence": "Genotypes AA + AG are associated with increased dose of warfarin as compared to genotype GG.",
            "Alleles": "AA + AG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682722",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1800566",
              "variant_id": "PA166155017",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 4,
            "Variant/Haplotypes": "VKORC1-1639G>A",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "VKORC1-1639G>A is associated with a 13% decrease in warfarin dose per A allele.",
            "Sentence": "Genotype VKORC1-1639AA is associated with decreased dose of warfarin in Caribbean Hispanics as compared to genotype VKORC1-1639GG.",
            "Alleles": "VKORC1-1639GA",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Population types": "in Caribbean Hispanics",
            "Population Phenotypes or diseases": null,
            "Multiple drugs And/or": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "VKORC1-1639GG",
            "Comparison Metabolizer types": null,
            "Citations": [
              "\"Combined VKORC1-1639AA and GA genotypes explained approximately 2.1% of the dose variability in this population. Moreover, this covariate was associated with a 13% reduction in the therapeutic warfarin dose per number of A alleles.\"",
              "\"The *VKORC1*-1639 AA status is a carrier code, where 1 = AA and 0 = otherwise; *VKORC1*-1639 GA status is another code, where 1 = GA and 0 = otherwise.\"",
              "\"The *VKORC1*-1639G>A is associated with a 13% decrease in warfarin dose per A allele.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "VKORC1-1639G>A",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 6,
            "Variant/Haplotypes": "NQO1*2",
            "Gene": "NQO1",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "dosage",
            "Significance": "yes",
            "Notes": "NQO1*2 is associated with a 10% increase in warfarin dose per variant allele.",
            "Sentence": "Genotype NQO1*2 is associated with increased dose of warfarin in Caribbean Hispanics as compared to genotype NQO1*1/*1.",
            "Alleles": "NQO1*1/*2",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "dose of",
            "Population types": "in Caribbean Hispanics",
            "Population Phenotypes or diseases": null,
            "Multiple drugs And/or": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "NQO1*1/*1",
            "Comparison Metabolizer types": null,
            "Citations": [
              "\"Notably, CYP4F2*3 and NQO1*2 variants were independently associated with a 17% and 10% increase of the dose per variant allele, respectively;\"",
              "\"The frequencies of the CYP4F2*3 (g.18000G>A, p.V433M, rs2108622) and NQO1*2 (g.559C>T, p.P187S, rs1800566) 'resistant' polymorphisms in the study population were 0.11 (95%CI: 0.09\u20130.14) and 0.10 (95%CI: 0.07\u20130.13), respectively.\"",
              "\"For patients at the highest risk of adverse events, 45.5% of the dose predictions using the developed pharmacogenetic model resulted in ideal dose as compared with only 29% when using the clinical non-genetic algorithm (p<0.001).\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "NQO1*2",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "warfarin",
              "drug_id": "PA451906",
              "confidence": 1.0
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.2958883575030736,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.36689679111753193,
            "scores": [
              0.8579404950141907,
              0.848345160484314,
              0.8619918823242188,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.07142857142857142,
            "scores": [
              0.5,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 7,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8579404950141907,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1447682693,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1447682688,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort, retrospective"
              },
              "Study Cases": {
                "ground_truth": 255.0,
                "prediction": 255
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "NCT01318057; VKORC1 rs9923231 AA partial reg. coeff. -0.896 (SE 0.2169), adj R sq .0.641",
                "prediction": "Patients at highest risk of adverse events requiring warfarin"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.0001",
                "prediction": "< 0.001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.848345160484314,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1447682695,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1447682688,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort, retrospective"
              },
              "Study Cases": {
                "ground_truth": 255.0,
                "prediction": 255
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "NCT01318057; VKORC1 rs9923231 AG partial reg. coeff. -0.379 (SE 0.1391), adj R sq .0.659",
                "prediction": "Caribbean Hispanic patients receiving warfarin therapy"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.007",
                "prediction": "< 0.001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8619918823242188,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.0,
              "Allele Of Frequency In Controls": 0.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1447682664,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1447682605,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, retrospective",
                "prediction": "cohort, retrospective"
              },
              "Study Cases": {
                "ground_truth": 255.0,
                "prediction": 55
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Study Cohort: NCT01318057; CYP2C9 *3 partial reg. coeff. -0.544 (SE 0.2224), adj R sq 0.625",
                "prediction": "External validation cohort of Caribbean Hispanic patients"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": 0.05,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "*3",
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": 0.83,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": "*1",
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.015",
                "prediction": null
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cohort, retrospective:NCT01318057; VKORC1 ",
          "cohort, retrospective:NCT01318057; VKORC1 ",
          "cohort, retrospective:Study Cohort: NCT013"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1447682702,
            "Variant Annotation ID": 1447682700,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; CYP4F3 *3 partial reg. coeff. 0.560 (SE 0.2274), adj R sq0.0.673",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.115,
            "Allele Of Frequency In Cases": "*3",
            "Frequency In Controls": 0.885,
            "Allele Of Frequency In Controls": "*1",
            "P Value": "= 0.014",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682700"
          },
          {
            "Study Parameters ID": 1447682655,
            "Variant Annotation ID": 1447682605,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; CYP2C9 *2 partial reg. coeff. -0.245 (SE 0.1654), adj R sq0.613",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.09,
            "Allele Of Frequency In Cases": "*2",
            "Frequency In Controls": 0.83,
            "Allele Of Frequency In Controls": "*1",
            "P Value": "= 0.014",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682605"
          },
          {
            "Study Parameters ID": 1447682687,
            "Variant Annotation ID": 1447682605,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; CYP2C9 *8 partial reg. coeff. -1.00 (SE 0.6014), adj R sq 0.638",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.006,
            "Allele Of Frequency In Cases": "*8",
            "Frequency In Controls": 0.83,
            "Allele Of Frequency In Controls": "*1",
            "P Value": "= 0.098",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682605"
          },
          {
            "Study Parameters ID": 1447682724,
            "Variant Annotation ID": 1447682722,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; NQO1 rs1800566 A allele partial reg. coeff. 0.346 (SE 0.2246), adj R sq .0.689",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.098,
            "Allele Of Frequency In Cases": "A",
            "Frequency In Controls": 0.902,
            "Allele Of Frequency In Controls": "G",
            "P Value": "= 0.125",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682722"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC8790808": {
      "var-pheno": {
        "overall_score": 0.7338900957256556,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.7254362851381302,
            "scores": [
              0.9694335460662842,
              0.9734699726104736,
              0.9588416218757629,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.6810927242040634,
            "scores": [
              0.9145167469978333,
              0.9054141044616699,
              0.9044400453567505,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.7173028886318207,
            "scores": [
              0.9564038515090942,
              0.9564038515090942,
              0.9564038515090942,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0
            ]
          }
        },
        "total_samples": 4,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 0.9694335460662842,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9145167469978333,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9564038515090942,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-DQA1*02:01",
                "prediction": "HLA-DQA1*02:01"
              },
              "Gene": {
                "ground_truth": "HLA-DQA1",
                "prediction": "HLA-DQB1, HLA-DRB1, HLA-DQA1"
              },
              "Drug(s)": {
                "ground_truth": "pegaspargase",
                "prediction": "pegaspargase"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*02:01",
                "prediction": "HLA-DQB1*02:02, HLA-DRB1*07:01, HLA-DQA1*02:01"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Hypersensitivity",
                "prediction": "hypersensitivity reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 0.9734699726104736,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9054141044616699,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9564038515090942,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-DQB1*02:02",
                "prediction": "HLA-DQB1*02:02"
              },
              "Gene": {
                "ground_truth": "HLA-DQB1",
                "prediction": "HLA-DQB1, HLA-DRB1, HLA-DQA1"
              },
              "Drug(s)": {
                "ground_truth": "pegaspargase",
                "prediction": "pegaspargase"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*02:02",
                "prediction": "HLA-DQB1*02:02, HLA-DRB1*07:01, HLA-DQA1*02:01"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Hypersensitivity",
                "prediction": "hypersensitivity reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 0.9588416218757629,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9044400453567505,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9564038515090942,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-DRB1*07:01",
                "prediction": "HLA-DRB1*07:01"
              },
              "Gene": {
                "ground_truth": "HLA-DRB1",
                "prediction": "HLA-DQB1, HLA-DRB1, HLA-DQA1"
              },
              "Drug(s)": {
                "ground_truth": "pegaspargase",
                "prediction": "pegaspargase"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*07:01",
                "prediction": "HLA-DQB1*02:02, HLA-DRB1*07:01, HLA-DQA1*02:01"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Hypersensitivity",
                "prediction": "hypersensitivity reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA165951292",
          "PA165958162",
          "PA165951644"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1451510773,
            "Variant/Haplotypes": "rs9958628",
            "Gene": "ARHGAP28",
            "Drug(s)": "pegaspargase",
            "PMID": 33768542,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "This variant is significantly associated with pegaspargase hypersensitivity in all patients and also had the strongest genetic association (P = 8.9 \u00d7 10-9 ) in non-EAs.",
            "Sentence": "Allele T is associated with increased risk of Hypersensitivity when treated with pegaspargase as compared to allele A.",
            "Alleles": "T",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Hypersensitivity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "A",
            "Comparison Metabolizer types": null,
            "PMID_norm": "33768542",
            "Variant Annotation ID_norm": "1451510773",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs9958628",
              "variant_id": "PA166250701",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "pegaspargase",
              "drug_id": "PA164760860",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.40802384475866954,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.375,
            "scores": [
              1.0,
              0.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.1125,
            "scores": [
              0.9,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.40785767138004303,
            "scores": [
              0.8270601630210876,
              0.8161147236824036,
              0.8098432421684265,
              0.8098432421684265,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.225,
            "scores": [
              0.8,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 8,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.8270601630210876,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.8,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451510890,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451510886,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 593.0,
                "prediction": 598.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "AALL0232 cohort",
                "prediction": "Pediatric leukemia patients treated with pegaspargase"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 9.29e-5",
                "prediction": "< 5.0\u00d710\u22125"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.94,
                "prediction": 2.13
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8161147236824036,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451510821,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451510773,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis, GWAS",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 1607.0,
                "prediction": 3897.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "non European ancestry",
                "prediction": "Pediatric leukemia patients treated with pegaspargase"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 8.9e-9",
                "prediction": "< 5.0\u00d710\u22128"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 3.69,
                "prediction": 3.69
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8098432421684265,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451510741,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451510720,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 402.0,
                "prediction": 2472.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "TXVI cohort",
                "prediction": "Pediatric leukemia patients treated with pegaspargase"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 3.28e-5",
                "prediction": "< 5.0\u00d710\u22125"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.91,
                "prediction": 1.96
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8098432421684265,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451510895,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451510891,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 402.0,
                "prediction": 1189.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "TXVI cohort",
                "prediction": "Pediatric leukemia patients treated with pegaspargase"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 3.289e-5",
                "prediction": "< 5.0\u00d710\u22125"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.91,
                "prediction": 1.96
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cohort:AALL0232 cohort",
          "meta-analysis, GWAS:non European ancestr",
          "cohort:TXVI cohort",
          "cohort:TXVI cohort"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1451510724,
            "Variant Annotation ID": 1451510720,
            "Study Type": "meta-analysis, GWAS",
            "Study Cases": 2168.0,
            "Study Controls": null,
            "Characteristics": "meta-analysis",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 2.74e-5",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.99,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1451510720"
          },
          {
            "Study Parameters ID": 1451510920,
            "Variant Annotation ID": 1451510886,
            "Study Type": "meta-analysis, GWAS",
            "Study Cases": 2168.0,
            "Study Controls": null,
            "Characteristics": "meta-analysis",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 3.76e-9",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.14,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1451510886"
          },
          {
            "Study Parameters ID": 1451510941,
            "Variant Annotation ID": 1451510891,
            "Study Type": "meta-analysis, GWAS",
            "Study Cases": 2168.0,
            "Study Controls": null,
            "Characteristics": "meta-analysis",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 2.22e-5",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.99,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1451510891"
          },
          {
            "Study Parameters ID": 1451510810,
            "Variant Annotation ID": 1451510773,
            "Study Type": "cohort, meta-analysis",
            "Study Cases": 3897.0,
            "Study Controls": null,
            "Characteristics": "all patients",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 1.2e-7",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 3.03,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1451510773"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC11603346": {
      "var-pheno": {
        "overall_score": 0.9207328855991364,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Alleles": {
            "mean_score": 0.9961822032928467,
            "scores": [
              0.9956770539283752,
              0.9966873526573181,
              0.9966873526573181,
              0.9956770539283752
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Direction of effect": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.9461563229560852,
            "scores": [
              0.9461563229560852,
              0.9461563229560852,
              0.9461563229560852,
              0.9461563229560852
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.9122086763381958,
            "scores": [
              0.9122086763381958,
              0.9122086763381958,
              0.9122086763381958,
              0.9122086763381958
            ]
          }
        },
        "total_samples": 4,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9956770539283752,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9461563229560852,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9122086763381958
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*6",
                "prediction": "CYP2B6*6"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*1/*6 + *6/*6",
                "prediction": "*6/*6, *1/*6"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug-induced liver injury",
                "prediction": "liver injury"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2B6*1/*1"
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9966873526573181,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9461563229560852,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9122086763381958
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*1",
                "prediction": "CYP2B6*1/*6"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*1/*6 + *6/*6",
                "prediction": "*1/*6, *6/*6"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug-induced liver injury",
                "prediction": "liver injury"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2B6*1/*1"
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9966873526573181,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9461563229560852,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9122086763381958
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*1",
                "prediction": "CYP2B6*6/*6"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*1/*6 + *6/*6",
                "prediction": "*1/*6, *6/*6"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug-induced liver injury",
                "prediction": "liver injury"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2B6*1/*1"
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9956770539283752,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9461563229560852,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9122086763381958
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*6",
                "prediction": "(rs3745274"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*1/*6 + *6/*6",
                "prediction": "*6/*6, *1/*6"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug-induced liver injury",
                "prediction": "liver injury"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2B6*1/*1"
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "cyp2b6*1",
          "cyp2b6*6",
          "cyp2b6*6",
          "cyp2b6+efavirenz"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "rs2279343)",
            "Gene": "CYP2B6",
            "Drug(s)": "efavirenz",
            "PMID": 39604537,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "CYP2B6*6 carriers were significantly more susceptible to EFV-induced liver injury with an odds ratio of 1.83 (1.15\u20132.90).",
            "Sentence": "CYP2B6*6 is associated with increased risk of efavirenz-induced liver injury in people living with HIV.",
            "Alleles": "*6/*6, *1/*6",
            "Specialty Population": "African",
            "Metabolizer types": "poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "liver injury",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "HIV",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CYP2B6*1/*1",
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "39604537",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "CYP2B6*6 carriers were significantly more susceptible to EFV-induced liver injury, with an odds ratio (OR) and 95% confidence interval (CI) of 1.83 (1.15\u20132.90).",
              "Interestingly, CYP2B6*6 haplotype is characterized by the existence of two variants, G516T (rs3745274) and A785G (rs2279343), with or without promoter variants. This allele has been associated with a 50\u201375% decrease in CYP2B6 enzyme levels but not with the protein\u2019s active or substrate recognition sites.",
              "Our findings demonstrated that a genotype known as CYP2B6*6, which is related with a decreased ability to metabolize drugs, was linked to an increased risk of ARVDILI in PLHIV patients who were using EFV."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2B6*6 (rs3745274, rs2279343)",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "efavirenz",
              "drug_id": "PA449441",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.7052876194318135,
        "field_scores": {
          "Study Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.8293142914772034,
            "scores": [
              0.8141757845878601,
              0.8444527983665466
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.9,
            "scores": [
              1.0,
              0.8
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.9,
            "scores": [
              1.0,
              0.8
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.95,
            "scores": [
              1.0,
              0.9
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8141757845878601,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452720988,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452720980,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis",
                "prediction": "meta-analysis"
              },
              "Study Cases": {
                "ground_truth": 504.0,
                "prediction": 38
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": 782
              },
              "Characteristics": {
                "ground_truth": "2 studies (Carr, Giacomelli): DILI",
                "prediction": "PLHIV receiving nevirapine"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "< 0.05"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 0.42,
                "prediction": 0.42
              },
              "Confidence Interval Start": {
                "ground_truth": 0.21,
                "prediction": 0.21
              },
              "Confidence Interval Stop": {
                "ground_truth": 0.84,
                "prediction": 0.84
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, \"The meta-analysis of the link between CYP2B6 genotypes and EFV-induced liver injury was only derived from the African population, as well as NVP-induced liver injury were obtained from only African and Caucasian populations. \"",
                "prediction": "African, Caucasian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8444527983665466,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.8,
              "Confidence Interval Start": 0.8,
              "Confidence Interval Stop": 0.9,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452721009,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452721001,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis",
                "prediction": "meta-analysis"
              },
              "Study Cases": {
                "ground_truth": 795.0,
                "prediction": 106
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": 795
              },
              "Characteristics": {
                "ground_truth": "3 studies (Yimer 2011, Mugusi, Yimer 2012): DILI",
                "prediction": "PLHIV receiving efavirenz"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.003",
                "prediction": "< 0.05"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.94,
                "prediction": 1.83
              },
              "Confidence Interval Start": {
                "ground_truth": 1.24,
                "prediction": 1.15
              },
              "Confidence Interval Stop": {
                "ground_truth": 3.01,
                "prediction": 2.9
              },
              "Biogeographical Groups": {
                "ground_truth": "Sub-Saharan African",
                "prediction": "African"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "meta-analysis:2 studies (Carr, Gia",
          "meta-analysis:3 studies (Yimer 201"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "meta-analysis",
            "Study Cases": 106,
            "Study Controls": 795,
            "Characteristics": "PLHIV receiving efavirenz",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.05",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.48,
            "Confidence Interval Start": 1.28,
            "Confidence Interval Stop": 4.79,
            "Biogeographical Groups": "African",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "meta-analysis",
            "Study Cases": 38,
            "Study Controls": 782,
            "Characteristics": "PLHIV receiving nevirapine",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.05",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.44,
            "Confidence Interval Start": 0.22,
            "Confidence Interval Stop": 0.91,
            "Biogeographical Groups": "African, Caucasian",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC5561238": {
      "var-pheno": {
        "overall_score": 0.07999560283135998,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.11627906976744186,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.11627906976744186,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.11627906976744186,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.11627906976744186,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.11627906976744186,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.10206664024397384,
            "scores": [
              0.877773106098175,
              0.877773106098175,
              0.877773106098175,
              0.877773106098175,
              0.877773106098175,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.11627906976744186,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.11627906976744186,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 43,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.877773106098175,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-C*05:01",
                "prediction": "HLA-C*05:01"
              },
              "Gene": {
                "ground_truth": "HLA-C",
                "prediction": "HLA-C"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*05:01",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": null,
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "cutaneous hypersensitivity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.877773106098175,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*35:05",
                "prediction": "HLA-B*35:05"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*35:05",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": null,
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "cutaneous hypersensitivity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.877773106098175,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-DRB1*01:01",
                "prediction": "HLA-DRB1*01:01"
              },
              "Gene": {
                "ground_truth": "HLA-DRB1",
                "prediction": "HLA-DRB1"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*01:01",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": null,
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "cutaneous hypersensitivity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.877773106098175,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-C*04:01",
                "prediction": "HLA-C*04:01"
              },
              "Gene": {
                "ground_truth": "HLA-C",
                "prediction": "HLA-C"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*04:01",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": null,
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "cutaneous hypersensitivity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.877773106098175,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-C*18:01",
                "prediction": "HLA-C*18:01"
              },
              "Gene": {
                "ground_truth": "HLA-C",
                "prediction": "HLA-C"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*18:01",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": null,
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "cutaneous hypersensitivity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA165957192",
          "PA165955262",
          "PA165951320",
          "PA165957046",
          "PA165958003"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1448926055,
            "Variant/Haplotypes": "HLA-B*67:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *67:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*67:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926055",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*67:01",
              "variant_id": "PA165956680",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926065,
            "Variant/Haplotypes": "HLA-B*78:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *78:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*78:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926065",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*78:01",
              "variant_id": "PA165956686",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448925992,
            "Variant/Haplotypes": "HLA-B*51:02",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *51:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*51:02",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448925992",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*51:02",
              "variant_id": "PA165956231",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926045,
            "Variant/Haplotypes": "HLA-B*56:06",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *56:06 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*56:06",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926045",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*56:06",
              "variant_id": "PA165956537",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926109,
            "Variant/Haplotypes": "HLA-B*39:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *39:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*39:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926109",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*39:01",
              "variant_id": "PA165955543",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448925913,
            "Variant/Haplotypes": "HLA-C*05:09",
            "Gene": "HLA-C",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
            "Sentence": "HLA-C *05:09 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*05:09",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448925913",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-C*05:09",
              "variant_id": "PA165957217",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926229,
            "Variant/Haplotypes": "HLA-B*15:32",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *15:32 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*15:32",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926229",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:32",
              "variant_id": "PA165954823",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448925982,
            "Variant/Haplotypes": "HLA-B*51:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *51:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*51:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448925982",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*51:01",
              "variant_id": "PA165956201",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926239,
            "Variant/Haplotypes": "HLA-B*15:35",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *15:35 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*15:35",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926239",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:35",
              "variant_id": "PA165954826",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926169,
            "Variant/Haplotypes": "HLA-B*15:12",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *15:12 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*15:12",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926169",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:12",
              "variant_id": "PA165954792",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926299,
            "Variant/Haplotypes": "HLA-DRB1*08:01",
            "Gene": "HLA-DRB1",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
            "Sentence": "HLA-DRB1 *08:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*08:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926299",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-DRB1*08:01",
              "variant_id": "PA165951669",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448925972,
            "Variant/Haplotypes": "HLA-B*39:10",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *39:10 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*39:10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448925972",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*39:10",
              "variant_id": "PA165955566",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926099,
            "Variant/Haplotypes": "HLA-B*38:02",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *38:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*38:02",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926099",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*38:02",
              "variant_id": "PA165955505",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926089,
            "Variant/Haplotypes": "HLA-B*38:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *38:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*38:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926089",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*38:01",
              "variant_id": "PA165955500",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926289,
            "Variant/Haplotypes": "HLA-DRB1*04:04",
            "Gene": "HLA-DRB1",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
            "Sentence": "HLA-DRB1 *04:04 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*04:04",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926289",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-DRB1*04:04",
              "variant_id": "PA165951511",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926035,
            "Variant/Haplotypes": "HLA-B*56:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *56:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*56:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926035",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*56:01",
              "variant_id": "PA165956528",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926269,
            "Variant/Haplotypes": "HLA-DRB1*01:02",
            "Gene": "HLA-DRB1",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
            "Sentence": "HLA-DRB1 *01:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*01:02",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926269",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-DRB1*01:02",
              "variant_id": "PA165951340",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926139,
            "Variant/Haplotypes": "HLA-B*39:09",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *39:09 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*39:09",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926139",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*39:09",
              "variant_id": "PA165955565",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926159,
            "Variant/Haplotypes": "HLA-B*15:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *15:01 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*15:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926159",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:01",
              "variant_id": "PA165954745",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926209,
            "Variant/Haplotypes": "HLA-B*15:27",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *15:27 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*15:27",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926209",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:27",
              "variant_id": "PA165954816",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448998275,
            "Variant/Haplotypes": "HLA-B*35:10",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-B*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *35:10 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Severe Cutaneous Adverse Reactions and Drug Reaction with Eosinophilia and Systemic Symptoms when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*35:10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Severe Cutaneous Adverse Reactions, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448998275",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*35:10",
              "variant_id": "PA165955274",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448925883,
            "Variant/Haplotypes": "HLA-C*04:06",
            "Gene": "HLA-C",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
            "Sentence": "HLA-C *04:06 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*04:06",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448925883",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-C*04:06",
              "variant_id": "PA165957089",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926149,
            "Variant/Haplotypes": "HLA-B*57:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *57:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*57:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926149",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*57:01",
              "variant_id": "PA165987830",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448925893,
            "Variant/Haplotypes": "HLA-C*04:07",
            "Gene": "HLA-C",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
            "Sentence": "HLA-C *04:07 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Severe Cutaneous Adverse Reactions or Drug Reaction with Eosinophilia and Systemic Symptoms when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*04:07",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Severe Cutaneous Adverse Reactions, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448925893",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-C*04:07",
              "variant_id": "PA165957090",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926022,
            "Variant/Haplotypes": "HLA-B*55:02",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *55:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*55:02",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926022",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*55:02",
              "variant_id": "PA165956471",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926279,
            "Variant/Haplotypes": "HLA-DRB1*01:03",
            "Gene": "HLA-DRB1",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
            "Sentence": "HLA-DRB1 *01:03 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*01:03",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926279",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-DRB1*01:03",
              "variant_id": "PA165951348",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926012,
            "Variant/Haplotypes": "HLA-B*55:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *55:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*55:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926012",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*55:01",
              "variant_id": "PA165956463",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926075,
            "Variant/Haplotypes": "HLA-B*13:02",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *13:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*13:02",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926075",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*13:02",
              "variant_id": "PA165954649",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926199,
            "Variant/Haplotypes": "HLA-B*15:25",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *15:25 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*15:25",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926199",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:25",
              "variant_id": "PA165954812",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926129,
            "Variant/Haplotypes": "HLA-B*39:06",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *39:06 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*39:06",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926129",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*39:06",
              "variant_id": "PA165955561",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448925873,
            "Variant/Haplotypes": "HLA-C*04:03",
            "Gene": "HLA-C",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Primary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-C alleles that share a common \"binding groove F pocket\" with HLA-C*04:01. The authors do not distinguish between the following HLA-C alleles, which is why the OR is the same: HLA-C*04:03/06/07, HLA-C*05:01/09, HLA-C*18:0.",
            "Sentence": "HLA-C *04:03 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*04:03",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448925873",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-C*04:03",
              "variant_id": "PA165957085",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926002,
            "Variant/Haplotypes": "HLA-B*54:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles that share a common \"E pocket sequence\". The authors do not distinguish between the following HLA-B alleles, which is why the OR is the same: HLA-N*35:05, HLA-B*39:10, HLA-B*51:01/02, HLA-B*54:01, HLA-B*55:01/02, HLA-B*56:01/06, HLA-B*67:01, HLA-B*78:01.",
            "Sentence": "HLA-B *54:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*54:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926002",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*54:01",
              "variant_id": "PA165956438",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926249,
            "Variant/Haplotypes": "HLA-B*52:01",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *52:01 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Severe Cutaneous Adverse Reactions or Drug Reaction with Eosinophilia and Systemic Symptoms when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*52:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Severe Cutaneous Adverse Reactions, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926249",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*52:01",
              "variant_id": "PA165956366",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926309,
            "Variant/Haplotypes": "HLA-DRB1*10:01",
            "Gene": "HLA-DRB1",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk of severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-DRB1*01:01/02/03, HLA-DRB1*04:04/05/08/10",
            "Sentence": "HLA-DRB1 *10:01 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms and Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*10:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926309",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-DRB1*10:01",
              "variant_id": "PA165951757",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926119,
            "Variant/Haplotypes": "HLA-B*39:05",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary predisposition to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine is attributed to a cluster of HLA-B alleles which the authors do not distinguish between and is why the OR is the same for the following: HLA-B*13:02, HLA-B*38:01/02, HLA-B*39:01/05/06/09, HLA-B*51:07.",
            "Sentence": "HLA-B *39:05 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*39:05",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926119",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*39:05",
              "variant_id": "PA165955559",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1448926179,
            "Variant/Haplotypes": "HLA-B*15:24",
            "Gene": "HLA-B",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "Secondary risk protection to severe adverse cutaneous reactions/hypersensitivity (SACR/H) to nevirapine are attributed to several alleles and does not distinguish between them which is why ORs are the same: HLA-B*15:01/12/24/25/27/32/35, HLA-B*52:01",
            "Sentence": "HLA-B *15:24 is associated with decreased risk of Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections.",
            "Alleles": "*15:24",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1448926179",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:24",
              "variant_id": "PA165954811",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1449155757,
            "Variant/Haplotypes": "rs28399499",
            "Gene": "CYP2B6",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "The authors analyze rs28399499 T>C and rs3745274 G>A/T together as \"slow metabolizer\" genotypes.",
            "Sentence": "Allele C is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms and Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections as compared to allele T.",
            "Alleles": "C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms, Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "T",
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1449155757",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs28399499",
              "variant_id": "PA166155478",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1449155771,
            "Variant/Haplotypes": "rs3745274",
            "Gene": "CYP2B6",
            "Drug(s)": "nevirapine",
            "PMID": 28819312,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "The authors analyze rs28399499 T>C and rs3745274 G>A/T together as \"slow metabolizer\" genotypes.",
            "Sentence": "Allele T is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome and Drug Reaction with Eosinophilia and Systemic Symptoms when treated with nevirapine in people with HIV Infections as compared to allele G.",
            "Alleles": "T",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Toxic Epidermal Necrolysis, Side Effect:Stevens-Johnson Syndrome, Side Effect:Drug Reaction with Eosinophilia and Systemic Symptoms",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "G",
            "Comparison Metabolizer types": null,
            "PMID_norm": "28819312",
            "Variant Annotation ID_norm": "1449155771",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs3745274",
              "variant_id": "PA166155409",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.1018439822049104,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.1183574074922606,
            "scores": [
              0.8490323424339294,
              0.8642784357070923,
              0.8420981764793396,
              0.854907214641571,
              0.8458736538887024,
              0.833178699016571,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.023255813953488372,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.13953488372093023,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.06046511627906977,
            "scores": [
              0.0,
              0.9,
              0.9,
              0.8,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.023255813953488372,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.023255813953488372,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.023255813953488372,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 43,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8490323424339294,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448925872,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448925862,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 151.0,
                "prediction": 151
              },
              "Study Controls": {
                "ground_truth": 413.0,
                "prediction": 413
              },
              "Characteristics": {
                "ground_truth": "NCT00310843",
                "prediction": "Patients with severe cutaneous toxicity (grade 3 or 4) categorized by NIAID Division of AIDS criteria"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 1.0E-4",
                "prediction": "= 0.0001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 4.06,
                "prediction": 3.06
              },
              "Confidence Interval Start": {
                "ground_truth": 2.39,
                "prediction": 2.39
              },
              "Confidence Interval Stop": {
                "ground_truth": 6.88,
                "prediction": 6.88
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8642784357070923,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.9,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448925915,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448925913,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 151.0,
                "prediction": 151
              },
              "Study Controls": {
                "ground_truth": 413.0,
                "prediction": 413
              },
              "Characteristics": {
                "ground_truth": "NCT00310843)",
                "prediction": "Caucasian patients carrying HLA-C*05:01"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": "= 0.002"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.91,
                "prediction": 2.84
              },
              "Confidence Interval Start": {
                "ground_truth": 1.62,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": 5.23,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Caucasian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8420981764793396,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.9,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448926301,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448926299,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 151.0,
                "prediction": 151
              },
              "Study Controls": {
                "ground_truth": 413.0,
                "prediction": 413
              },
              "Characteristics": {
                "ground_truth": "NCT00310843",
                "prediction": "Caucasian patients with cutaneous nevirapine hypersensitivity"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": "= 0.02"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.0,
                "prediction": 2.08
              },
              "Confidence Interval Start": {
                "ground_truth": 1.23,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": 3.24,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Caucasian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.854907214641571,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.8,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448925905,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448925903,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 151.0,
                "prediction": 151
              },
              "Study Controls": {
                "ground_truth": 413.0,
                "prediction": 413
              },
              "Characteristics": {
                "ground_truth": "NCT00310843)",
                "prediction": "African patients carrying HLA-C*18:01"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": "= 0.2"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.91,
                "prediction": 2.67
              },
              "Confidence Interval Start": {
                "ground_truth": 1.62,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": 5.23,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "African"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8458736538887024,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448926057,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448926055,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 151.0,
                "prediction": 151
              },
              "Study Controls": {
                "ground_truth": 413.0,
                "prediction": 413
              },
              "Characteristics": {
                "ground_truth": "NCT00310843)",
                "prediction": "African patients with cutaneous nevirapine hypersensitivity"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": "= 0.04"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.32,
                "prediction": 3.84
              },
              "Confidence Interval Start": {
                "ground_truth": 1.42,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": 3.79,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "African"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 5,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.833178699016571,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448926067,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448926065,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 151.0,
                "prediction": 151
              },
              "Study Controls": {
                "ground_truth": 413.0,
                "prediction": 413
              },
              "Characteristics": {
                "ground_truth": "NCT00310843)",
                "prediction": "Asian patients with cutaneous nevirapine hypersensitivity"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": "= 0.0001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.32,
                "prediction": 5.49
              },
              "Confidence Interval Start": {
                "ground_truth": 1.42,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": 3.79,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "case/control:NCT00310843",
          "case/control:NCT00310843)",
          "case/control:NCT00310843",
          "case/control:NCT00310843)",
          "case/control:NCT00310843)",
          "case/control:NCT00310843)"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1448925994,
            "Variant Annotation ID": 1448925992,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925992"
          },
          {
            "Study Parameters ID": 1448926047,
            "Variant Annotation ID": 1448926045,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926045"
          },
          {
            "Study Parameters ID": 1448926111,
            "Variant Annotation ID": 1448926109,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926109"
          },
          {
            "Study Parameters ID": 1448926231,
            "Variant Annotation ID": 1448926229,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926229"
          },
          {
            "Study Parameters ID": 1448925984,
            "Variant Annotation ID": 1448925982,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925982"
          },
          {
            "Study Parameters ID": 1448926241,
            "Variant Annotation ID": 1448926239,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926239"
          },
          {
            "Study Parameters ID": 1448926171,
            "Variant Annotation ID": 1448926169,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926169"
          },
          {
            "Study Parameters ID": 1448925974,
            "Variant Annotation ID": 1448925972,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925972"
          },
          {
            "Study Parameters ID": 1448926101,
            "Variant Annotation ID": 1448926099,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926099"
          },
          {
            "Study Parameters ID": 1448926091,
            "Variant Annotation ID": 1448926089,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926089"
          },
          {
            "Study Parameters ID": 1448926291,
            "Variant Annotation ID": 1448926289,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.0,
            "Confidence Interval Start": 1.23,
            "Confidence Interval Stop": 3.24,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926289"
          },
          {
            "Study Parameters ID": 1448926037,
            "Variant Annotation ID": 1448926035,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926035"
          },
          {
            "Study Parameters ID": 1448925960,
            "Variant Annotation ID": 1448925958,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925958"
          },
          {
            "Study Parameters ID": 1448926271,
            "Variant Annotation ID": 1448926269,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.0,
            "Confidence Interval Start": 1.23,
            "Confidence Interval Stop": 3.24,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926269"
          },
          {
            "Study Parameters ID": 1448926141,
            "Variant Annotation ID": 1448926139,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926139"
          },
          {
            "Study Parameters ID": 1448926161,
            "Variant Annotation ID": 1448926159,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926159"
          },
          {
            "Study Parameters ID": 1448926211,
            "Variant Annotation ID": 1448926209,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926209"
          },
          {
            "Study Parameters ID": 1448998277,
            "Variant Annotation ID": 1448998275,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448998275"
          },
          {
            "Study Parameters ID": 1448925885,
            "Variant Annotation ID": 1448925883,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.91,
            "Confidence Interval Start": 1.62,
            "Confidence Interval Stop": 5.23,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925883"
          },
          {
            "Study Parameters ID": 1448926151,
            "Variant Annotation ID": 1448926149,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926149"
          },
          {
            "Study Parameters ID": 1448925895,
            "Variant Annotation ID": 1448925893,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.91,
            "Confidence Interval Start": 1.62,
            "Confidence Interval Stop": 5.23,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925893"
          },
          {
            "Study Parameters ID": 1448926024,
            "Variant Annotation ID": 1448926022,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926022"
          },
          {
            "Study Parameters ID": 1448926281,
            "Variant Annotation ID": 1448926279,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.0,
            "Confidence Interval Start": 1.23,
            "Confidence Interval Stop": 3.24,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926279"
          },
          {
            "Study Parameters ID": 1448926014,
            "Variant Annotation ID": 1448926012,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926012"
          },
          {
            "Study Parameters ID": 1448926077,
            "Variant Annotation ID": 1448926075,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926075"
          },
          {
            "Study Parameters ID": 1448926201,
            "Variant Annotation ID": 1448926199,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926199"
          },
          {
            "Study Parameters ID": 1448926131,
            "Variant Annotation ID": 1448926129,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926129"
          },
          {
            "Study Parameters ID": 1448925875,
            "Variant Annotation ID": 1448925873,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.91,
            "Confidence Interval Start": 1.62,
            "Confidence Interval Stop": 5.23,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925873"
          },
          {
            "Study Parameters ID": 1448926004,
            "Variant Annotation ID": 1448926002,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.32,
            "Confidence Interval Start": 1.42,
            "Confidence Interval Stop": 3.79,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926002"
          },
          {
            "Study Parameters ID": 1448926261,
            "Variant Annotation ID": 1448926259,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.0,
            "Confidence Interval Start": 1.23,
            "Confidence Interval Stop": 3.24,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926259"
          },
          {
            "Study Parameters ID": 1448926251,
            "Variant Annotation ID": 1448926249,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926249"
          },
          {
            "Study Parameters ID": 1448926311,
            "Variant Annotation ID": 1448926309,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.0,
            "Confidence Interval Start": 1.23,
            "Confidence Interval Stop": 3.24,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926309"
          },
          {
            "Study Parameters ID": 1448926121,
            "Variant Annotation ID": 1448926119,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.76,
            "Confidence Interval Start": 1.02,
            "Confidence Interval Stop": 3.02,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926119"
          },
          {
            "Study Parameters ID": 1448925925,
            "Variant Annotation ID": 1448925923,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.91,
            "Confidence Interval Start": 1.62,
            "Confidence Interval Stop": 5.23,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448925923"
          },
          {
            "Study Parameters ID": 1448926181,
            "Variant Annotation ID": 1448926179,
            "Study Type": "case/control",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "NCT00310843)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 0.18,
            "Confidence Interval Start": 0.07,
            "Confidence Interval Stop": 0.46,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448926179"
          },
          {
            "Study Parameters ID": 1449155766,
            "Variant Annotation ID": 1449155757,
            "Study Type": "case/control, clinical trial",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "Study Cohort: NCT00310843",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.07,
            "Confidence Interval Start": 1.12,
            "Confidence Interval Stop": 3.82,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1449155757"
          },
          {
            "Study Parameters ID": 1449155773,
            "Variant Annotation ID": 1449155771,
            "Study Type": "case/control, clinical trial",
            "Study Cases": 151.0,
            "Study Controls": 413.0,
            "Characteristics": "Study Cohort: NCT00310843",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.07,
            "Confidence Interval Start": 1.12,
            "Confidence Interval Stop": 3.82,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1449155771"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC10993165": {
      "var-pheno": {
        "overall_score": 0.9787770633896192,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.9615678191184998,
            "scores": [
              0.9615678191184998,
              0.9615678191184998,
              0.9615678191184998
            ]
          },
          "Phenotype Category": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Alleles": {
            "mean_score": 0.9436516761779785,
            "scores": [
              0.9375396370887756,
              0.9470509886741638,
              0.9463644027709961
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Direction of effect": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.9437477588653564,
            "scores": [
              0.9843463897705078,
              0.9234484434127808,
              0.9234484434127808
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 0.9615678191184998,
              "Phenotype Category": 1.0,
              "Alleles": 0.9375396370887756,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9843463897705078,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*13:01",
                "prediction": "HLA-B*13:01"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "sulfamethoxazole, sulfamethoxazole / trimethoprim",
                "prediction": "sulfamethoxazole, cotrimoxazole"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*13:01",
                "prediction": "HLA-B*13:01"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "severe cutaneous adverse reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 0.9615678191184998,
              "Phenotype Category": 1.0,
              "Alleles": 0.9470509886741638,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9234484434127808,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*38:02",
                "prediction": "HLA-B*38:02"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "sulfamethoxazole, sulfamethoxazole / trimethoprim",
                "prediction": "sulfamethoxazole, cotrimoxazole"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*38:02",
                "prediction": "HLA-B*38:02"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Stevens-Johnson Syndrome, Side Effect:Toxic Epidermal Necrolysis, Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "severe cutaneous adverse reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 0.9615678191184998,
              "Phenotype Category": 1.0,
              "Alleles": 0.9463644027709961,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9234484434127808,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*15:02",
                "prediction": "HLA-B*15:02"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "sulfamethoxazole, sulfamethoxazole / trimethoprim",
                "prediction": "sulfamethoxazole, cotrimoxazole"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*15:02",
                "prediction": "HLA-B*15:02"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Stevens-Johnson Syndrome, Side Effect:Toxic Epidermal Necrolysis, Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "severe cutaneous adverse reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA165954769",
          "PA165954643",
          "PA165955505"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "HLA-A*11:01",
            "Gene": "HLA-A",
            "Drug(s)": "sulfamethoxazole, cotrimoxazole",
            "PMID": 38568509,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Significant association with SMX/CTX-induced SCARs in multiple studies.",
            "Sentence": "HLA-A*11:01 is associated with increased risk of severe cutaneous adverse reactions when treated with sulfamethoxazole in people with SCARs.",
            "Alleles": "HLA-A*11:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "severe cutaneous adverse reactions",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "severe cutaneous adverse reactions",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "38568509",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "\"In this systematic review and meta-analysis of 6 studies involving 322 patients with SCARs, significant associations were identified between the HLA-A*11:01, HLA-B*13:01, HLA-B*15:02, HLA-B*38:02, and HLA-C*08:01 genotypes and SMX/CTX-induced SCARs.\"",
              "\"The results of this systematic review and meta-analysis suggest that multiple HLA alleles (HLA-A*11:01, HLA-B*13:01, HLA-B*15:02, HLA-B*38:02, and HLA-C*08:01) are associated with SMX/CTX-induced SCARs.\"",
              "\"A significant association has been identified between the HLA-A*11:01 allele and SMX-induced SCARs.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-A*11:01",
              "variant_id": "PA165953358",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "sulfamethoxazole",
              "drug_id": "PA451544",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 5,
            "Variant/Haplotypes": "HLA-C*08:01",
            "Gene": "HLA-C",
            "Drug(s)": "sulfamethoxazole, cotrimoxazole",
            "PMID": 38568509,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Significant association with SMX/CTX-induced SCARs in multiple studies.",
            "Sentence": "HLA-C*08:01 is associated with increased risk of severe cutaneous adverse reactions when treated with sulfamethoxazole in people with SCARs.",
            "Alleles": "HLA-C*08:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "severe cutaneous adverse reactions",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "severe cutaneous adverse reactions",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "38568509",
            "Variant Annotation ID_norm": "5",
            "Citations": [
              "\"In this systematic review and meta-analysis of 6 studies involving 322 patients with SCARs, significant associations were identified between the HLA-A*11:01, HLA-B*13:01, HLA-B*15:02, HLA-B*38:02, and HLA-C*08:01 genotypes and SMX/CTX-induced SCARs.\"",
              "\"The results of this systematic review and meta-analysis suggest that multiple HLA alleles (HLA-A*11:01, HLA-B*13:01, HLA-B*15:02, HLA-B*38:02, and HLA-C*08:01) are associated with SMX/CTX-induced SCARs.\"",
              "\"Significant associations were found in HLA-C*08:01 (OR, 2.63; 95% CI, 1.07-6.44) compared with tolerant controls.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-C*08:01",
              "variant_id": "PA166123426",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "sulfamethoxazole",
              "drug_id": "PA451544",
              "confidence": 1.0
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.6924222747484843,
        "field_scores": {
          "Study Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.8863341212272644,
            "scores": [
              0.9124831557273865,
              0.8813441395759583,
              0.8813441395759583,
              0.8813441395759583,
              0.8751550316810608
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.1,
            "scores": [
              0.5,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          }
        },
        "total_samples": 5,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.9124831557273865,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452437520,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452437420,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis",
                "prediction": "meta-analysis"
              },
              "Study Cases": {
                "ground_truth": null,
                "prediction": 236.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": 8448.0
              },
              "Characteristics": {
                "ground_truth": "2 studies, SJS/TEN v tolerant controls",
                "prediction": "Patients with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.001",
                "prediction": "< .001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 3.01,
                "prediction": 3.01
              },
              "Confidence Interval Start": {
                "ground_truth": 1.56,
                "prediction": 1.56
              },
              "Confidence Interval Stop": {
                "ground_truth": 5.8,
                "prediction": 5.8
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8813441395759583,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452437426,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452437420,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis",
                "prediction": "meta-analysis"
              },
              "Study Cases": {
                "ground_truth": 158.0,
                "prediction": 322.0
              },
              "Study Controls": {
                "ground_truth": 226.0,
                "prediction": 8448.0
              },
              "Characteristics": {
                "ground_truth": "2 studies, SCAR v tolerant controls",
                "prediction": "Patients with SCARs induced by SMX/CTX"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "< .001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.23,
                "prediction": 2.23
              },
              "Confidence Interval Start": {
                "ground_truth": 1.2,
                "prediction": 1.2
              },
              "Confidence Interval Stop": {
                "ground_truth": 4.14,
                "prediction": 4.14
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8813441395759583,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452438988,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452438980,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis",
                "prediction": "meta-analysis"
              },
              "Study Cases": {
                "ground_truth": 158.0,
                "prediction": 322.0
              },
              "Study Controls": {
                "ground_truth": 226.0,
                "prediction": 8448.0
              },
              "Characteristics": {
                "ground_truth": "2 studies, SCAR v tolerant controls",
                "prediction": "Patients with SCARs induced by SMX/CTX"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "< .001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 5.96,
                "prediction": 5.96
              },
              "Confidence Interval Start": {
                "ground_truth": 1.58,
                "prediction": 1.58
              },
              "Confidence Interval Stop": {
                "ground_truth": 22.56,
                "prediction": 22.56
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8813441395759583,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452438989,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452439000,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis",
                "prediction": "meta-analysis"
              },
              "Study Cases": {
                "ground_truth": 158.0,
                "prediction": 322.0
              },
              "Study Controls": {
                "ground_truth": 226.0,
                "prediction": 8448.0
              },
              "Characteristics": {
                "ground_truth": "2 studies, SCAR v tolerant controls",
                "prediction": "Patients with SCARs induced by SMX/CTX"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "< .001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 3.47,
                "prediction": 3.47
              },
              "Confidence Interval Start": {
                "ground_truth": 1.42,
                "prediction": 1.42
              },
              "Confidence Interval Stop": {
                "ground_truth": 8.48,
                "prediction": 8.48
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8751550316810608,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452438990,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452439000,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "meta-analysis",
                "prediction": "meta-analysis"
              },
              "Study Cases": {
                "ground_truth": null,
                "prediction": 86.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": 8448.0
              },
              "Characteristics": {
                "ground_truth": "2 studies, SJS/TEN v tolerant controls",
                "prediction": "Patients with drug reaction with eosinophilia and systemic symptoms (DRESS)"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": "< .001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 5.13,
                "prediction": 12.86
              },
              "Confidence Interval Start": {
                "ground_truth": 1.96,
                "prediction": 1.09
              },
              "Confidence Interval Stop": {
                "ground_truth": 13.47,
                "prediction": 151.34
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "meta-analysis:2 studies, SJS/TEN v",
          "meta-analysis:2 studies, SCAR v to",
          "meta-analysis:2 studies, SCAR v to",
          "meta-analysis:2 studies, SCAR v to",
          "meta-analysis:2 studies, SJS/TEN v"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "meta-analysis",
            "Study Cases": 322.0,
            "Study Controls": 8448.0,
            "Characteristics": "Patients with severe cutaneous adverse reactions (SCARs) induced by sulfamethoxazole (SMX) or cotrimoxazole (CTX)",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< .001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.1,
            "Confidence Interval Start": 1.11,
            "Confidence Interval Stop": 4.0,
            "Biogeographical Groups": "Multiple Groups",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "meta-analysis",
            "Study Cases": 322.0,
            "Study Controls": 8448.0,
            "Characteristics": "Patients with SCARs induced by SMX/CTX",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< .001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.63,
            "Confidence Interval Start": 1.07,
            "Confidence Interval Stop": 6.44,
            "Biogeographical Groups": "Multiple Groups",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "meta-analysis",
            "Study Cases": 86.0,
            "Study Controls": 8448.0,
            "Characteristics": "Patients with drug reaction with eosinophilia and systemic symptoms (DRESS)",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< .001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 23.09,
            "Confidence Interval Start": 3.31,
            "Confidence Interval Stop": 161.0,
            "Biogeographical Groups": "Multiple Groups",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC2859392": {
      "var-drug": {
        "overall_score": 0.0,
        "field_scores": {},
        "total_samples": 0,
        "detailed_results": [],
        "aligned_variants": [],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1448993666,
            "Variant/Haplotypes": "rs3745274",
            "Gene": "CYP2B6",
            "Drug(s)": "efavirenz",
            "PMID": 20338069,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "No significant difference in median CD4 T cell counts of each genotype at different time points was seen in efavirenz group (p = 0.818, 0.838, 0.783, 0.753 and 0.587 for baseline, weeks 12, 24, 36 and 48 of ART, respectively).",
            "Sentence": "Genotype TT is not associated with response to efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": "response to",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease, Disease:Tuberculosis",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "GG + GT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "20338069",
            "Variant Annotation ID_norm": "1448993666",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs3745274",
              "variant_id": "PA166155409",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "efavirenz",
              "drug_id": "PA449441",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1184988061,
            "Variant/Haplotypes": "rs3745274",
            "Gene": "CYP2B6",
            "Drug(s)": "efavirenz",
            "PMID": 20338069,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "Association with significantly increased efavirenz plasma levels. Was significant at week 6, 12 of treatment and 1 month after rifampicin discontinuation.",
            "Sentence": "Genotype TT is associated with decreased metabolism of efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "metabolism of",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease, Disease:Tuberculosis",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "GG + GT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "20338069",
            "Variant Annotation ID_norm": "1184988061",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs3745274",
              "variant_id": "PA166155409",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "efavirenz",
              "drug_id": "PA449441",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "CYP2B6-G516T",
            "Gene": "CYP2B6",
            "Drug(s)": "efavirenz",
            "PMID": 20338069,
            "Phenotype Category": "metabolism/PK",
            "Significance": "yes",
            "Notes": "Mean plasma efavirenz concentration in patients with TT genotype was significantly higher than those with GT or GG genotypes (p < 0.0001).",
            "Sentence": "Genotypes TT is associated with increased concentrations of efavirenz in HIV/TB co-infected Thai adults as compared to genotype GG.",
            "Alleles": "TT, GT, GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in HIV/TB co-infected Thai adults",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Citations": [
              "The mean 12-hour post-dose plasma efavirenz concentration in patients with TT genotype at weeks 6 and 12 of ART and 1 month after rifampicin discontinuation (10.97 \u00b1 2.32, 13.62 \u00b1 4.21 and 8.48 \u00b1 1.30 mg/L, respectively) were significantly higher than those with GT (3.43 \u00b1 0.29, 3.35 \u00b1 0.27 and 3.21 \u00b1 0.22 mg/L, respectively) or GG genotypes (2.88 \u00b1 0.33, 2.45 \u00b1 0.26 and 2.08 \u00b1 0.16 mg/L, respectively) (p < 0.0001).",
              "This is the first report to demonstrate the effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine concentrations when co-administered with rifampicin in HIV/TB co-infected Thai adults.",
              "Compared with the effects of CYP2B6-516TT genotype, we could observe only small effects of rifampicin on plasma efavirenz and nevirapine levels."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs28399499",
              "variant_id": "PA166155478",
              "confidence": 0.8421052631578947
            },
            "Drug(s)_normalized": {
              "normalized": "efavirenz",
              "drug_id": "PA449441",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "CYP2B6-G516T",
            "Gene": "CYP2B6",
            "Drug(s)": "nevirapine",
            "PMID": 20338069,
            "Phenotype Category": "metabolism/PK",
            "Significance": "yes",
            "Notes": "Mean plasma nevirapine concentration in patients with TT genotype tended to be higher than those with GT or GG genotypes (p = 0.003).",
            "Sentence": "Genotypes TT is associated with increased concentrations of nevirapine in HIV/TB co-infected Thai adults as compared to genotype GG.",
            "Alleles": "TT, GT, GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in HIV/TB co-infected Thai adults",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Citations": [
              "\"The mean 12-hour post-dose plasma nevirapine concentration in patients carrying TT genotype at weeks 6 and 12 of ART and 1 month after rifampicin discontinuation (14.09 \u00b1 9.49, 7.94 \u00b1 2.76 and 9.44 \u00b1 0.17 mg/L, respectively) tended to be higher than those carrying GT (5.65 \u00b1 0.54, 5.58 \u00b1 0.48 and 7.03 \u00b1 0.64 mg/L, respectively) or GG genotypes (5.42 \u00b1 0.48, 5.34 \u00b1 0.50 and 6.43 \u00b1 0.64 mg/L, respectively) (p = 0.003, p = 0.409 and p = 0.448, respectively).\"",
              "\"This is the first report to demonstrate the effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine concentrations when co-administered with rifampicin in HIV/TB co-infected Thai adults.\"",
              "\"Compared with the effects of CYP2B6-516TT genotype, we could observe only small effects of rifampicin on plasma efavirenz and nevirapine levels.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs28399499",
              "variant_id": "PA166155478",
              "confidence": 0.8421052631578947
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.6897660624980927,
        "field_scores": {
          "Study Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.475,
            "scores": [
              0.0,
              0.95
            ]
          },
          "Study Controls": {
            "mean_score": 0.975,
            "scores": [
              1.0,
              0.95
            ]
          },
          "Characteristics": {
            "mean_score": 0.9400722980499268,
            "scores": [
              0.9715948104858398,
              0.9085497856140137
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.481418639421463,
            "scores": [
              0.962837278842926,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.975,
            "scores": [
              1.0,
              0.95
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9715948104858398,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.962837278842926,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1184988079,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1184988061,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 65.0,
                "prediction": 124.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
                "prediction": "HIV-1/TB co-infected Thai adults receiving efavirenz or nevirapine based ART"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": 0.62,
                "prediction": 0.3846
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "G",
                "prediction": "GG"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.0001",
                "prediction": "< 0.0001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Thai"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.95,
              "Study Controls": 0.95,
              "Characteristics": 0.9085497856140137,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 0.0,
              "Allele Of Frequency In Cases": 0.0,
              "Frequency In Controls": 0.95,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448993668,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993666,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 65.0,
                "prediction": 65.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
                "prediction": "Efavirenz group with CYP2B6-G516T genotypes"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": 0.62,
                "prediction": 10.97
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "G",
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "> 0.05",
                "prediction": "< 0.0001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Thai"
              }
            },
            "dependency_issues": [
              "Frequency In Cases (10.97) should be between 0 and 1"
            ],
            "penalty_info": {
              "total_penalty": 0.05,
              "penalized_fields": {
                "Frequency In Cases": {
                  "original_score": 0.0,
                  "penalized_score": 0.0,
                  "penalty_percentage": 5.0
                },
                "Study Controls": {
                  "original_score": 1.0,
                  "penalized_score": 0.95,
                  "penalty_percentage": 5.0
                },
                "Study Cases": {
                  "original_score": 1.0,
                  "penalized_score": 0.95,
                  "penalty_percentage": 5.0
                },
                "Frequency In Controls": {
                  "original_score": 1.0,
                  "penalized_score": 0.95,
                  "penalty_percentage": 5.0
                }
              },
              "issues_by_field": {
                "Frequency In Cases": [
                  "Frequency In Cases (10.97) should be between 0 and 1"
                ],
                "Frequency In Controls": [
                  "Frequency In Cases (10.97) should be between 0 and 1"
                ],
                "Study Cases": [
                  "Frequency In Cases (10.97) should be between 0 and 1"
                ],
                "Study Controls": [
                  "Frequency In Cases (10.97) should be between 0 and 1"
                ]
              }
            }
          }
        ],
        "aligned_variants": [
          "cohort:HIV-1/TB co-infected",
          "cohort:HIV-1/TB co-infected"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 124.0,
            "Study Controls": null,
            "Characteristics": "HIV-1/TB co-infected Thai adults receiving efavirenz or nevirapine based ART",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.4769,
            "Allele Of Frequency In Cases": "GT",
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Thai",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 124.0,
            "Study Controls": null,
            "Characteristics": "HIV-1/TB co-infected Thai adults receiving efavirenz or nevirapine based ART",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.1385,
            "Allele Of Frequency In Cases": "TT",
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Thai",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 65.0,
            "Study Controls": null,
            "Characteristics": "Efavirenz group with CYP2B6-G516T genotypes",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 13.62,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Thai",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 65.0,
            "Study Controls": null,
            "Characteristics": "Efavirenz group with CYP2B6-G516T genotypes",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 8.48,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Thai",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 59.0,
            "Study Controls": null,
            "Characteristics": "Nevirapine group with CYP2B6-G516T genotypes",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 14.09,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "0.003",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Thai",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 59.0,
            "Study Controls": null,
            "Characteristics": "Nevirapine group with CYP2B6-G516T genotypes",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 7.94,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "0.409",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Thai",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 59.0,
            "Study Controls": null,
            "Characteristics": "Nevirapine group with CYP2B6-G516T genotypes",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 9.44,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "0.448",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Thai",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC11430164": {
      "var-fa": {
        "overall_score": 0.3601974871597792,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "PMID": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.43250998697782816,
            "scores": [
              0.9200920462608337,
              0.9142707586288452,
              0.896486222743988,
              0.9037529230117798,
              0.8956841230392456,
              0.8954018354415894,
              0.9150903224945068,
              0.9366949200630188,
              0.940216600894928,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Specialty Population": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Assay type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "isPlural": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.21052631578947367,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Functional terms": {
            "mean_score": 0.4449080322918139,
            "scores": [
              0.9392502903938293,
              0.9392502903938293,
              0.9392502903938293,
              0.9392502903938293,
              0.9392502903938293,
              0.9392502903938293,
              0.9392502903938293,
              0.9392502903938293,
              0.9392502903938293,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene/gene product": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Cell type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.4317948818206787,
            "scores": [
              0.911566972732544,
              0.911566972732544,
              0.911566972732544,
              0.911566972732544,
              0.911566972732544,
              0.911566972732544,
              0.911566972732544,
              0.911566972732544,
              0.911566972732544,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 0.47368421052631576,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 19,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9200920462608337,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*1",
                "prediction": "CYP3A4*1"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
                "prediction": "*1"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9142707586288452,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*2",
                "prediction": "CYP3A4*2"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
                "prediction": "*2"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.896486222743988,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*3",
                "prediction": "CYP3A4*3"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
                "prediction": "*3"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9037529230117798,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*4",
                "prediction": "CYP3A4*4"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
                "prediction": "*4"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8956841230392456,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*5",
                "prediction": "CYP3A4*5"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
                "prediction": "*5"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 5,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8954018354415894,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*24",
                "prediction": "CYP3A4*24"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
                "prediction": "*24"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 6,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9150903224945068,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*1",
                "prediction": "CYP3A4*11"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*11 + *18 + *33",
                "prediction": "*11"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 7,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.9366949200630188,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*18",
                "prediction": "CYP3A4*18"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*11 + *18 + *33",
                "prediction": "*18"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 8,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.940216600894928,
              "Specialty Population": 1.0,
              "Assay type": 0.0,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Functional terms": 0.9392502903938293,
              "Gene/gene product": 0.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.911566972732544,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP3A4*33",
                "prediction": "CYP3A4*33"
              },
              "Gene": {
                "ground_truth": "CYP3A4",
                "prediction": "CYP3A4"
              },
              "Drug(s)": {
                "ground_truth": "ticagrelor",
                "prediction": "ticagrelor"
              },
              "PMID": {
                "ground_truth": 39346054,
                "prediction": 39346054
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*11 + *18 + *33",
                "prediction": "*33"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": null,
                "prediction": "insect cell expression system"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Functional terms": {
                "ground_truth": "clearance of",
                "prediction": "metabolism of"
              },
              "Gene/gene product": {
                "ground_truth": null,
                "prediction": "CYP3A4"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": "insect cells"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "CYP3A4*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cyp3a4*1",
          "cyp3a4*2",
          "cyp3a4*3",
          "cyp3a4*4",
          "cyp3a4*5",
          "cyp3a4*24",
          "cyp3a4*1",
          "cyp3a4*18",
          "cyp3a4*33"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*9",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*14",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*15",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*16",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*17",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*19",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*28",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*29",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626580,
            "Variant/Haplotypes": "CYP3A4*31",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31 is associated with decreased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*2 + *3 + *4 + *5 + *9 + *14 + *15 + *16 + *17 + *19 + *24 + *28 + *29 + *31",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626580",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*9, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*19, CYP3A4*24, CYP3A4*28, CYP3A4*29, CYP3A4*31",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452626560,
            "Variant/Haplotypes": "CYP3A4*11",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"CYP3A4 variants could be classified into the following three categories according to the relative clearance values compare with CYP3A4*1: CYP3A4*11, CYP3A4*18 and CYP3A4*33 showed significantly higher intrinsic clearance than that of CYP3A4*1; four CYP3A4 variants (CYP3A4*10, CYP3A4*23, CYP3A4*32 and CYP3A4*34) were not significantly different from that of wild-type; the remaining fourteen variants (CYP3A4*2-*5, *9, *14-*17, *19, *24, *28, *29, and *31,) exhibited significantly reduced CLint in different degrees (1.48%\u201375.11% relative clearance) compared to that of wild-type\"",
            "Sentence": "CYP3A4 *11 + *18 + *33 is associated with increased clearance of ticagrelor as compared to CYP3A4 *1.",
            "Alleles": "*11 + *18 + *33",
            "Specialty Population": null,
            "Assay type": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Functional terms": "clearance of",
            "Gene/gene product": null,
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "39346054",
            "Variant Annotation ID_norm": "1452626560",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*1, CYP3A4*11, CYP3A4*18, CYP3A4*33",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 8,
            "Variant/Haplotypes": "CYP3A4*30",
            "Gene": "CYP3A4",
            "Drug(s)": "ticagrelor",
            "PMID": 39346054,
            "Phenotype Category": "metabolism/PK",
            "Significance": "no",
            "Notes": "No detectable enzymatic activity towards ticagrelor.",
            "Sentence": "CYP3A4*30 is not associated with metabolism of ticagrelor as compared to CYP3A4*1.",
            "Alleles": "*30",
            "Metabolizer types": null,
            "Comparison Allele(s) or Genotype(s)": "CYP3A4*1",
            "Assay type": "insect cell expression system",
            "Cell type": "insect cells",
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "Functional terms": "metabolism of",
            "Gene/gene product": "CYP3A4",
            "When treated with/exposed to/when assayed with": "when assayed with",
            "Multiple drugs And/or": null,
            "Citations": [
              "CYP3A4*30 displayed weak or no activity.",
              "CYP3A4*30 (R130STOP) could not be determined because of no detectable enzymatic activity toward ticagrelor.",
              "Thus, CYP3A4*30 may exhibit complete loss of function."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP3A4*30",
              "variant_id": "PA166245586",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "ticagrelor",
              "drug_id": "PA165374673",
              "confidence": 1.0
            }
          }
        ]
      }
    },
    "PMC11971672": {
      "var-pheno": {
        "overall_score": 0.22036806059380373,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.2207765430212021,
            "scores": [
              0.8831061720848083,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.21912595629692078,
            "scores": [
              0.8765038251876831,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 4,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8831061720848083,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8765038251876831,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19*2",
                "prediction": "CYP2C19*2"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "Drug(s)": {
                "ground_truth": "clopidogrel",
                "prediction": "clopidogrel"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Alleles": {
                "ground_truth": "*1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3",
                "prediction": "CYP2C19*2"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Stroke, Efficacy:Myocardial Infarction, Efficacy:Death",
                "prediction": "cardiovascular events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1 + *1/*17 + *17/*17",
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "cyp2c19*2"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1453096120,
            "Variant/Haplotypes": "CYP2C19*1",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40184070,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "\"Overall, 49 of 1785 LOF allele carriers (2.7%) and 18 of 1125 LOF allele noncarriers (1.6%) experienced cardiovascular events, defined as a composite of recurrent stroke, myocardial infarction, and all-cause mortality at 180 days...The primary outcome of composite cardiovascular events occurred significantly more in the LOF allele carrier group (49 of 1785 [2.7%]) compared with the noncarrier group (18 of 1125 [1.6%]) (HR, 0.58; 95% CI, 0.34-1.00; P\u2009=\u2009.048 for log-rank test).\"",
            "Sentence": "CYP2C19 *1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3 (assigned as intermediate metabolizer and poor metabolizer phenotype) is associated with increased likelihood of Stroke, Myocardial Infarction or Death when treated with clopidogrel in people with Stroke as compared to CYP2C19 *1/*1 + *1/*17 + *17/*17 (assigned as normal metabolizer phenotype) .",
            "Alleles": "*1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3",
            "Specialty Population": null,
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Stroke, Efficacy:Myocardial Infarction, Efficacy:Death",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stroke",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*17 + *17/*17",
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "40184070",
            "Variant Annotation ID_norm": "1453096120",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "clopidogrel",
              "drug_id": "PA449053",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1453096120,
            "Variant/Haplotypes": "CYP2C19*3",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40184070,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "\"Overall, 49 of 1785 LOF allele carriers (2.7%) and 18 of 1125 LOF allele noncarriers (1.6%) experienced cardiovascular events, defined as a composite of recurrent stroke, myocardial infarction, and all-cause mortality at 180 days...The primary outcome of composite cardiovascular events occurred significantly more in the LOF allele carrier group (49 of 1785 [2.7%]) compared with the noncarrier group (18 of 1125 [1.6%]) (HR, 0.58; 95% CI, 0.34-1.00; P\u2009=\u2009.048 for log-rank test).\"",
            "Sentence": "CYP2C19 *1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3 (assigned as intermediate metabolizer and poor metabolizer phenotype) is associated with increased likelihood of Stroke, Myocardial Infarction or Death when treated with clopidogrel in people with Stroke as compared to CYP2C19 *1/*1 + *1/*17 + *17/*17 (assigned as normal metabolizer phenotype) .",
            "Alleles": "*1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3",
            "Specialty Population": null,
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Stroke, Efficacy:Myocardial Infarction, Efficacy:Death",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stroke",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*17 + *17/*17",
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "40184070",
            "Variant Annotation ID_norm": "1453096120",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "clopidogrel",
              "drug_id": "PA449053",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1453096120,
            "Variant/Haplotypes": "CYP2C19*17",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40184070,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "\"Overall, 49 of 1785 LOF allele carriers (2.7%) and 18 of 1125 LOF allele noncarriers (1.6%) experienced cardiovascular events, defined as a composite of recurrent stroke, myocardial infarction, and all-cause mortality at 180 days...The primary outcome of composite cardiovascular events occurred significantly more in the LOF allele carrier group (49 of 1785 [2.7%]) compared with the noncarrier group (18 of 1125 [1.6%]) (HR, 0.58; 95% CI, 0.34-1.00; P\u2009=\u2009.048 for log-rank test).\"",
            "Sentence": "CYP2C19 *1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3 (assigned as intermediate metabolizer and poor metabolizer phenotype) is associated with increased likelihood of Stroke, Myocardial Infarction or Death when treated with clopidogrel in people with Stroke as compared to CYP2C19 *1/*1 + *1/*17 + *17/*17 (assigned as normal metabolizer phenotype) .",
            "Alleles": "*1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3",
            "Specialty Population": null,
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Stroke, Efficacy:Myocardial Infarction, Efficacy:Death",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stroke",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*17 + *17/*17",
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "40184070",
            "Variant Annotation ID_norm": "1453096120",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "clopidogrel",
              "drug_id": "PA449053",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.6276209036509196,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.914313554763794,
            "scores": [
              0.9206077456474304,
              0.9080193638801575
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.5,
            "scores": [
              0.5,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9206077456474304,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1453096116,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1453096120,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "clinical trial",
                "prediction": "prospective, nonrandomized clinical trial"
              },
              "Study Cases": {
                "ground_truth": 2910.0,
                "prediction": 2910
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "PLATELET trial, composite outcome (recurrent stroke, myocardial infarction, and all-cause mortality at 180 days)",
                "prediction": "Patients with acute ischemic stroke treated with clopidogrel"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.048",
                "prediction": "= 0.56"
              },
              "Ratio Stat Type": {
                "ground_truth": "HR",
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": 0.58,
                "prediction": 1.29
              },
              "Confidence Interval Start": {
                "ground_truth": 0.34,
                "prediction": 0.53
              },
              "Confidence Interval Stop": {
                "ground_truth": 1.0,
                "prediction": 3.13
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9080193638801575,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1453096140,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1453096120,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "clinical trial",
                "prediction": "prospective, nonrandomized clinical trial"
              },
              "Study Cases": {
                "ground_truth": 2910.0,
                "prediction": 2910
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "PLATELET trial, Recurrent stroke",
                "prediction": "Patients with acute ischemic stroke treated with clopidogrel"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.047",
                "prediction": "= 0.27"
              },
              "Ratio Stat Type": {
                "ground_truth": "HR",
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": 0.56,
                "prediction": 0.31
              },
              "Confidence Interval Start": {
                "ground_truth": 0.32,
                "prediction": 0.04
              },
              "Confidence Interval Stop": {
                "ground_truth": 1.0,
                "prediction": 2.71
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "clinical trial:PLATELET trial, comp",
          "clinical trial:PLATELET trial, Recu"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "prospective, nonrandomized clinical trial",
            "Study Cases": 2910,
            "Study Controls": null,
            "Characteristics": "Patients with acute ischemic stroke treated with clopidogrel",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.027,
            "Allele Of Frequency In Cases": "CYP2C19 LOF allele",
            "Frequency In Controls": 0.016,
            "Allele Of Frequency In Controls": "CYP2C19 non-LOF allele",
            "P Value": "= 0.048",
            "Ratio Stat Type": "HR",
            "Ratio Stat": 0.58,
            "Confidence Interval Start": 0.34,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "prospective, nonrandomized clinical trial",
            "Study Cases": 2910,
            "Study Controls": null,
            "Characteristics": "Patients with acute ischemic stroke treated with clopidogrel",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.025,
            "Allele Of Frequency In Cases": "CYP2C19 LOF allele",
            "Frequency In Controls": 0.014,
            "Allele Of Frequency In Controls": "CYP2C19 non-LOF allele",
            "P Value": "= 0.047",
            "Ratio Stat Type": "HR",
            "Ratio Stat": 0.56,
            "Confidence Interval Start": 0.32,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC12319246": {
      "var-pheno": {
        "overall_score": 0.5634382401282588,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.6128570809960365,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.9028566479682922,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.625,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.375,
            "scores": [
              1.0,
              0.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.5936780795454979,
            "scores": [
              1.0,
              1.0,
              0.9427328109741211,
              0.9622328281402588,
              0.8444589972496033,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.625,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.625,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.5351923406124115,
            "scores": [
              0.9629747271537781,
              0.8325313925743103,
              0.8270606994628906,
              0.8091926574707031,
              0.8497792482376099,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.625,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.375,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 8,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9629747271537781,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4244285",
                "prediction": "rs4244285"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "Drug(s)": {
                "ground_truth": "tacrolimus",
                "prediction": "tacrolimus"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "AA",
                "prediction": "AA"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Nephrotoxicity",
                "prediction": "nephrotoxicity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8325313925743103,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs3745274",
                "prediction": "rs3745274"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "tacrolimus",
                "prediction": "tacrolimus"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "GT",
                "prediction": "GT"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Transplant rejection",
                "prediction": "tumor occurrence"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9427328109741211,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8270606994628906,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs9282564",
                "prediction": "rs9282564"
              },
              "Gene": {
                "ground_truth": "ABCB1",
                "prediction": "ABCB1"
              },
              "Drug(s)": {
                "ground_truth": "tacrolimus",
                "prediction": "tacrolimus"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Alleles": {
                "ground_truth": "TT",
                "prediction": "AA"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Death",
                "prediction": "exitus"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC + CT",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9622328281402588,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8091926574707031,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs2273697",
                "prediction": "rs2273697"
              },
              "Gene": {
                "ground_truth": "ABCC2",
                "prediction": "ABCC2"
              },
              "Drug(s)": {
                "ground_truth": "tacrolimus",
                "prediction": "tacrolimus"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Alleles": {
                "ground_truth": "GG",
                "prediction": "GA"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Overall survival",
                "prediction": "exitus"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "AA + AG",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 0.9028566479682922,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.8444589972496033,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8497792482376099,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4244285",
                "prediction": "CYP3A5*3"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP3A5"
              },
              "Drug(s)": {
                "ground_truth": "tacrolimus",
                "prediction": "tacrolimus"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "metabolism/PK"
              },
              "Alleles": {
                "ground_truth": "AA",
                "prediction": "*3/*3"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Nephrotoxicity",
                "prediction": "tacrolimus concentration"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA166155409",
          "PA166157435",
          "PA166154007",
          "PA166154053",
          "cyp3a5+tacrolimus"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1454211330,
            "Variant/Haplotypes": "rs2740574",
            "Gene": "CYP3A4",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "\"Regarding acute rejection, statistical analysis showed that the CYP3A4 rs2740574 AA variant in the recipient could offer a protective effect (OR: 0.080; p-value: 0.047) compared to other variants at that location. \" Alleles complemented.",
            "Sentence": "Genotype TT is associated with decreased likelihood of Transplant rejection when treated with tacrolimus in people with Kidney Transplantation as compared to genotypes CC + CT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Transplant rejection",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC + CT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211330",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs2740574",
              "variant_id": "PA166157367",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "tacrolimus",
              "drug_id": "PA451578",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1454211400,
            "Variant/Haplotypes": "rs2306283",
            "Gene": "SLCO1B1",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "From Table 3. AA and AG genotype of Recipient and AG genotype of donor were association with lower odds of nephrotoxicity",
            "Sentence": "Genotypes AA + AG is associated with decreased likelihood of Nephrotoxicity when treated with tacrolimus in people with Kidney Transplantation.",
            "Alleles": "AA + AG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Nephrotoxicity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211400",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs2306283",
              "variant_id": "PA166154547",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "tacrolimus",
              "drug_id": "PA451578",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1454211340,
            "Variant/Haplotypes": "rs4149056",
            "Gene": "SLCO1B1",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "\"The presence of the TT variant in SLCO1B1 rs4149056 in the recipient and the GT variant in CYP2B6 rs3745274 in the donor were also statistically associated with a reduced risk (OR: 0.16 and 0.2, respectively) of acute rejection.\" \"Recipients with the TT variant in SLCO1B1 rs4149056 showed higher dose-adjusted tacrolimus concentrations, possibly mediating a greater immunosuppressive effect and protecting against rejection, consistent with our logistic regression results (OR: 0.157). \"",
            "Sentence": "Genotype TT is associated with decreased likelihood of Transplant rejection when treated with tacrolimus in people with Kidney Transplantation.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Transplant rejection",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211340",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs4149056",
              "variant_id": "PA166154579",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "tacrolimus",
              "drug_id": "PA451578",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "CYP2B6",
            "Gene": "CYP2B6",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Decreased tumor risk in recipients with GT variant",
            "Sentence": "CYP2B6 rs3745274 is associated with decreased tumor risk when treated with tacrolimus in kidney transplant recipients.",
            "Alleles": "GT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "tumor occurrence",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in kidney transplant recipients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "Increased tumor risk correlated with ABCC2 variants in donors and decreased risk with CYP2B6 rs3745274 in recipients.",
              "Notable associations include survival related to ABCB1 and ABCC2 variants, tumor occurrence linked to CYP2B6 rs3745274, and renal function affected by multiple pharmacogenes.",
              "Our results show that: ... b) increased risk of tumor occurrence associated with ABCC2 variants in donors and, conversely, reduced risk was observed in recipients with the GT variant in CYP2B6 rs3745274."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2B6 rs3745274",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tacrolimus",
              "drug_id": "PA451578",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "ABCB1",
            "Gene": "ABCB1",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "efficacy",
            "Significance": "yes",
            "Notes": "Reduced risk of exitus in patients with AA variant",
            "Sentence": "ABCB1 rs9282564 is associated with reduced risk of exitus when treated with tacrolimus in kidney transplant recipients.",
            "Alleles": "AA",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "exitus",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in kidney transplant recipients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "The AA variant in the rs9282564 SNP of the donor's ABCB1 gene was significantly associated (p-value: 0.029) with a reduced risk (OR: 0.116) of exitus during the follow-up period.",
              "Kaplan-Meier curves were plotted. The AG variant in ABCB1 gene rs9282564 of the donor was significantly associated (p-value: 0.042; log-rank) with reduced cumulative survival compared to the AA variant.",
              "Our findings support that pharmacogene variants influence transplant outcomes. Notable associations include survival related to ABCB1 and ABCC2 variants..."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "ABCB1 rs9282564",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tacrolimus",
              "drug_id": "PA451578",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 4,
            "Variant/Haplotypes": "ABCC2",
            "Gene": "ABCC2",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "efficacy",
            "Significance": "yes",
            "Notes": "Increased risk of exitus in patients with GA variant",
            "Sentence": "ABCC2 rs2273697 is associated with increased risk of exitus when treated with tacrolimus in kidney transplant recipients.",
            "Alleles": "GA",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "exitus",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in kidney transplant recipients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "Conversely, patients receiving a graft from a donor with the GA genotype in rs2273697 of ABCC2 were significantly associated (p-value: 0.021) with an increased risk (OR: 4.133) of exitus.",
              "The genotype in the donor's ABCC2 rs2273697 could significantly (p-value: 0.003; log-rank) affect survival, with the GG variant providing a higher rate during the entire follow-up compared to AA and GA.",
              "Our findings indicate the presence of associations between pharmacogene variants and clinical outcomes, including survival, renal function, and tumor occurrence. Specifically, our results show that... increased risk of tumor occurrence associated with ABCC2 variants in donors..."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "ABCC2 rs2273697",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tacrolimus",
              "drug_id": "PA451578",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 5,
            "Variant/Haplotypes": "CYP2C19",
            "Gene": "CYP2C19",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Increased nephrotoxicity risk in patients with AA variant",
            "Sentence": "CYP2C19 rs4244285 is associated with increased nephrotoxicity risk when treated with tacrolimus in kidney transplant recipients.",
            "Alleles": "AA",
            "Specialty Population": null,
            "Metabolizer types": "poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "nephrotoxicity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in kidney transplant recipients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "Increased nephrotoxicity risk was associated with CYP2C19 rs4244285 and reduced by SLCO1B1 rs2306283 AA and AG variants.",
              "The AA variant in CYP2C19 rs4244285 has been previously associated with increased tacrolimus concentration/dose (C/D) which aligns with our findings of significantly higher (p-value <0.001) C/D in AA recipients.",
              "Our study also found a strong association (p-value: 0.026) with a substantial increase in nephrotoxicity risk (OR: 11.6) in patients with the AA variant in CYP2C19 rs4244285, which defines the \u22172 poor metabolizer haplotype and has been reported to require lower tacrolimus doses for therapeutic concentrations."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19 rs4244285",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "tacrolimus",
              "drug_id": "PA451578",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.4818670338392258,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.6717555075883865,
            "scores": [
              0.8884787559509277,
              0.9125195145606995,
              0.9125195145606995,
              0.906588613986969,
              0.9064449667930603,
              0.8474926948547363,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.43125,
            "scores": [
              0.5,
              0.95,
              0.5,
              0.5,
              0.5,
              0.5,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.125,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.75,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 8,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8884787559509277,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454211329,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454211323,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 79.0,
                "prediction": 79
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "nephrotoxicity during 12-year follow-up",
                "prediction": "Kidney transplant recipients treated with tacrolimus"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.026",
                "prediction": "= 0.029"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 11.652,
                "prediction": 0.116
              },
              "Confidence Interval Start": {
                "ground_truth": 1.509,
                "prediction": 0.019
              },
              "Confidence Interval Stop": {
                "ground_truth": 89.957,
                "prediction": 0.726
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9125195145606995,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.95,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454211336,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454211330,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 79.0,
                "prediction": 79
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "acute rejection during 12-year follow-up, recipient",
                "prediction": "Kidney transplant recipients treated with tacrolimus"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.047",
                "prediction": "= 0.048"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 0.099
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.012
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 0.85
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9125195145606995,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454211346,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454211340,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 79.0,
                "prediction": 79
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "acute rejection during 12-year follow-up, recipient",
                "prediction": "Kidney transplant recipients treated with tacrolimus"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.024",
                "prediction": "= 0.021"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 4.133
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 1.301
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 13.125
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.906588613986969,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454211353,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454211347,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 79.0,
                "prediction": 79
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "acute rejection during 12-year follow-up, donor",
                "prediction": "Kidney transplant recipients treated with tacrolimus"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.027",
                "prediction": "= 0.016"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 0.133
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.028
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 0.643
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9064449667930603,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454211406,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454211400,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 79.0,
                "prediction": 79
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "nephrotoxicity during 12-year follow-up, donor",
                "prediction": "Kidney transplant recipients treated with tacrolimus"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.024",
                "prediction": "= 0.009"
              },
              "Ratio Stat Type": {
                "ground_truth": "Unknown",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 0.076
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.012
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 0.492
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 5,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8474926948547363,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454211277,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454211271,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 79.0,
                "prediction": 79
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "survival during 12-year follow-up",
                "prediction": "Kidney transplant recipients treated with tacrolimus"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.003",
                "prediction": "= 0.020"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 0.048
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.004
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 0.559
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:nephrotoxicity durin",
          "None:acute rejection duri",
          "None:acute rejection duri",
          "None:acute rejection duri",
          "None:nephrotoxicity durin",
          "None:survival during 12-y"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1454211266,
            "Variant Annotation ID": 1454211260,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "exitus during 12-year follow-up",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.029",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211260"
          },
          {
            "Study Parameters ID": 1454211300,
            "Variant Annotation ID": 1454211280,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "survival during 12-year follow-up",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.138",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211280"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC12035587": {
      "var-pheno": {
        "overall_score": 0.9106903374195099,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Alleles": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Direction of effect": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.9641420245170593,
            "scores": [
              0.9641420245170593
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          }
        },
        "total_samples": 1,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9641420245170593,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "NUDT15*3",
                "prediction": "NUDT15"
              },
              "Gene": {
                "ground_truth": "NUDT15",
                "prediction": "NUDT15"
              },
              "Drug(s)": {
                "ground_truth": "mercaptopurine",
                "prediction": "mercaptopurine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*3/*3",
                "prediction": "*3/*3"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Myelosuppression, Side Effect:Toxic liver disease, Side Effect:Alopecia",
                "prediction": "severe myelosuppression, hepatotoxicity, alopecia"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": ""
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA166131621"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "*3/*3",
            "Gene": "NUDT15",
            "Drug(s)": "mercaptopurine",
            "PMID": 40099566,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Severe myelosuppression, hepatotoxicity, and alopecia observed after thiopurine initiation in a patient with homozygous *3/*3 loss\u2010of\u2010function alleles in the NUDT15 gene.",
            "Sentence": "NUDT15 *3/*3 is associated with increased risk of severe myelosuppression, hepatotoxicity, and alopecia when treated with mercaptopurine in a South Asian female with acute promyelocytic leukaemia.",
            "Alleles": "*3/*3",
            "Specialty Population": "Pediatric",
            "Metabolizer types": "poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "severe myelosuppression, hepatotoxicity, alopecia",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:acute promyelocytic leukaemia",
            "Multiple phenotypes or diseases And/or": "",
            "Comparison Allele(s) or Genotype(s)": "",
            "Comparison Metabolizer types": "",
            "Citations": [
              "\"We present a case of thiopurine toxicity resulting in severe myelosuppression, hepatotoxicity and alopecia in an individual with homozygous *3/*3 loss\u2010of\u2010function alleles in the NUDT15 gene.\"",
              "\"The patient underwent genetic testing and was found to have wildtype alleles in the thiopurine\u2010S\u2010methyltransferase (*TPMT*) gene, but homozygous loss\u2010of\u2010function alleles in the *NUDT15* gene (c.415C > T; *3/*3), resulting in complete loss of NUDT15 protein function.\"",
              "\"Our case also adds to a handful of existing reports suggesting that alopecia may be an early manifestation of thiopurine toxicity.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "NUDT15 *3/*3",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "mercaptopurine",
              "drug_id": "PA450379",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.7968936244646708,
        "field_scores": {
          "Study Type": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.9534043669700623,
            "scores": [
              0.9534043669700623
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "P Value": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          }
        },
        "total_samples": 1,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9534043669700623,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1453076188,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1453076180,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case series",
                "prediction": "case series"
              },
              "Study Cases": {
                "ground_truth": 0.0,
                "prediction": 1.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "41-year-old South Asian female, severe mercaptopurine toxicity secondary to an inherited NUDT15 protein deficiency, resulting in myelosuppression, hepatotoxicity and alopecia.",
                "prediction": "41-year-old South Asian female with high-risk acute promyelocytic leukaemia treated with mercaptopurine"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": null,
                "prediction": null
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Central/South Asian",
                "prediction": "South Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "case series:41-year-old South As"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": []
      }
    },
    "PMC6465603": {
      "var-pheno": {
        "overall_score": 0.44885828470190364,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.4526715576648712,
            "scores": [
              0.9053431153297424,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.47864603996276855,
            "scores": [
              0.9572920799255371,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9053431153297424,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9572920799255371,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs116855232",
                "prediction": "rs116855232"
              },
              "Gene": {
                "ground_truth": "NUDT15",
                "prediction": "NUDT15"
              },
              "Drug(s)": {
                "ground_truth": "azathioprine",
                "prediction": "azathioprine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CT + TT",
                "prediction": "T"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Leukopenia",
                "prediction": "leukopenia"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA166154759"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1451237464,
            "Variant/Haplotypes": "rs1142345",
            "Gene": "TPMT",
            "Drug(s)": "azathioprine",
            "PMID": 31024313,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "TPMT\u22173C alleles were only observed in four subjects including 3 patients who were heterozygotes (TC) and 1 patient who was homozygous (CC).Authors state in discussion \"the lack of significance observed for rs1142345 in the present study is likely due to its low prevalence in East Asian populations and the small sample size of our cohort.\"",
            "Sentence": "Allele C is not associated with increased likelihood of Leukopenia when treated with azathioprine in people with Hepatitis, Autoimmune as compared to allele T.",
            "Alleles": "C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Leukopenia",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Autoimmune hepatitis",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "T",
            "Comparison Metabolizer types": null,
            "PMID_norm": "31024313",
            "Variant Annotation ID_norm": "1451237464",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1142345",
              "variant_id": "PA166156978",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "azathioprine",
              "drug_id": "PA448515",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.24739948709805806,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.46099230647087097,
            "scores": [
              0.9219846129417419,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.25,
            "scores": [
              0.5,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.9219846129417419,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1451237506,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1451237500,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 12.0,
                "prediction": 149
              },
              "Study Controls": {
                "ground_truth": 137.0,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "AZA-induced leukopenia in Chinese patients with AIH",
                "prediction": "Chinese patients with autoimmune hepatitis and related cirrhosis treated with azathioprine"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.0001",
                "prediction": "< 0.00001"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 89.47,
                "prediction": 20.41
              },
              "Confidence Interval Start": {
                "ground_truth": 10.78,
                "prediction": 7.84
              },
              "Confidence Interval Stop": {
                "ground_truth": 742.53,
                "prediction": 53.13
              },
              "Biogeographical Groups": {
                "ground_truth": null,
                "prediction": "Asian"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "case/control:AZA-induced leukopen"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1451237470,
            "Variant Annotation ID": 1451237464,
            "Study Type": "case/control",
            "Study Cases": 12.0,
            "Study Controls": 137.0,
            "Characteristics": "AZA-induced leukopenia in Chinese patients with AIH",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.042,
            "Allele Of Frequency In Cases": "C",
            "Frequency In Controls": 0.015,
            "Allele Of Frequency In Controls": "C",
            "P Value": "= 0.283",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": null,
            "Variant Annotation ID_norm": "1451237464"
          }
        ],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "retrospective",
            "Study Cases": 149,
            "Study Controls": null,
            "Characteristics": "Chinese patients with autoimmune hepatitis and related cirrhosis treated with azathioprine",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.028",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": 0.95,
            "Confidence Interval Stop": 1.53,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "retrospective",
            "Study Cases": 149,
            "Study Controls": null,
            "Characteristics": "Chinese patients with autoimmune hepatitis and related cirrhosis treated with azathioprine",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.00001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 20.41,
            "Confidence Interval Start": 7.84,
            "Confidence Interval Stop": 53.13,
            "Biogeographical Groups": "Asian",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC3839910": {
      "var-pheno": {
        "overall_score": 0.31529534856478375,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.16666666666666666,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.3084387580553691,
            "scores": [
              0.9858835935592651,
              0.8647489547729492,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 6,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9858835935592651,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*15:02",
                "prediction": "HLA-B*15:02"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "carbamazepine",
                "prediction": "carbamazepine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*15:02",
                "prediction": "*15:02"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Disease:Stevens-Johnson Syndrome",
                "prediction": "Stevens-Johnson Syndrome"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 1.0,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8647489547729492,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-A*31:01",
                "prediction": "HLA-A*31:01"
              },
              "Gene": {
                "ground_truth": "HLA-A",
                "prediction": "HLA-A"
              },
              "Drug(s)": {
                "ground_truth": "carbamazepine",
                "prediction": "carbamazepine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*31:01",
                "prediction": "*31:01"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Disease:Stevens-Johnson Syndrome",
                "prediction": "hypersensitivity syndrome, maculopapular exanthems"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA165954769",
          "PA165954030"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 994531642,
            "Variant/Haplotypes": "HLA-B*15:02",
            "Gene": "HLA-B",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": null,
            "Sentence": "HLA-B *15:02 is not associated with increased risk of Maculopapular Exanthema when treated with carbamazepine in children.",
            "Alleles": "*15:02",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Maculopapular Exanthema",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "994531642",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:02",
              "variant_id": "PA165954769",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "carbamazepine",
              "drug_id": "PA448785",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 993813998,
            "Variant/Haplotypes": "HLA-A*31:01",
            "Gene": "HLA-A",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": null,
            "Sentence": "HLA-A *31:01 is associated with increased risk of Maculopapular Exanthema when treated with carbamazepine in children.",
            "Alleles": "*31:01",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Disease:Maculopapular Exanthema",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "993813998",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-A*31:01",
              "variant_id": "PA165954030",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "carbamazepine",
              "drug_id": "PA448785",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 992282434,
            "Variant/Haplotypes": "HLA-A*31:01",
            "Gene": "HLA-A",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": null,
            "Sentence": "HLA-A *31:01 is associated with increased risk of Carbamazepine-induced hypersensitivity syndrome when treated with carbamazepine in children.",
            "Alleles": "*31:01",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Carbamazepine-induced hypersensitivity syndrome",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "992282434",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-A*31:01",
              "variant_id": "PA165954030",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "carbamazepine",
              "drug_id": "PA448785",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 994398056,
            "Variant/Haplotypes": "HLA-B*15:02",
            "Gene": "HLA-B",
            "Drug(s)": "carbamazepine",
            "PMID": 23588310,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": null,
            "Sentence": "HLA-B *15:02 is not associated with increased risk of Carbamazepine-induced hypersensitivity syndrome (HSS) when treated with carbamazepine in children.",
            "Alleles": "*15:02",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Carbamazepine-induced hypersensitivity syndrome (HSS)",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "23588310",
            "Variant Annotation ID_norm": "994398056",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*15:02",
              "variant_id": "PA165954769",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "carbamazepine",
              "drug_id": "PA448785",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.520684165292316,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.5935958127180735,
            "scores": [
              0.9173092842102051,
              0.925166666507721,
              0.8638383746147156,
              0.8552605509757996,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.4166666666666667,
            "scores": [
              1.0,
              0.5,
              0.5,
              0.5,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.4666666666666666,
            "scores": [
              1.0,
              0.8,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 6,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9173092842102051,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 993728141,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 992282434,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 42.0,
                "prediction": 42
              },
              "Study Controls": {
                "ground_truth": 91.0,
                "prediction": 91
              },
              "Characteristics": {
                "ground_truth": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
                "prediction": "Children with carbamazepine hypersensitivity reactions"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.0025",
                "prediction": "= 0.0025"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 26.4,
                "prediction": 26.4
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 2.53
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 307.89
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.925166666507721,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.8,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 993818102,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 993813998,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 42.0,
                "prediction": 42
              },
              "Study Controls": {
                "ground_truth": 91.0,
                "prediction": 91
              },
              "Characteristics": {
                "ground_truth": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
                "prediction": "All CBZ hypersensitivity cases"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.0037",
                "prediction": "= 2.6\u00d710^-4"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 8.6,
                "prediction": 8.14
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 2.25
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 37.34
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8638383746147156,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 994166721,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 994166507,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 42.0,
                "prediction": 9
              },
              "Study Controls": {
                "ground_truth": 91.0,
                "prediction": 91
              },
              "Characteristics": {
                "ground_truth": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
                "prediction": "Children with Stevens-Johnson syndrome"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.002",
                "prediction": "= 0.0022"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 38.6,
                "prediction": 38.6
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 2.68
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 2239.5
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8552605509757996,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 994531644,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 994531642,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 42.0,
                "prediction": 26
              },
              "Study Controls": {
                "ground_truth": 91.0,
                "prediction": 91
              },
              "Characteristics": {
                "ground_truth": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
                "prediction": "Children with maculopapular exanthems"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 1.0",
                "prediction": "= 0.0037"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.09,
                "prediction": 8.6
              },
              "Confidence Interval Start": {
                "ground_truth": 0.04,
                "prediction": 1.67
              },
              "Confidence Interval Stop": {
                "ground_truth": 27.5,
                "prediction": 57.5
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "case/control:pediatric patients f",
          "case/control:pediatric patients f",
          "case/control:pediatric patients f",
          "case/control:pediatric patients f"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 993944507,
            "Variant Annotation ID": 993944301,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 1.0",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 1.33,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "993944301"
          },
          {
            "Study Parameters ID": 994398281,
            "Variant Annotation ID": 994398056,
            "Study Type": "case/control",
            "Study Cases": 42.0,
            "Study Controls": 91.0,
            "Characteristics": "pediatric patients from North America with a diverse ethnic background, 42 children with CBZ hypersensitivity and 91 CBZ-tolerant children from across Canada.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 1.0",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 4.44,
            "Confidence Interval Start": 0.16,
            "Confidence Interval Stop": 120.0,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "994398056"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC3584248": {
      "var-drug": {
        "overall_score": 0.1490730028403433,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "PMID": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.1774076759815216,
            "scores": [
              0.8781163096427917,
              0.8959604501724243,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Specialty Population": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "isPlural": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.1,
            "scores": [
              0.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Population types": {
            "mean_score": 0.18084110021591188,
            "scores": [
              0.9042055010795593,
              0.9042055010795593,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.1962343454360962,
            "scores": [
              0.981171727180481,
              0.981171727180481,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.17790393233299256,
            "scores": [
              0.886114239692688,
              0.8929250836372375,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 10,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8781163096427917,
              "Specialty Population": 1.0,
              "Metabolizer types": 0.0,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.9042055010795593,
              "Population Phenotypes or diseases": 0.981171727180481,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.886114239692688,
              "Comparison Metabolizer types": 0.0,
              "Drug(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2D6*1",
                "prediction": "CYP2D6*1/*1"
              },
              "Gene": {
                "ground_truth": "CYP2D6",
                "prediction": "CYP2D6"
              },
              "PMID": {
                "ground_truth": 23476897,
                "prediction": 23476897
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
                "prediction": "CYP2D6*1/*1"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": "normal metabolizer"
              },
              "isPlural": {
                "ground_truth": "Are",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "increased"
              },
              "PD/PK terms": {
                "ground_truth": "concentrations of",
                "prediction": "concentrations of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in women with",
                "prediction": "in Filipino and Vietnamese women"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Disease:Breast Neoplasms",
                "prediction": "Disease:Breast Cancer"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1 + *1/*2 + *2/*2",
                "prediction": "CYP2D6*10/*10"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": "intermediate metabolizer"
              },
              "Drug(s)": {
                "ground_truth": "endoxifen",
                "prediction": "tamoxifen"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8959604501724243,
              "Specialty Population": 1.0,
              "Metabolizer types": 0.0,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 1.0,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.9042055010795593,
              "Population Phenotypes or diseases": 0.981171727180481,
              "Multiple phenotypes or diseases And/or": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8929250836372375,
              "Comparison Metabolizer types": 0.0,
              "Drug(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2D6*10",
                "prediction": "CYP2D6*10/*10"
              },
              "Gene": {
                "ground_truth": "CYP2D6",
                "prediction": "CYP2D6"
              },
              "PMID": {
                "ground_truth": 23476897,
                "prediction": 23476897
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
                "prediction": "CYP2D6*10/*10"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": "intermediate metabolizer"
              },
              "isPlural": {
                "ground_truth": "Are",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "PD/PK terms": {
                "ground_truth": "concentrations of",
                "prediction": "concentrations of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in women with",
                "prediction": "in Filipino and Vietnamese women"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Disease:Breast Neoplasms",
                "prediction": "Disease:Breast Cancer"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1 + *1/*2 + *2/*2",
                "prediction": "CYP2D6*1/*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": "normal metabolizer"
              },
              "Drug(s)": {
                "ground_truth": "endoxifen",
                "prediction": "tamoxifen"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cyp2d6*1",
          "cyp2d6*10"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1444930388,
            "Variant/Haplotypes": "CYP2D6*2",
            "Gene": "CYP2D6",
            "Drug(s)": "endoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes] An additional nested case-control study (n=48) showed an  increased risk of recurrence at low and high (>70 ng/ml) endoxifen concentrations.",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are associated with decreased concentrations of endoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930388",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "endoxifen",
              "drug_id": "PA166124478",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444930388,
            "Variant/Haplotypes": "CYP2D6*5",
            "Gene": "CYP2D6",
            "Drug(s)": "endoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes] An additional nested case-control study (n=48) showed an  increased risk of recurrence at low and high (>70 ng/ml) endoxifen concentrations.",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are associated with decreased concentrations of endoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930388",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "endoxifen",
              "drug_id": "PA166124478",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444930388,
            "Variant/Haplotypes": "CYP2D6*41",
            "Gene": "CYP2D6",
            "Drug(s)": "endoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes] An additional nested case-control study (n=48) showed an  increased risk of recurrence at low and high (>70 ng/ml) endoxifen concentrations.",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are associated with decreased concentrations of endoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930388",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "endoxifen",
              "drug_id": "PA166124478",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444930474,
            "Variant/Haplotypes": "CYP2D6*1",
            "Gene": "CYP2D6",
            "Drug(s)": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "no",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes]",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are not associated with decreased concentrations of 4-hydroxytamoxifen, n-desmethyltamoxifen and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": "and",
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930474",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444930474,
            "Variant/Haplotypes": "CYP2D6*2",
            "Gene": "CYP2D6",
            "Drug(s)": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "no",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes]",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are not associated with decreased concentrations of 4-hydroxytamoxifen, n-desmethyltamoxifen and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": "and",
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930474",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444930474,
            "Variant/Haplotypes": "CYP2D6*5",
            "Gene": "CYP2D6",
            "Drug(s)": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "no",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes]",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are not associated with decreased concentrations of 4-hydroxytamoxifen, n-desmethyltamoxifen and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": "and",
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930474",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444930474,
            "Variant/Haplotypes": "CYP2D6*10",
            "Gene": "CYP2D6",
            "Drug(s)": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "no",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes]",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are not associated with decreased concentrations of 4-hydroxytamoxifen, n-desmethyltamoxifen and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": "and",
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930474",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1444930474,
            "Variant/Haplotypes": "CYP2D6*41",
            "Gene": "CYP2D6",
            "Drug(s)": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
            "PMID": 23476897,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "no",
            "Notes": "No information on menopausal status or if tamoxifen only treatment. No co-treatment with CYP2D6 inhibitors CYP2D6 alleles *2, *3, *4, *5, *6, *10, and *41 are genotyped with predeveloped TaqMan Genotyping Assays. Genotypes were categorized as normal (fully functional CYP2D6 alleles: *1 and *2 -*1/*1, *1/*2, *2/*2), intermediate (alleles associated with reduced enzyme activity: heterozygous for *10 and *41-*1/*10, *2/*10, *1/*41), and slow (homozygous for *10, *41 variants and one or more non-functional null alleles: *3-*6-*10/*10, *10/*41, *1/*5, *2/*5, *5/*10). [pre-menopausal][post-menopausal] [adjuvant]  [DNA source: leukocytes] [HWE: Vietnamese *1, 2, 4, 5, 10, 41 yes Filipino *1 and *2 no rest yes]",
            "Sentence": "CYP2D6 *10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10 are not associated with decreased concentrations of 4-hydroxytamoxifen, n-desmethyltamoxifen and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*2 + *2/*2.",
            "Alleles": "*10/*10 + *10/*41 + *1/*5 + *2/*5 + *5/*10",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Multiple drugs And/or": "and",
            "Population types": "in women with",
            "Population Phenotypes or diseases": "Disease:Breast Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *2/*2",
            "Comparison Metabolizer types": null,
            "PMID_norm": "23476897",
            "Variant Annotation ID_norm": "1444930474",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "4-hydroxytamoxifen, N-desmethyltamoxifen, tamoxifen",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "CYP2D6*3-*6",
            "Gene": "CYP2D6",
            "Drug(s)": "tamoxifen",
            "PMID": 23476897,
            "Phenotype Category": "metabolism/PK",
            "Significance": "yes",
            "Notes": "p = 0.0001 for trend: normal > intermediate > slow",
            "Sentence": "Genotypes CYP2D6*3-*6 are associated with decreased concentrations of endoxifen in Filipino and Vietnamese women with operable breast cancer as compared to genotype CYP2D6*1/*1.",
            "Alleles": "CYP2D6*3-*6",
            "Specialty Population": null,
            "Metabolizer types": "slow metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "concentrations of",
            "Population types": "in Filipino and Vietnamese women",
            "Population Phenotypes or diseases": "Disease:Breast Cancer",
            "Multiple drugs And/or": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CYP2D6*1/*1",
            "Comparison Metabolizer types": "normal metabolizer",
            "Citations": [
              "\"We found a significant association of reduced endoxifen plasma concentrations with functionally important CYP2D6 genotypes.\"",
              "\"Endoxifen plasma concentrations by CYP2D6 genotype metabolic status in Filipino (n = 138) and Vietnamese (n = 86) patients (p = 0.0001 for trend: normal > intermediate > slow).\"",
              "\"CYP2D6 genotypes were also associated with concentrations of 4-hydroxytamoxifen, another active metabolite of tamoxifen, although this association was less strong, consistent with the partial role CYP2D6 plays in its formation.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs3892097",
              "variant_id": "PA166156104",
              "confidence": 0.8
            },
            "Drug(s)_normalized": {
              "normalized": "tamoxifen",
              "drug_id": "PA451581",
              "confidence": 1.0
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.33724453250567116,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.43366798758506775,
            "scores": [
              0.8774243593215942,
              0.8572475910186768,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.125,
            "scores": [
              0.0,
              0.5,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 4,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8774243593215942,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1444930476,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1444930474,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "clinical trial",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 224.0,
                "prediction": 224.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "endpoint: tamoxifen concentration after 4 month; slow vs normal metabolizer; p = 0.39 for trend: normal > intermediate > slow",
                "prediction": "Filipino and Vietnamese women receiving adjuvant tamoxifen"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.39",
                "prediction": null
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": null
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8572475910186768,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1444930497,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1444930474,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "clinical trial",
                "prediction": "nested-case\u2013control"
              },
              "Study Cases": {
                "ground_truth": 224.0,
                "prediction": 48.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": 48.0
              },
              "Characteristics": {
                "ground_truth": "endpoint: 4-hydroxytamoxifen concentration after 4 month; slow vs normal metabolizer; p = 0.13 for trend: normal > intermediate > slow",
                "prediction": "Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.13",
                "prediction": "= 0.002"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "clinical trial:endpoint: tamoxifen ",
          "clinical trial:endpoint: 4-hydroxyt"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1444930473,
            "Variant Annotation ID": 1444930388,
            "Study Type": "clinical trial",
            "Study Cases": 224.0,
            "Study Controls": null,
            "Characteristics": "endpoint: endoxifen concentration after 4 month; slow vs normal metabolizer; p = 0.0001 for trend: normal > intermediate > slow",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.0001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1444930388"
          },
          {
            "Study Parameters ID": 1444930499,
            "Variant Annotation ID": 1444930474,
            "Study Type": "clinical trial",
            "Study Cases": 224.0,
            "Study Controls": null,
            "Characteristics": "endpoint: N-desmethyltamoxifen concentration after 4 month; slow vs normal metabolizer; p = 0.06 for trend: normal > intermediate > slow",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.06",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1444930474"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC10786722": {
      "var-fa": {
        "overall_score": 0.3117399950822194,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "PMID": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.29027215639750165,
            "scores": [
              0.8708164691925049,
              0.0,
              0.0
            ]
          },
          "Specialty Population": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Assay type": {
            "mean_score": 0.3278041084607442,
            "scores": [
              0.9834123253822327,
              0.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "isPlural": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Functional terms": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Gene/gene product": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Cell type": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.28339030345280963,
            "scores": [
              0.850170910358429,
              0.0,
              0.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.8708164691925049,
              "Specialty Population": 1.0,
              "Assay type": 0.9834123253822327,
              "Metabolizer types": 1.0,
              "isPlural": 1.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Functional terms": 1.0,
              "Gene/gene product": 1.0,
              "When treated with/exposed to/when assayed with": 0.0,
              "Multiple drugs And/or": 1.0,
              "Cell type": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.850170910358429,
              "Comparison Metabolizer types": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs56038477",
                "prediction": "rs56038477"
              },
              "Gene": {
                "ground_truth": "DPYD",
                "prediction": "DPYD"
              },
              "Drug(s)": {
                "ground_truth": null,
                "prediction": null
              },
              "PMID": {
                "ground_truth": 38216550,
                "prediction": 38216550
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": "CT + TT",
                "prediction": "*1/*1"
              },
              "Specialty Population": {
                "ground_truth": null,
                "prediction": null
              },
              "Assay type": {
                "ground_truth": "plasma dihydrouracil/uracil",
                "prediction": "plasma dihydrouracil/uracil ratio"
              },
              "Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Is"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Functional terms": {
                "ground_truth": "activity of",
                "prediction": "activity of"
              },
              "Gene/gene product": {
                "ground_truth": "DPYD",
                "prediction": "DPYD"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": null,
                "prediction": "when assayed with"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Cell type": {
                "ground_truth": null,
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": "*1/*1"
              },
              "Comparison Metabolizer types": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "PA166153889"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1452352325,
            "Variant/Haplotypes": "rs1801160",
            "Gene": "DPYD",
            "Drug(s)": null,
            "PMID": 38216550,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"The association between common DPYD genetic variants (MAF\u2009\u2265\u20091%) and DPD activity is summarized in Fig. 2. Among the seven genetic variants identified, three variants (c.1236G>A or rs56038477 p.Glu412Glu ; c.496A>G or rs2297595 p.Met166Val; DPYD*6 c.2194G>A or rs1801160 p.Val732Ile) were significantly more frequent in the group of patients exhibiting partial DPD deficiency. Consistent with previous reports, the c.1236G>A (rs56038477) which is included in the risk haplotype B3 was significantly associated with low DPD activity [30, 31]. Nevertheless, compared to the most clinically relevant DPYD defective variants, the association of these three variants with DPD activity was rather modest (Fig. 2).",
            "Sentence": "Genotypes CT + TT is associated with decreased activity of DPYD as compared to genotype CC.",
            "Alleles": "CT + TT",
            "Specialty Population": null,
            "Assay type": "plasma dihydrouracil/uracil",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "activity of",
            "Gene/gene product": "DPYD",
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38216550",
            "Variant Annotation ID_norm": "1452352325",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1801160",
              "variant_id": "PA166153647",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": null,
              "drug_id": null,
              "confidence": 0.0
            }
          },
          {
            "Variant Annotation ID": 1452352320,
            "Variant/Haplotypes": "rs2297595",
            "Gene": "DPYD",
            "Drug(s)": null,
            "PMID": 38216550,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "\"The association between common DPYD genetic variants (MAF\u2009\u2265\u20091%) and DPD activity is summarized in Fig. 2. Among the seven genetic variants identified, three variants (c.1236G>A or rs56038477 p.Glu412Glu ; c.496A>G or rs2297595 p.Met166Val; DPYD*6 c.2194G>A or rs1801160 p.Val732Ile) were significantly more frequent in the group of patients exhibiting partial DPD deficiency. Consistent with previous reports, the c.1236G>A (rs56038477) which is included in the risk haplotype B3 was significantly associated with low DPD activity [30, 31]. Nevertheless, compared to the most clinically relevant DPYD defective variants, the association of these three variants with DPD activity was rather modest (Fig. 2).",
            "Sentence": "Genotypes CC + CT is associated with decreased activity of DPYD as compared to genotype TT.",
            "Alleles": "CC + CT",
            "Specialty Population": null,
            "Assay type": "plasma dihydrouracil/uracil",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "activity of",
            "Gene/gene product": "DPYD",
            "When treated with/exposed to/when assayed with": null,
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "TT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38216550",
            "Variant Annotation ID_norm": "1452352320",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs2297595",
              "variant_id": "PA166153696",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": null,
              "drug_id": null,
              "confidence": 0.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "c.1905+1G>A",
            "Gene": "DPYD",
            "Drug(s)": null,
            "PMID": 38216550,
            "Phenotype Category": "metabolism/PK",
            "Significance": "yes",
            "Notes": "c.1905+1G>A was significantly associated with low DPD activity (P < 0.001).",
            "Sentence": "c.1905+1G>A is associated with decreased DPD activity when assayed with plasma uracil and dihydrouracil as compared to wild-type.",
            "Alleles": "*2A",
            "Specialty Population": null,
            "Assay type": "plasma dihydrouracil/uracil ratio",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "activity of",
            "Gene/gene product": "DPYD",
            "When treated with/exposed to/when assayed with": "when assayed with",
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "\"Dose adjustment based on pretreatment screening for the most clinically relevant DPYD defective variants, i.e. c.1679T>G (DPYD13, rs55886062), c.1905+1G>A (DPYD2A, rs3918290) and c.2846A>T (p.Asp949Val or rs67376798), has been shown to improve the safety of chemotherapy regimens based on fluorouracil.\"",
              "\"As expected, our data showed a significant association between each of these genetic variants and low DPD activity (Fig. 1).\"",
              "\"Our results also show that rare DPYD genetic variants account for a significative part of the interindividual variability of DPD activity.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "c.1905+1G>A",
              "variant_id": null,
              "confidence": 0.0
            }
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "c.1679T>G",
            "Gene": "DPYD",
            "Drug(s)": null,
            "PMID": 38216550,
            "Phenotype Category": "metabolism/PK",
            "Significance": "yes",
            "Notes": "c.1679T>G was significantly associated with low DPD activity (P < 0.001).",
            "Sentence": "c.1679T>G is associated with decreased DPD activity when assayed with plasma uracil and dihydrouracil as compared to wild-type.",
            "Alleles": "*13",
            "Specialty Population": null,
            "Assay type": "plasma dihydrouracil/uracil ratio",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Functional terms": "activity of",
            "Gene/gene product": "DPYD",
            "When treated with/exposed to/when assayed with": "when assayed with",
            "Multiple drugs And/or": null,
            "Cell type": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "\"Dose adjustment based on pretreatment screening for the most clinically relevant DPYD defective variants, i.e. c.1679T>G (DPYD13, rs55886062), c.1905+1G>A (DPYD2A, rs3918290) and c.2846A>T (p.Asp949Val or rs67376798), has been shown to improve the safety of chemotherapy regimens based on fluorouracil.\"",
              "\"As expected, our data showed a significant association between each of these genetic variants and low DPD activity (Fig. 1).\"",
              "\"Our results also show that rare DPYD genetic variants account for a significative part of the interindividual variability of DPD activity.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "c.1679T>G",
              "variant_id": null,
              "confidence": 0.0
            }
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.6695802066061233,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.877036432425181,
            "scores": [
              0.8873451352119446,
              0.8469565510749817,
              0.8968076109886169
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.5,
            "scores": [
              0.5,
              0.5,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8873451352119446,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452352264,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452352260,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 855.0,
                "prediction": 2972
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "plasma dihydrouracil/uracil",
                "prediction": "Patients eligible for uracil analog-based chemotherapy"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.05",
                "prediction": "< 0.00001"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8469565510749817,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452352360,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452352325,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 1055.0,
                "prediction": 446
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "plasma dihydrouracil/uracil",
                "prediction": "Patients harboring at least one genetic variant"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.01",
                "prediction": "< 0.00001"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8968076109886169,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452352324,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452352320,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 1265.0,
                "prediction": 628
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "plasma dihydrouracil/uracil",
                "prediction": "Patients with DPD deficiency identified by [U] and [UH2]/[U] values"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.01",
                "prediction": "< 0.00001"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "European"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:plasma dihydrouracil",
          "None:plasma dihydrouracil",
          "None:plasma dihydrouracil"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "retrospective",
            "Study Cases": 580,
            "Study Controls": null,
            "Characteristics": "Patients with partial DPD deficiency",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.00001",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC4916189": {
      "var-pheno": {
        "overall_score": 0.7167461536203822,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.25,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.875,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.875,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.5,
            "scores": [
              0.0,
              0.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.8206127360463142,
            "scores": [
              0.8396958112716675,
              0.839335560798645,
              0.9980491399765015,
              0.973807692527771,
              0.973807692527771,
              0.9427328109741211,
              0.9974731802940369,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.875,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.875,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.8100173696875572,
            "scores": [
              0.9333196878433228,
              0.8651432394981384,
              0.9370890855789185,
              0.9370890855789185,
              0.9370890855789185,
              0.9370890855789185,
              0.9333196878433228,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.875,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 8,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.8396958112716675,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9333196878433228,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*1",
                "prediction": "CYP2B6"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "discontinuation"
              },
              "Alleles": {
                "ground_truth": "*9",
                "prediction": "GT, TT"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Discontinuation",
                "prediction": "overall discontinuation"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.839335560798645,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8651432394981384,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2B6*1",
                "prediction": "CYP2B6"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*9",
                "prediction": "CT, TT"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Discontinuation",
                "prediction": "CNS-related adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9980491399765015,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9370890855789185,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4803419",
                "prediction": "15582CT/TT"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CT + TT",
                "prediction": "CT, TT"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.973807692527771,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9370890855789185,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs28399499",
                "prediction": "CYP2B6"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CC + CT",
                "prediction": "TC, CC"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "TT",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.973807692527771,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9370890855789185,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs28399499",
                "prediction": "983TC/CC"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CC + CT",
                "prediction": "TC, CC"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "TT",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 5,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9427328109741211,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9370890855789185,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs1045642",
                "prediction": "ABCB1"
              },
              "Gene": {
                "ground_truth": "ABCB1",
                "prediction": "ABCB1"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "AA",
                "prediction": "TT"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Central Nervous System Disorder",
                "prediction": "CNS-related adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "GG",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 6,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.9974731802940369,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9333196878433228,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs3745274",
                "prediction": "516GT/TT"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "efavirenz",
                "prediction": "efavirenz"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "discontinuation"
              },
              "Alleles": {
                "ground_truth": "GT + TT",
                "prediction": "GT, TT"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Discontinuation",
                "prediction": "overall discontinuation"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "GG",
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "cyp2b6*1",
          "cyp2b6*9",
          "cyp2b6+efavirenz",
          "cyp2b6+efavirenz",
          "abcb1+efavirenz",
          "cyp2b6+efavirenz",
          "cyp2b6+efavirenz"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1448993794,
            "Variant/Haplotypes": "rs2472677",
            "Gene": "NR1I2",
            "Drug(s)": "efavirenz",
            "PMID": 26715213,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": null,
            "Sentence": "Genotype TT is associated with decreased likelihood of discontinuation when treated with efavirenz in people with HIV Infections as compared to genotypes CC + CT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Discontinuation",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC + CT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26715213",
            "Variant Annotation ID_norm": "1448993794",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs2472677",
              "variant_id": "PA166156358",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "efavirenz",
              "drug_id": "PA449441",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "3435TT",
            "Gene": "ABCB1",
            "Drug(s)": "efavirenz",
            "PMID": 26715213,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Higher risk of CNS-related adverse events associated with ABCB1 3435TT (OR 2.31, 95% CI 1.33\u20134.02, p = 0.003)",
            "Sentence": "ABCB1 3435TT is associated with increased risk of CNS-related adverse events when treated with efavirenz in treatment-na\u00efve HIV-infected patients.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "Side Effect:CNS-related adverse events",
            "Phenotype": "CNS-related adverse events",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in treatment-na\u00efve HIV-infected patients",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "\"Lower risk of CNS-related adverse events was associated with CYP2B6 983TC/CC (OR 0.35, 95 % CI 0.15\u20130.81, p = 0.015) and higher risk was associated with CYP2B6 15582CT/TT and ABCB1 3435TT (OR 1.46, 95 % CI 1.02\u20132.09, p = 0.040; OR 2.31, 95 % CI 1.33\u20134.02, p = 0.003, respectively).\"",
              "\"Possession of the CYP2B6 516GT and TT variants and CYP2A6*9B CA/AA carriers was associated with a higher risk of overall EFV discontinuation (80, 166 and 100 %, respectively), whereas NR1I2 63396TT carriers were at decreased risk (22 %).\"",
              "\"CNS adverse events were similar between doses (42 % EFV400 vs. 46 % EFV600, p = 0.287).\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "ABCB1 3435TT",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "efavirenz",
              "drug_id": "PA449441",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.4542857142857143,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.6571428571428571,
            "scores": [
              1.0,
              0.8,
              1.0,
              1.0,
              0.8,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.7142857142857143,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.7142857142857143,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.7142857142857143,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.7142857142857143,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.7142857142857143,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.2857142857142857,
            "scores": [
              0.5,
              0.0,
              0.5,
              0.5,
              0.5,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.5714285714285714,
            "scores": [
              1.0,
              0.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.2571428571428572,
            "scores": [
              0.8,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.38571428571428573,
            "scores": [
              0.8,
              1.0,
              0.9,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.37142857142857144,
            "scores": [
              0.8,
              1.0,
              0.0,
              0.8,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.7142857142857143,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 7,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.8,
              "Confidence Interval Start": 0.8,
              "Confidence Interval Stop": 0.8,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448993822,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993820,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 606.0,
                "prediction": 606.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "CYP2B6 15582CT/TT and ABCB1 3435TT carriers"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.011",
                "prediction": "= 0.040"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.59,
                "prediction": 1.46
              },
              "Confidence Interval Start": {
                "ground_truth": 1.11,
                "prediction": 1.02
              },
              "Confidence Interval Stop": {
                "ground_truth": 2.27,
                "prediction": 2.09
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.8,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448993785,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993783,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 569.0,
                "prediction": 606.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "C12 between 0.47 and 0.76 mg/L"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.016",
                "prediction": null
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.9,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448993833,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993831,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 606.0,
                "prediction": 606.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Discontinuation due to adverse events (clinician decision)"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.006",
                "prediction": "= 0.016"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 2.14,
                "prediction": 2.54
              },
              "Confidence Interval Start": {
                "ground_truth": 1.25,
                "prediction": 1.19
              },
              "Confidence Interval Stop": {
                "ground_truth": 3.67,
                "prediction": 5.43
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.8,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448993812,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993810,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 606.0,
                "prediction": 606.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "CYP2B6 983TC/CC carriers"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "= 0.015"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 0.3,
                "prediction": 0.35
              },
              "Confidence Interval Start": {
                "ground_truth": 0.12,
                "prediction": 0.15
              },
              "Confidence Interval Stop": {
                "ground_truth": 0.75,
                "prediction": 0.81
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.8,
              "Study Controls": 1.0,
              "Characteristics": 0.0,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1448993769,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993767,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "cohort, clinical trial",
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 573.0,
                "prediction": 606.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": null,
                "prediction": "Treatment-na\u00efve HIV-infected adults; 32% female; 37% African, 33% Asian"
              },
              "Characteristics Type": {
                "ground_truth": "Unknown",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.01",
                "prediction": "= 0.204"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 5.25
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.41
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 67.9
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cohort, clinical trial",
          "cohort, clinical trial",
          "cohort, clinical trial",
          "cohort, clinical trial",
          "cohort, clinical trial"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1448993796,
            "Variant Annotation ID": 1448993794,
            "Study Type": "cohort, clinical trial",
            "Study Cases": 570.0,
            "Study Controls": null,
            "Characteristics": null,
            "Characteristics Type": "Unknown",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.008",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448993794"
          },
          {
            "Study Parameters ID": 1448993766,
            "Variant Annotation ID": 1448993759,
            "Study Type": "cohort, clinical trial",
            "Study Cases": 546.0,
            "Study Controls": null,
            "Characteristics": null,
            "Characteristics Type": "Unknown",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.42",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Multiple groups",
            "Variant Annotation ID_norm": "1448993759"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC10399933": {
      "var-pheno": {
        "overall_score": 0.24830093412172224,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.25622245243617464,
            "scores": [
              0.9050131440162659,
              0.8885440230369568,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.24011141913277761,
            "scores": [
              0.8365076184272766,
              0.8442723155021667,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.25791183539799284,
            "scores": [
              0.9026914238929749,
              0.9026914238929749,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 7,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9050131440162659,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8365076184272766,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9026914238929749
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4149056",
                "prediction": "SLCO1B1"
              },
              "Gene": {
                "ground_truth": "SLCO1B1",
                "prediction": "SLCO1B1"
              },
              "Drug(s)": {
                "ground_truth": "simvastatin",
                "prediction": "simvastatin"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CC",
                "prediction": "C/C"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Discontinuation",
                "prediction": "simvastatin intolerance"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "TT",
                "prediction": "T/T"
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8885440230369568,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8442723155021667,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9026914238929749
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs4149056",
                "prediction": "SLCO1B1"
              },
              "Gene": {
                "ground_truth": "SLCO1B1",
                "prediction": "SLCO1B1"
              },
              "Drug(s)": {
                "ground_truth": "pravastatin",
                "prediction": "pravastatin"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CC + CT",
                "prediction": "T/C or C/C"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Discontinuation",
                "prediction": "pravastatin intolerance"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "TT",
                "prediction": "T/T"
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "slco1b1+simvastatin",
          "slco1b1+pravastatin"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1452196120,
            "Variant/Haplotypes": "CYP2C9*1",
            "Gene": "CYP2C9",
            "Drug(s)": "fluvastatin",
            "PMID": 37490620,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "effect is described as \"Statin switch\" as measured by changes in prescription refills in the medical record, and attributed to muscle side effects (therefore tagged as toxicity). \"The sample sizes for fluvastatin and pravastatin were relatively small\"\"No statistically significant association was found for fluvastatin\"",
            "Sentence": "CYP2C9 *2/*2 + *2/*3 + *3/*3 (assigned as poor metabolizer phenotype) is not associated with increased risk of discontinuation when treated with fluvastatin as compared to CYP2C9 *1/*1 + *1/*2 + *1/*3 (assigned as intermediate metabolizer and normal metabolizer phenotype) .",
            "Alleles": "*2/*2 + *2/*3 + *3/*3",
            "Specialty Population": null,
            "Metabolizer types": "poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Discontinuation",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *1/*3",
            "Comparison Metabolizer types": "normal metabolizer and intermediate metabolizer",
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "1452196120",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "fluvastatin",
              "drug_id": "PA449688",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452196120,
            "Variant/Haplotypes": "CYP2C9*2",
            "Gene": "CYP2C9",
            "Drug(s)": "fluvastatin",
            "PMID": 37490620,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "effect is described as \"Statin switch\" as measured by changes in prescription refills in the medical record, and attributed to muscle side effects (therefore tagged as toxicity). \"The sample sizes for fluvastatin and pravastatin were relatively small\"\"No statistically significant association was found for fluvastatin\"",
            "Sentence": "CYP2C9 *2/*2 + *2/*3 + *3/*3 (assigned as poor metabolizer phenotype) is not associated with increased risk of discontinuation when treated with fluvastatin as compared to CYP2C9 *1/*1 + *1/*2 + *1/*3 (assigned as intermediate metabolizer and normal metabolizer phenotype) .",
            "Alleles": "*2/*2 + *2/*3 + *3/*3",
            "Specialty Population": null,
            "Metabolizer types": "poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Discontinuation",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *1/*3",
            "Comparison Metabolizer types": "normal metabolizer and intermediate metabolizer",
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "1452196120",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "fluvastatin",
              "drug_id": "PA449688",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452196120,
            "Variant/Haplotypes": "CYP2C9*3",
            "Gene": "CYP2C9",
            "Drug(s)": "fluvastatin",
            "PMID": 37490620,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "effect is described as \"Statin switch\" as measured by changes in prescription refills in the medical record, and attributed to muscle side effects (therefore tagged as toxicity). \"The sample sizes for fluvastatin and pravastatin were relatively small\"\"No statistically significant association was found for fluvastatin\"",
            "Sentence": "CYP2C9 *2/*2 + *2/*3 + *3/*3 (assigned as poor metabolizer phenotype) is not associated with increased risk of discontinuation when treated with fluvastatin as compared to CYP2C9 *1/*1 + *1/*2 + *1/*3 (assigned as intermediate metabolizer and normal metabolizer phenotype) .",
            "Alleles": "*2/*2 + *2/*3 + *3/*3",
            "Specialty Population": null,
            "Metabolizer types": "poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Discontinuation",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*2 + *1/*3",
            "Comparison Metabolizer types": "normal metabolizer and intermediate metabolizer",
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "1452196120",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "fluvastatin",
              "drug_id": "PA449688",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452196040,
            "Variant/Haplotypes": "rs4149056",
            "Gene": "SLCO1B1",
            "Drug(s)": "atorvastatin, fluvastatin, rosuvastatin",
            "PMID": 37490620,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "effect is described as \"Statin switch\" as measured by changes in prescription refills in the medical record, and attributed to muscle side effects (therefore tagged as toxicity). \"No significant association was observed with atorvastatin and rosuvastatin.\" \"The sample sizes for fluvastatin and pravastatin were relatively small\"\"No statistically significant association was found for fluvastatin\"",
            "Sentence": "Genotypes CC + CT is not associated with increased risk of discontinuation when treated with atorvastatin, fluvastatin or rosuvastatin as compared to genotype TT.",
            "Alleles": "CC + CT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Discontinuation",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "TT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "1452196040",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs4149056",
              "variant_id": "PA166154579",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "fluvastatin",
              "drug_id": "PA449688",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1452196080,
            "Variant/Haplotypes": "rs2231142",
            "Gene": "ABCG2",
            "Drug(s)": "atorvastatin, fluvastatin, rosuvastatin",
            "PMID": 37490620,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "effect is described as \"Statin switch\" as measured by changes in prescription refills in the medical record, and attributed to muscle side effects (therefore tagged as toxicity). \"No significant association was observed with atorvastatin and rosuvastatin.\" \"The sample sizes for fluvastatin and pravastatin were relatively small\"\"No statistically significant association was found for fluvastatin\" Alleles complemented to plus chromosomal strand.",
            "Sentence": "Genotypes GT + TT is not associated with increased risk of discontinuation when treated with atorvastatin, fluvastatin or rosuvastatin as compared to genotype GG.",
            "Alleles": "GT + TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Discontinuation",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "1452196080",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs2231142",
              "variant_id": "PA166156544",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "fluvastatin",
              "drug_id": "PA449688",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "c.521C/C",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin",
            "PMID": 37490620,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HR 1.88, P = 0.025 for statin switching; HR 5.44, P = 0.011 for statin switching with CK measurement.",
            "Sentence": "SLCO1B1 c.521C/C is associated with increased risk of simvastatin intolerance when treated with simvastatin in people initiating statin therapy.",
            "Alleles": "C/C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "simvastatin intolerance",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people initiating statin therapy",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "T/T",
            "Comparison Metabolizer types": null,
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "\"We confirmed the association of SLCO1B1 c.521C/C genotype with simvastatin intolerance both by using phenotype of switching initial statin to another as a marker of statin intolerance [hazard ratio (HR) 1.88, 95% confidence interval (CI) 1.08\u20133.25, P = 0.025] and statin switching along with creatine kinase measurement (HR 5.44, 95% CI 1.49\u201319.9, P = 0.011).\"",
              "\"In the Cox proportional hazards model accounting for the statin dose, SLCO1B1 c.521C/C genotype was associated with an increased risk of simvastatin intolerance when compared to homozygous reference T/T genotype using both statin switcher [hazard ratio (HR) 1.88, 95% confidence interval (CI) 1.08\u20133.25, P = 0.025] and statin switcher with CK measurement (HR 5.44, 95% CI 1.49\u201319.9, P = 0.011) phenotypes.\"",
              "\"The current study corroborates the well-characterized association of SLCO1B1 genotype with simvastatin intolerance in a real-world setting.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "SLCO1B1 c.521C/C",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "simvastatin",
              "drug_id": "PA451363",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "c.521T>C",
            "Gene": "SLCO1B1",
            "Drug(s)": "pravastatin",
            "PMID": 37490620,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HR 2.11, P = 0.047 for statin switching compared to T/T genotype.",
            "Sentence": "SLCO1B1 c.521T>C is associated with increased risk of pravastatin intolerance when treated with pravastatin in people initiating statin therapy.",
            "Alleles": "T/C or C/C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "pravastatin intolerance",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people initiating statin therapy",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "T/T",
            "Comparison Metabolizer types": null,
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "2",
            "Citations": [
              "\"The sample sizes for fluvastatin and pravastatin were relatively small, but SLCO1B1 c.521T>C carriers had an increased risk of pravastatin intolerance defined by statin switching when compared to homozygous reference T/T genotype (HR 2.11, 95% CI 1.01\u20134.39, P = 0.047).\"",
              "\"In addition to simvastatin, we observed that heterozygous or homozygous SLCO1B1 c.521T>C carriers had a higher risk of pravastatin intolerance based on statin switching phenotype when compared to reference allele homozygotes.\"",
              "\"The current study has several clinical implications. First, it corroborates the well-characterized association of SLCO1B1 genotype with simvastatin intolerance in a real-world setting. Second, despite limited numbers, the SLCO1B1 genotype associated with pravastatin intolerance at a dose range of 20\u201340 mg, supporting the role of OATP1B1 activity in pravastatin adverse effects.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "SLCO1B1 c.521T>C",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "pravastatin",
              "drug_id": "PA451089",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "SLCO1B1",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin",
            "PMID": 37490620,
            "Phenotype Category": "toxicity",
            "Significance": "no",
            "Notes": "No significant association observed with atorvastatin and rosuvastatin.",
            "Sentence": "SLCO1B1 c.521T>C is not associated with simvastatin intolerance when treated with atorvastatin or rosuvastatin in people initiating statin therapy.",
            "Alleles": "T/C or C/C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "simvastatin intolerance",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people initiating statin therapy",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "T/T",
            "Comparison Metabolizer types": null,
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "3",
            "Citations": [
              "No significant association was observed with atorvastatin and rosuvastatin.",
              "We confirmed the association of SLCO1B1 c.521C/C genotype with simvastatin intolerance... No significant association was observed with atorvastatin and rosuvastatin.",
              "Neither the SLCO1B1 or ABCG2 genotypes nor atorvastatin dose were associated with the statin intolerance phenotypes."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "SLCO1B1 c.521T>C",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "simvastatin",
              "drug_id": "PA451363",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "c.521T>C",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin",
            "PMID": 37490620,
            "Phenotype Category": "toxicity",
            "Significance": "no",
            "Notes": "No significant association observed with atorvastatin and rosuvastatin.",
            "Sentence": "SLCO1B1 c.521T>C is not associated with simvastatin intolerance when treated with atorvastatin or rosuvastatin in people initiating statin therapy.",
            "Alleles": "T/C or C/C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "simvastatin intolerance",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people initiating statin therapy",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "T/T",
            "Comparison Metabolizer types": null,
            "PMID_norm": "37490620",
            "Variant Annotation ID_norm": "3",
            "Citations": [
              "No significant association was observed with atorvastatin and rosuvastatin.",
              "We confirmed the association of SLCO1B1 c.521C/C genotype with simvastatin intolerance... No significant association was observed with atorvastatin and rosuvastatin.",
              "Neither the SLCO1B1 or ABCG2 genotypes nor atorvastatin dose were associated with the statin intolerance phenotypes."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "SLCO1B1 c.521T>C",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "simvastatin",
              "drug_id": "PA451363",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.23756865461667379,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.1,
            "scores": [
              0.0,
              0.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.2635298192501068,
            "scores": [
              0.901880145072937,
              0.8739205002784729,
              0.8594975471496582,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.3,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 10,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.901880145072937,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452195945,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452195940,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 916.0,
                "prediction": 2042
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Statin switch",
                "prediction": "Patients initiating statin therapy"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.025",
                "prediction": "= 0.025"
              },
              "Ratio Stat Type": {
                "ground_truth": "HR",
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": 1.88,
                "prediction": 1.88
              },
              "Confidence Interval Start": {
                "ground_truth": 1.08,
                "prediction": 1.08
              },
              "Confidence Interval Stop": {
                "ground_truth": 3.25,
                "prediction": 3.25
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8739205002784729,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452195946,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452195940,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 916.0,
                "prediction": 2042
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Statin switch",
                "prediction": "Patients initiating statin therapy with CK measurement"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.011",
                "prediction": "= 0.011"
              },
              "Ratio Stat Type": {
                "ground_truth": "HR",
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": 5.44,
                "prediction": 5.44
              },
              "Confidence Interval Start": {
                "ground_truth": 1.49,
                "prediction": 1.49
              },
              "Confidence Interval Stop": {
                "ground_truth": 19.9,
                "prediction": 19.9
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8594975471496582,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452195960,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452195947,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 92.0,
                "prediction": 92
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Statin switch",
                "prediction": "Pravastatin users with SLCO1B1 c.521T/C or C/C genotype"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.047",
                "prediction": "= 0.047"
              },
              "Ratio Stat Type": {
                "ground_truth": "HR",
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": 2.11,
                "prediction": 2.11
              },
              "Confidence Interval Start": {
                "ground_truth": 1.01,
                "prediction": 1.01
              },
              "Confidence Interval Stop": {
                "ground_truth": 4.39,
                "prediction": 4.39
              },
              "Biogeographical Groups": {
                "ground_truth": "European",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:Statin switch",
          "None:Statin switch",
          "None:Statin switch"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1452196130,
            "Variant Annotation ID": 1452196120,
            "Study Type": null,
            "Study Cases": 70.0,
            "Study Controls": null,
            "Characteristics": "Statin switch, fluvastatin",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.394",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1452196120"
          },
          {
            "Study Parameters ID": 1452196046,
            "Variant Annotation ID": 1452196040,
            "Study Type": null,
            "Study Cases": 184.0,
            "Study Controls": null,
            "Characteristics": "Statin switch, rosuvastatin",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.301",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1452196040"
          },
          {
            "Study Parameters ID": 1452196045,
            "Variant Annotation ID": 1452196040,
            "Study Type": null,
            "Study Cases": 70.0,
            "Study Controls": null,
            "Characteristics": "Statin switch, fluvastatin",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.36",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1452196040"
          },
          {
            "Study Parameters ID": 1452196060,
            "Variant Annotation ID": 1452196040,
            "Study Type": null,
            "Study Cases": 780.0,
            "Study Controls": null,
            "Characteristics": "Statin switch, atorvastatin",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.759",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1452196040"
          },
          {
            "Study Parameters ID": 1452196085,
            "Variant Annotation ID": 1452196080,
            "Study Type": null,
            "Study Cases": 70.0,
            "Study Controls": null,
            "Characteristics": "Statin switch, fluvastatin",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.113",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1452196080"
          },
          {
            "Study Parameters ID": 1452196100,
            "Variant Annotation ID": 1452196080,
            "Study Type": null,
            "Study Cases": 184.0,
            "Study Controls": null,
            "Characteristics": "Statin switch, rosuvastatin",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.660",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1452196080"
          },
          {
            "Study Parameters ID": 1452196101,
            "Variant Annotation ID": 1452196080,
            "Study Type": null,
            "Study Cases": 780.0,
            "Study Controls": null,
            "Characteristics": "Statin switch, atorvastatin",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.877",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "European",
            "Variant Annotation ID_norm": "1452196080"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC10880264": {
      "var-pheno": {
        "overall_score": 0.6865968356529871,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.8000042608806065,
            "scores": [
              1.0,
              0.8632351160049438,
              1.0,
              1.0,
              0.8632351160049438,
              0.8735595941543579,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.5714285714285714,
            "scores": [
              1.0,
              1.0,
              0.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.3638466937201364,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.852333664894104,
              0.8472965955734253,
              0.8472965955734253,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.7324081489018032,
            "scores": [
              0.8522008061408997,
              0.8532854914665222,
              0.8386486768722534,
              0.8938753008842468,
              0.8501980900764465,
              0.8386486768722534,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.42857142857142855,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 7,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8522008061408997,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2D6",
                "prediction": "CYP2D6"
              },
              "Gene": {
                "ground_truth": "CYP2D6",
                "prediction": "CYP2D6"
              },
              "Drug(s)": {
                "ground_truth": "escitalopram",
                "prediction": "escitalopram"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": null,
                "prediction": "IM"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Psychomotor Agitation, Side Effect:Hyperkinesis, Side Effect:Impulse control disorder",
                "prediction": "akathisia"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 0.8632351160049438,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8532854914665222,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "poor",
                "prediction": "or"
              },
              "Gene": {
                "ground_truth": "CYP2D6",
                "prediction": "HTR2A"
              },
              "Drug(s)": {
                "ground_truth": "escitalopram",
                "prediction": "escitalopram"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": null,
                "prediction": "A/A, A/G"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Psychomotor Agitation, Side Effect:Hyperkinesis, Side Effect:Impulse control disorder",
                "prediction": "self-injury"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8386486768722534,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "Drug(s)": {
                "ground_truth": "escitalopram",
                "prediction": "escitalopram"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "metabolism/PK"
              },
              "Alleles": {
                "ground_truth": null,
                "prediction": "IM"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:suicidal ideation, Side Effect:adverse events, Side Effect:deliberate self-harm",
                "prediction": "pharmacokinetics"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.852333664894104,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8938753008842468,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs6311",
                "prediction": "HTR2A"
              },
              "Gene": {
                "ground_truth": "HTR2A",
                "prediction": "HTR2A"
              },
              "Drug(s)": {
                "ground_truth": "escitalopram",
                "prediction": "escitalopram"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CT + TT",
                "prediction": "A/A, A/G"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:suicidal ideation, Side Effect:adverse events, Side Effect:deliberate self-harm",
                "prediction": "self-injury"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 0.8632351160049438,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8472965955734253,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8501980900764465,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs6311",
                "prediction": "IM"
              },
              "Gene": {
                "ground_truth": "HTR2A",
                "prediction": "CYP2D6"
              },
              "Drug(s)": {
                "ground_truth": "escitalopram",
                "prediction": "escitalopram"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "CT + TT",
                "prediction": "IM"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:suicidal ideation, Side Effect:adverse events, Side Effect:deliberate self-harm",
                "prediction": "akathisia"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 5,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 0.8735595941543579,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.8472965955734253,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8386486768722534,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs6311",
                "prediction": "IM"
              },
              "Gene": {
                "ground_truth": "HTR2A",
                "prediction": "CYP2C19"
              },
              "Drug(s)": {
                "ground_truth": "escitalopram",
                "prediction": "escitalopram"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "metabolism/PK"
              },
              "Alleles": {
                "ground_truth": "CT + TT",
                "prediction": "IM"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:suicidal ideation, Side Effect:adverse events, Side Effect:deliberate self-harm",
                "prediction": "pharmacokinetics"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "CC",
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "cyp2d6",
          "poor",
          "cyp2c19",
          "cyp2d6+escitalopram",
          "cyp2c19+escitalopram",
          "htr2a+escitalopram"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1452390301,
            "Variant/Haplotypes": "metabolizer",
            "Gene": "CYP2C19",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "Toxicity",
            "Significance": "not stated",
            "Notes": "CPIC guidelines used to assign CYP2C19  metabolizer phenotypes based on CYP2C19: *1, *2,*3, *4, *5, *6, *7, *8, *17. \"Slower CYP2C19 metabolizers tended to have greater TEASAP \u201cself-injury, suicidality, and harm to others\u201d subscale scores (F\u2009=\u20092.32, df\u2009=\u20092, p\u2009=\u20090.09), though CYP2C19 phenotype was not associated with increases in other TEASAP subscales scores\" \"CYP2C19 metabolizer phenotypes were almost exclusively rapid metabolizer (RM n\u2009=\u200917), normal metabolizer (NM n\u2009=\u200931), or intermediate metabolizer (IM n\u2009=\u200917), with only one ultrarapid metabolizer (UM) and no poor metabolizers (PMs).\"",
            "Sentence": "CYP2C19 intermediate metabolizer is associated with increased likelihood of suicidal ideation, adverse events or deliberate self-harm when treated with escitalopram in children with Depression or Anxiety Disorders as compared to CYP2C19 normal metabolizer.",
            "Alleles": null,
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:suicidal ideation, Side Effect:adverse events, Side Effect:deliberate self-harm",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Other:Depression, Other:Anxiety Disorders",
            "Multiple phenotypes or diseases And/or": "or",
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "38377518",
            "Variant Annotation ID_norm": "1452390301",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19 intermediate metabolizer",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "A/A",
            "Gene": "HTR2A",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HTR2A A/A and A/G genotypes were associated with increased TEASAP self-injury, suicidality, and harm to others scores (p = 0.017).",
            "Sentence": "HTR2A A/A or A/G is associated with increased risk of self-injury when treated with escitalopram in youth with a family history of bipolar disorder.",
            "Alleles": "A/A, A/G",
            "Specialty Population": "youth",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "side effect",
            "Phenotype": "self-injury",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "bipolar disorder",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "HTR2A A/A and A/G genotypes were associated with increased TEASAP \"self-injury, suicidality, and harm to others\" subscale scores (p = 0.017).",
              "Participants with HTR2A A/A or A/G genotypes had a greater increase in TEASAP \"Self-injury, Suicidality, and Harm to Others\" subscale scores relative to those with HTR2A G/G genotypes (p = 0.017).",
              "CYP2C19 phenotype influences escitalopram pharmacokinetics whereas CYP2D6 phenotype does not. Slower CYP2D6 metabolism was associated with increased akathisia, and HTR2A A/A or A/G genotypes were associated with increased risk of self-harm or harm to others."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HTR2A A/A or A/G",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "A/G",
            "Gene": "HTR2A",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HTR2A A/A and A/G genotypes were associated with increased TEASAP self-injury, suicidality, and harm to others scores (p = 0.017).",
            "Sentence": "HTR2A A/A or A/G is associated with increased risk of self-injury when treated with escitalopram in youth with a family history of bipolar disorder.",
            "Alleles": "A/A, A/G",
            "Specialty Population": "youth",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "side effect",
            "Phenotype": "self-injury",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "bipolar disorder",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "HTR2A A/A and A/G genotypes were associated with increased TEASAP \"self-injury, suicidality, and harm to others\" subscale scores (p = 0.017).",
              "Participants with HTR2A A/A or A/G genotypes had a greater increase in TEASAP \"Self-injury, Suicidality, and Harm to Others\" subscale scores relative to those with HTR2A G/G genotypes (p = 0.017).",
              "CYP2C19 phenotype influences escitalopram pharmacokinetics whereas CYP2D6 phenotype does not. Slower CYP2D6 metabolism was associated with increased akathisia, and HTR2A A/A or A/G genotypes were associated with increased risk of self-harm or harm to others."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HTR2A A/A or A/G",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "var-drug": {
        "overall_score": 0.2553088340842933,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "PMID": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Significance": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Specialty Population": {
            "mean_score": 0.3039050300916036,
            "scores": [
              0.9117150902748108,
              0.0,
              0.0
            ]
          },
          "Metabolizer types": {
            "mean_score": 0.3164486090342204,
            "scores": [
              0.9493458271026611,
              0.0,
              0.0
            ]
          },
          "isPlural": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "PD/PK terms": {
            "mean_score": 0.30095863342285156,
            "scores": [
              0.9028759002685547,
              0.0,
              0.0
            ]
          },
          "Multiple drugs And/or": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Population types": {
            "mean_score": 0.3242225646972656,
            "scores": [
              0.9726676940917969,
              0.0,
              0.0
            ]
          },
          "Population Phenotypes or diseases": {
            "mean_score": 0.27199967702229816,
            "scores": [
              0.8159990310668945,
              0.0,
              0.0
            ]
          },
          "Multiple phenotypes or diseases And/or": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Metabolizer types": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "PMID": 1.0,
              "Phenotype Category": 1.0,
              "Significance": 1.0,
              "Alleles": 0.0,
              "Specialty Population": 0.9117150902748108,
              "Metabolizer types": 0.9493458271026611,
              "isPlural": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "PD/PK terms": 0.9028759002685547,
              "Multiple drugs And/or": 1.0,
              "Population types": 0.9726676940917969,
              "Population Phenotypes or diseases": 0.8159990310668945,
              "Multiple phenotypes or diseases And/or": 0.0,
              "Comparison Allele(s) or Genotype(s)": 0.0,
              "Comparison Metabolizer types": 1.0,
              "Drug(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "PMID": {
                "ground_truth": 38377518,
                "prediction": 38377518
              },
              "Phenotype Category": {
                "ground_truth": "Metabolism/PK",
                "prediction": "metabolism/PK"
              },
              "Significance": {
                "ground_truth": "yes",
                "prediction": "yes"
              },
              "Alleles": {
                "ground_truth": null,
                "prediction": "IM, NM, RM, UM"
              },
              "Specialty Population": {
                "ground_truth": "Pediatric",
                "prediction": "null"
              },
              "Metabolizer types": {
                "ground_truth": "intermediate metabolizer",
                "prediction": "intermediate metabolizer, normal metabolizer, rapid metabolizer, ultrarapid metabolizer"
              },
              "isPlural": {
                "ground_truth": "Is",
                "prediction": "Are"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "PD/PK terms": {
                "ground_truth": "dose-adjusted trough concentrations of",
                "prediction": "concentrations of"
              },
              "Multiple drugs And/or": {
                "ground_truth": null,
                "prediction": null
              },
              "Population types": {
                "ground_truth": "in children with",
                "prediction": "in youth with"
              },
              "Population Phenotypes or diseases": {
                "ground_truth": "Other:Depression, Other:Anxiety Disorders",
                "prediction": "null"
              },
              "Multiple phenotypes or diseases And/or": {
                "ground_truth": "or",
                "prediction": null
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": "normal metabolizer"
              },
              "Comparison Metabolizer types": {
                "ground_truth": "normal metabolizer",
                "prediction": "normal metabolizer"
              },
              "Drug(s)": {
                "ground_truth": "escitalopram",
                "prediction": "escitalopram"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "cyp2c19"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1452390346,
            "Variant/Haplotypes": "intermediate",
            "Gene": "CYP2C19",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "CPIC guidelines used to assign CYP2C19  metabolizer phenotypes based on CYP2C19: *1, *2,*3, *4, *5, *6, *7, *8, *17. \"CYP2C19 metabolizer phenotype had a significant effect on the dose-normalized AUC0\u201324 (p\u2009=\u20090.025), Ctrough (p\u2009=\u20090.013), and t1/2 (p\u2009=\u20090.0008) of escitalopram (Fig. 1).\u201d \"CYP2C19 metabolizer phenotypes were almost exclusively rapid metabolizer (RM n\u2009=\u200917), normal metabolizer (NM n\u2009=\u200931), or intermediate metabolizer (IM n\u2009=\u200917), with only one ultrarapid metabolizer (UM) and no poor metabolizers (PMs).\"",
            "Sentence": "CYP2C19 intermediate metabolizer is associated with increased dose-adjusted trough concentrations of escitalopram in children with Depression or Anxiety Disorders as compared to CYP2C19 normal metabolizer.",
            "Alleles": null,
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "dose-adjusted trough concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Other:Depression, Other:Anxiety Disorders",
            "Multiple phenotypes or diseases And/or": "or",
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "38377518",
            "Variant Annotation ID_norm": "1452390346",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19 intermediate metabolizer",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452390346,
            "Variant/Haplotypes": "metabolizer",
            "Gene": "CYP2C19",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "CPIC guidelines used to assign CYP2C19  metabolizer phenotypes based on CYP2C19: *1, *2,*3, *4, *5, *6, *7, *8, *17. \"CYP2C19 metabolizer phenotype had a significant effect on the dose-normalized AUC0\u201324 (p\u2009=\u20090.025), Ctrough (p\u2009=\u20090.013), and t1/2 (p\u2009=\u20090.0008) of escitalopram (Fig. 1).\u201d \"CYP2C19 metabolizer phenotypes were almost exclusively rapid metabolizer (RM n\u2009=\u200917), normal metabolizer (NM n\u2009=\u200931), or intermediate metabolizer (IM n\u2009=\u200917), with only one ultrarapid metabolizer (UM) and no poor metabolizers (PMs).\"",
            "Sentence": "CYP2C19 intermediate metabolizer is associated with increased dose-adjusted trough concentrations of escitalopram in children with Depression or Anxiety Disorders as compared to CYP2C19 normal metabolizer.",
            "Alleles": null,
            "Specialty Population": "Pediatric",
            "Metabolizer types": "intermediate metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "dose-adjusted trough concentrations of",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Other:Depression, Other:Anxiety Disorders",
            "Multiple phenotypes or diseases And/or": "or",
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "38377518",
            "Variant Annotation ID_norm": "1452390346",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19 intermediate metabolizer",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "CYP2D6",
            "Gene": "CYP2D6",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Slower CYP2D6 metabolizers had increased TEASAP akathisia (p = 0.015) scores.",
            "Sentence": "CYP2D6 is associated with increased akathisia in youth with a family history of Bipolar Disorder as compared to normal metabolizer.",
            "Alleles": "PM, IM, NM, UM",
            "Specialty Population": "null",
            "Metabolizer types": "poor metabolizer, intermediate metabolizer, normal metabolizer, ultrarapid metabolizer",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "TEASAP scores",
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "null",
            "Multiple drugs And/or": null,
            "Comparison Allele(s) or Genotype(s)": "normal metabolizer",
            "Comparison Metabolizer types": "normal metabolizer",
            "Citations": [
              "Slower CYP2D6 metabolizers had increased TEASAP akathisia (p = 0.015) scores.",
              "CYP2D6 phenotype was not significantly associated with any pharmacokinetic parameter. Slower CYP2D6 metabolizers had increased TEASAP akathisia (p = 0.015) scores.",
              "Our findings also suggest that adverse outcomes of interest were influenced by CYP2D6. Specifically, there were associations between slower CYP2D6 metabolizer phenotypes and increased caregiver reports of akathisia, disinhibition, and manic symptoms."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs3892097",
              "variant_id": "PA166156104",
              "confidence": 0.9230769230769231
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "HTR2A",
            "Gene": "HTR2A",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
            "Sentence": "HTR2A A/A or A/G is associated with increased risk of self-harm or harm to others in youth with a family history of Bipolar Disorder as compared to genotype G/G.",
            "Alleles": "A/A, A/G, G/G",
            "Specialty Population": "null",
            "Metabolizer types": "null",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "TEASAP scores",
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "null",
            "Multiple drugs And/or": null,
            "Comparison Allele(s) or Genotype(s)": "G/G",
            "Comparison Metabolizer types": "null",
            "Citations": [
              "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
              "CYP2C19 phenotype influences escitalopram pharmacokinetics whereas CYP2D6 phenotype does not. Slower CYP2D6 metabolism was associated with increased akathisia, and HTR2A A/A or A/G genotypes were associated with increased risk of self-harm or harm to others.",
              "Participants with HTR2A A/A or A/G genotypes had a greater increase in TEASAP 'Self-injury, Suicidality, and Harm to Others' subscale scores relative to those with HTR2A G/G genotypes (p = 0.017)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HTR2A A/A, HTR2A A/G",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "A/A",
            "Gene": "HTR2A",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
            "Sentence": "HTR2A A/A or A/G is associated with increased risk of self-harm or harm to others in youth with a family history of Bipolar Disorder as compared to genotype G/G.",
            "Alleles": "A/A, A/G, G/G",
            "Specialty Population": "null",
            "Metabolizer types": "null",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "TEASAP scores",
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "null",
            "Multiple drugs And/or": null,
            "Comparison Allele(s) or Genotype(s)": "G/G",
            "Comparison Metabolizer types": "null",
            "Citations": [
              "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
              "CYP2C19 phenotype influences escitalopram pharmacokinetics whereas CYP2D6 phenotype does not. Slower CYP2D6 metabolism was associated with increased akathisia, and HTR2A A/A or A/G genotypes were associated with increased risk of self-harm or harm to others.",
              "Participants with HTR2A A/A or A/G genotypes had a greater increase in TEASAP 'Self-injury, Suicidality, and Harm to Others' subscale scores relative to those with HTR2A G/G genotypes (p = 0.017)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HTR2A A/A, HTR2A A/G",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "HTR2A",
            "Gene": "HTR2A",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
            "Sentence": "HTR2A A/A or A/G is associated with increased risk of self-harm or harm to others in youth with a family history of Bipolar Disorder as compared to genotype G/G.",
            "Alleles": "A/A, A/G, G/G",
            "Specialty Population": "null",
            "Metabolizer types": "null",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "TEASAP scores",
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "null",
            "Multiple drugs And/or": null,
            "Comparison Allele(s) or Genotype(s)": "G/G",
            "Comparison Metabolizer types": "null",
            "Citations": [
              "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
              "CYP2C19 phenotype influences escitalopram pharmacokinetics whereas CYP2D6 phenotype does not. Slower CYP2D6 metabolism was associated with increased akathisia, and HTR2A A/A or A/G genotypes were associated with increased risk of self-harm or harm to others.",
              "Participants with HTR2A A/A or A/G genotypes had a greater increase in TEASAP 'Self-injury, Suicidality, and Harm to Others' subscale scores relative to those with HTR2A G/G genotypes (p = 0.017)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HTR2A A/A, HTR2A A/G",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "A/G",
            "Gene": "HTR2A",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
            "Sentence": "HTR2A A/A or A/G is associated with increased risk of self-harm or harm to others in youth with a family history of Bipolar Disorder as compared to genotype G/G.",
            "Alleles": "A/A, A/G, G/G",
            "Specialty Population": "null",
            "Metabolizer types": "null",
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "TEASAP scores",
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "null",
            "Multiple drugs And/or": null,
            "Comparison Allele(s) or Genotype(s)": "G/G",
            "Comparison Metabolizer types": "null",
            "Citations": [
              "HTR2A A/A and A/G genotypes were associated with increased TEASAP 'self-injury, suicidality, and harm to others' subscale scores (p = 0.017).",
              "CYP2C19 phenotype influences escitalopram pharmacokinetics whereas CYP2D6 phenotype does not. Slower CYP2D6 metabolism was associated with increased akathisia, and HTR2A A/A or A/G genotypes were associated with increased risk of self-harm or harm to others.",
              "Participants with HTR2A A/A or A/G genotypes had a greater increase in TEASAP 'Self-injury, Suicidality, and Harm to Others' subscale scores relative to those with HTR2A G/G genotypes (p = 0.017)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HTR2A A/A, HTR2A A/G",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 4,
            "Variant/Haplotypes": "SLC6A4",
            "Gene": "SLC6A4",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "other",
            "Significance": "not stated",
            "Notes": "No significant difference between SLC6A4 genotypes and clinical outcomes.",
            "Sentence": "SLC6A4 S/S is not associated with increased adverse events in youth with a family history of Bipolar Disorder as compared to L/L or L/S.",
            "Alleles": "S/S, L/L, L/S",
            "Specialty Population": "null",
            "Metabolizer types": "null",
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": "null",
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "null",
            "Multiple drugs And/or": null,
            "Comparison Allele(s) or Genotype(s)": "L/L, L/S",
            "Comparison Metabolizer types": "null",
            "Citations": [
              "\"Escitalopram maximum concentration, AUC0\u201324, CYP2C19 phenotype, and SLC6A4 genotype were not associated with adverse events.\"",
              "\"There was no significant difference in clinical outcomes between participants with SLC6A4 L/L or L/S versus S/S genotypes, including TEASAP increases (p = 0.40\u20130.81), max PAERS score (p = 0.72), or hyperarousal frequency (p = 0.72).\"",
              "\"Our analysis did not detect an association between SLC6A4 and clinical outcomes.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "SLC6A4 S/S",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 4,
            "Variant/Haplotypes": "S/S",
            "Gene": "SLC6A4",
            "Drug(s)": "escitalopram",
            "PMID": 38377518,
            "Phenotype Category": "other",
            "Significance": "not stated",
            "Notes": "No significant difference between SLC6A4 genotypes and clinical outcomes.",
            "Sentence": "SLC6A4 S/S is not associated with increased adverse events in youth with a family history of Bipolar Disorder as compared to L/L or L/S.",
            "Alleles": "S/S, L/L, L/S",
            "Specialty Population": "null",
            "Metabolizer types": "null",
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": "null",
            "Population types": "in youth with",
            "Population Phenotypes or diseases": "null",
            "Multiple drugs And/or": null,
            "Comparison Allele(s) or Genotype(s)": "L/L, L/S",
            "Comparison Metabolizer types": "null",
            "Citations": [
              "\"Escitalopram maximum concentration, AUC0\u201324, CYP2C19 phenotype, and SLC6A4 genotype were not associated with adverse events.\"",
              "\"There was no significant difference in clinical outcomes between participants with SLC6A4 L/L or L/S versus S/S genotypes, including TEASAP increases (p = 0.40\u20130.81), max PAERS score (p = 0.72), or hyperarousal frequency (p = 0.72).\"",
              "\"Our analysis did not detect an association between SLC6A4 and clinical outcomes.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "SLC6A4 S/S",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "escitalopram",
              "drug_id": "PA10074",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.753838866353035,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.725,
            "scores": [
              1.0,
              1.0,
              0.9,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.9575829952955246,
            "scores": [
              0.9566717743873596,
              0.9566717743873596,
              0.9556288123130798,
              0.9613596200942993
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.625,
            "scores": [
              1.0,
              0.5,
              0.5,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 4,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9566717743873596,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452390361,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452390352,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 66.0,
                "prediction": 66
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Outpatient youth aged 12\u201317 years who had at least one first-degree relative with bipolar I disorder; TEASAP subscale Self-injury, suicidality and harm to others",
                "prediction": "Children and adolescents aged 12\u201317 years with a first-degree relative with bipolar I disorder treated with escitalopram"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.017",
                "prediction": "= 0.017"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, Non-Hispanic Caucasian n=44, Hispanic Caucasian n=7, Black or African n = 7, Multiple or other n=8",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9566717743873596,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452390309,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452390301,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 66.0,
                "prediction": 66
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Outpatient youth aged 12\u201317 years who had at least one first-degree relative with bipolar I disorder; TEASAP subscale Self-injury, suicidality and harm to others",
                "prediction": "Children and adolescents aged 12\u201317 years with a first-degree relative with bipolar I disorder treated with escitalopram"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.09",
                "prediction": "= 0.025"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, Non-Hispanic Caucasian n=44, Hispanic Caucasian n=7, Black or African n = 7, Multiple or other n=8",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.9556288123130798,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452390397,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452390389,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 64.0,
                "prediction": 66
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Outpatient youth aged 12\u201317 years who had at least one first-degree relative with bipolar I disorder; TEASAP subscale Akathisia, hyperkinesis and somatic anxiety",
                "prediction": "Children and adolescents aged 12\u201317 years with a first-degree relative with bipolar I disorder treated with escitalopram"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.017",
                "prediction": "= 0.013"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, Non-Hispanic Caucasian n=44, Hispanic Caucasian n=7, Black or African n = 7, Multiple or other n=8",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9613596200942993,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452390351,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452390346,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 48.0,
                "prediction": 66
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Outpatient youth aged 12\u201317 years who had at least one first-degree relative with bipolar I disorder; dose-normalized AUC0\u201324",
                "prediction": "Children and adolescents aged 12\u201317 years with a first-degree relative with bipolar I disorder treated with escitalopram"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.025",
                "prediction": "= 0.015"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, Non-Hispanic Caucasian n=33, Hispanic Caucasian n=6, Black or African n = 6, Multiple or other n=6",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:Outpatient youth age",
          "None:Outpatient youth age",
          "None:Outpatient youth age",
          "None:Outpatient youth age"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 66,
            "Study Controls": null,
            "Characteristics": "Children and adolescents aged 12\u201317 years with a first-degree relative with bipolar I disorder treated with escitalopram",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.001",
            "Ratio Stat Type": "HR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC554812": {
      "var-pheno": {
        "overall_score": 0.1809047266840935,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.18474544286727906,
            "scores": [
              0.9237272143363953,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.19686927795410156,
            "scores": [
              0.9843463897705078,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.2,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 5,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9237272143363953,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9843463897705078,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*58:01",
                "prediction": "HLA-B*5801"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "allopurinol",
                "prediction": "allopurinol"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*58:01",
                "prediction": "*5801"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Severe Cutaneous Adverse Reactions",
                "prediction": "severe cutaneous adverse reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "hla-b+allopurinol"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1184755073,
            "Variant/Haplotypes": "HLA-DRB1*03:01",
            "Gene": "HLA-DRB1",
            "Drug(s)": "allopurinol",
            "PMID": 15743917,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Note: Alleles HLA-A*3303, HLA-C*0302, HLA-DRB1*0301 were in LD and formed an extended haplotype with HLA-B*5801. Chronic renal insufficiency was seen at a significantly higher frequency in patients with allopurinol-induced SCAR compared to allopurinol-tolerant patients p<0.0001 (OR=4.7 (2.3-9.3)).",
            "Sentence": "HLA-DRB1 *03:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
            "Alleles": "*03:01",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "15743917",
            "Variant Annotation ID_norm": "1184755073",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-DRB1*03:01",
              "variant_id": "PA166123430",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "allopurinol",
              "drug_id": "PA448320",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1184755032,
            "Variant/Haplotypes": "HLA-C*03:02",
            "Gene": "HLA-C",
            "Drug(s)": "allopurinol",
            "PMID": 15743917,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Note: Alleles HLA-A*3303, HLA-C*0302, HLA-DRB1*0301 were in LD and formed an extended haplotype with HLA-B*5801. Chronic renal insufficiency was seen at a significantly higher frequency in patients with allopurinol-induced SCAR compared to allopurinol-tolerant patients p<0.0001 (OR=4.7 (2.3-9.3)).",
            "Sentence": "HLA-C *03:02 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
            "Alleles": "*03:02",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "15743917",
            "Variant Annotation ID_norm": "1184755032",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-C*03:02",
              "variant_id": "PA166123425",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "allopurinol",
              "drug_id": "PA448320",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1184755056,
            "Variant/Haplotypes": "HLA-A*33:03",
            "Gene": "HLA-A",
            "Drug(s)": "allopurinol",
            "PMID": 15743917,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Note: Alleles HLA-A*3303, HLA-C*0302, HLA-DRB1*0301 were in LD and formed an extended haplotype with HLA-B*5801. Chronic renal insufficiency was seen at a significantly higher frequency in patients with allopurinol-induced SCAR compared to allopurinol-tolerant patients p<0.0001 (OR=4.7 (2.3-9.3)).",
            "Sentence": "HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
            "Alleles": "*33:03",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "15743917",
            "Variant Annotation ID_norm": "1184755056",
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-A*33:03",
              "variant_id": "PA166123428",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "allopurinol",
              "drug_id": "PA448320",
              "confidence": 1.0
            }
          },
          {
            "Variant Annotation ID": 1184755144,
            "Variant/Haplotypes": "rs1594",
            "Gene": "CFLAR",
            "Drug(s)": "allopurinol",
            "PMID": 15743917,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "An initial screen of 823 SNPs in the MHC region or in genes related to drug metabolism and immune response for association with allopurinol-induced SCAR. The direction of the association (i.e. which allele was associated with increased risk of SCARs and which allele was associated with decreased risk) was not clear. Unclear whether this was corrected for multiple comparisons or not.",
            "Sentence": "Allele A is associated with severe cutaneous adverse reactions when treated with allopurinol as compared to allele G.",
            "Alleles": "A",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": null,
            "Side effect/efficacy/other": null,
            "Phenotype": "Side Effect:Severe Cutaneous Adverse Reactions",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "G",
            "Comparison Metabolizer types": null,
            "PMID_norm": "15743917",
            "Variant Annotation ID_norm": "1184755144",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1594",
              "variant_id": "PA166155581",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "allopurinol",
              "drug_id": "PA448320",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.0749409190246037,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.12411378536905561,
            "scores": [
              0.8292081952095032,
              0.9083847999572754,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.07142857142857142,
            "scores": [
              0.5,
              0.5,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.07142857142857142,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 14,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.8292081952095032,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1184755147,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1184755144,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 21.0,
                "prediction": 51
              },
              "Study Controls": {
                "ground_truth": 75.0,
                "prediction": 228
              },
              "Characteristics": {
                "ground_truth": "cases n= 21, controls = 75 general population.",
                "prediction": "Patients with allopurinol\u2013SCAR"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.01",
                "prediction": "< 10\u201318"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 393.5,
                "prediction": 393.5
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 23.23
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 6665.26
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Han Chinese"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 1.0,
              "Study Cases": 0.0,
              "Study Controls": 0.0,
              "Characteristics": 0.9083847999572754,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1184755146,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1184755144,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control"
              },
              "Study Cases": {
                "ground_truth": 30.0,
                "prediction": 51
              },
              "Study Controls": {
                "ground_truth": 60.0,
                "prediction": 228
              },
              "Characteristics": {
                "ground_truth": "cases n= 30, controls = 60 tolerant to allopurinol.",
                "prediction": "Patients with allopurinol\u2013SCAR"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.01",
                "prediction": "< 10\u20137"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 580.3
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 34.4
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 9780.9
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Han Chinese"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "case/control:cases n= 21, control",
          "case/control:cases n= 30, control"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 981345658,
            "Variant Annotation ID": 981345654,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 135.0,
            "Characteristics": "cases n= 51, controls = 135 tolerant to allopurinol",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": "*58:01",
            "Frequency In Controls": 0.15,
            "Allele Of Frequency In Controls": "*58:01",
            "P Value": "= 4.7E-24",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 580.3,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "981345654"
          },
          {
            "Study Parameters ID": 1184754937,
            "Variant Annotation ID": 981345654,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 93.0,
            "Characteristics": "cases n= 51, controls = 93 general population.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 1.0,
            "Allele Of Frequency In Cases": "*58:01",
            "Frequency In Controls": 0.2,
            "Allele Of Frequency In Controls": "*58:01",
            "P Value": "= 8.1E-18",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 393.5,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "981345654"
          },
          {
            "Study Parameters ID": 1184755119,
            "Variant Annotation ID": 981345654,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 135.0,
            "Characteristics": "Cases n= 51, controls = 135 tolerant to allopurinol. Statistics and allele frequencies here are for the HLA-B*5801 extended haplotype: B*5801-C*0302-A*3303-DRB1*0301.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.41,
            "Allele Of Frequency In Cases": "*58:01",
            "Frequency In Controls": 0.07,
            "Allele Of Frequency In Controls": "*58:01",
            "P Value": "= 0.039",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 9.8,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "981345654"
          },
          {
            "Study Parameters ID": 1184755075,
            "Variant Annotation ID": 1184755073,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 135.0,
            "Characteristics": "cases n= 51, controls = 135 tolerant to allopurinol",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.65,
            "Allele Of Frequency In Cases": "*03:01",
            "Frequency In Controls": 0.13,
            "Allele Of Frequency In Controls": "*03:01",
            "P Value": "= 2.8E-6",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 12.7,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755073"
          },
          {
            "Study Parameters ID": 1184755076,
            "Variant Annotation ID": 1184755073,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 93.0,
            "Characteristics": "cases n= 51, controls = 93 general population.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.65,
            "Allele Of Frequency In Cases": "*03:01",
            "Frequency In Controls": 0.15,
            "Allele Of Frequency In Controls": "*03:01",
            "P Value": "= 8.5E-4",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 10.3,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755073"
          },
          {
            "Study Parameters ID": 1184755134,
            "Variant Annotation ID": 1184755073,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 93.0,
            "Characteristics": "Cases n= 51, controls = 135 tolerant to allopurinol. Statistics and allele frequencies here are for the HLA-B*5801 extended haplotype: B*5801-C*0302-A*3303-DRB1*0301.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.41,
            "Allele Of Frequency In Cases": "*03:01",
            "Frequency In Controls": 0.07,
            "Allele Of Frequency In Controls": "*03:01",
            "P Value": "= 0.039",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 9.8,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755073"
          },
          {
            "Study Parameters ID": 1184755034,
            "Variant Annotation ID": 1184755032,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 135.0,
            "Characteristics": "cases n= 51, controls = 135 tolerant to allopurinol",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.94,
            "Allele Of Frequency In Cases": "*03:02",
            "Frequency In Controls": 0.14,
            "Allele Of Frequency In Controls": "*03:02",
            "P Value": "= 1.4E-19",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 97.7,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755032"
          },
          {
            "Study Parameters ID": 1184755035,
            "Variant Annotation ID": 1184755032,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 93.0,
            "Characteristics": "cases n= 51, controls = 93 general population.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.94,
            "Allele Of Frequency In Cases": "*03:02",
            "Frequency In Controls": 0.2,
            "Allele Of Frequency In Controls": "*03:02",
            "P Value": "= 2.5E-13",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 62.3,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755032"
          },
          {
            "Study Parameters ID": 1184755127,
            "Variant Annotation ID": 1184755032,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 135.0,
            "Characteristics": "Cases n= 51, controls = 135 tolerant to allopurinol. Statistics and allele frequencies here are for the HLA-B*5801 extended haplotype: B*5801-C*0302-A*3303-DRB1*0301.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.41,
            "Allele Of Frequency In Cases": "*03:02",
            "Frequency In Controls": 0.07,
            "Allele Of Frequency In Controls": "*03:02",
            "P Value": "= 0.39",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 9.8,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755032"
          },
          {
            "Study Parameters ID": 1184755058,
            "Variant Annotation ID": 1184755056,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 135.0,
            "Characteristics": "cases n= 51, controls = 135 tolerant to allopurinol",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.67,
            "Allele Of Frequency In Cases": "*33:03",
            "Frequency In Controls": 0.18,
            "Allele Of Frequency In Controls": "*33:03",
            "P Value": "= 2.2E-4",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 9.3,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755056"
          },
          {
            "Study Parameters ID": 1184755113,
            "Variant Annotation ID": 1184755056,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 135.0,
            "Characteristics": "cases n= 51, controls = 135 tolerant to allopurinol. Statistics and allele frequencies here are for the HLA-B*5801 extended haplotype: B*5801-C*0302-A*3303-DRB1*0301.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.41,
            "Allele Of Frequency In Cases": "*33:03",
            "Frequency In Controls": 0.07,
            "Allele Of Frequency In Controls": "*33:03",
            "P Value": "= 0.039",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 9.8,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755056"
          },
          {
            "Study Parameters ID": 1184755059,
            "Variant Annotation ID": 1184755056,
            "Study Type": "case/control",
            "Study Cases": 51.0,
            "Study Controls": 93.0,
            "Characteristics": "cases n= 51, controls = 93 general population.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.67,
            "Allele Of Frequency In Cases": "*33:03",
            "Frequency In Controls": 0.22,
            "Allele Of Frequency In Controls": "*33:03",
            "P Value": "= 4.7E-2",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 7.3,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184755056"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC11062152": {
      "var-pheno": {
        "overall_score": 0.2377045295304722,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.3183574279149373,
            "scores": [
              0.955072283744812,
              0.955072283744812,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.312850018342336,
            "scores": [
              0.9385500550270081,
              0.9385500550270081,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.30121902624766034,
            "scores": [
              0.903657078742981,
              0.903657078742981,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.30320513248443604,
            "scores": [
              0.9096153974533081,
              0.9096153974533081,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 6,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 0.955072283744812,
              "Phenotype Category": 1.0,
              "Alleles": 0.9385500550270081,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.903657078742981,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9096153974533081
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "UGT1A1*6",
                "prediction": "UGT1A1*6"
              },
              "Gene": {
                "ground_truth": "UGT1A1",
                "prediction": "UGT1A1"
              },
              "Drug(s)": {
                "ground_truth": "fluorouracil, irinotecan, leucovorin",
                "prediction": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*6 + *28",
                "prediction": "UGT1A1*6, UGT1A1*28"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Diarrhea",
                "prediction": "neutropenia, leukopenia"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013)"
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 0.955072283744812,
              "Phenotype Category": 1.0,
              "Alleles": 0.9385500550270081,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.903657078742981,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.9096153974533081
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "UGT1A1*28",
                "prediction": "*28"
              },
              "Gene": {
                "ground_truth": "UGT1A1",
                "prediction": "UGT1A1"
              },
              "Drug(s)": {
                "ground_truth": "fluorouracil, irinotecan, leucovorin",
                "prediction": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*6 + *28",
                "prediction": "UGT1A1*6, UGT1A1*28"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Diarrhea",
                "prediction": "neutropenia, leukopenia"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013)"
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "ugt1a1*6",
          "ugt1a1*28"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1452474670,
            "Variant/Haplotypes": "UGT1A1*1",
            "Gene": "UGT1A1",
            "Drug(s)": "fluorouracil, irinotecan, leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "\"Diarrhea during nal-IRI/FL treatment was observed in seven (24.1%) of 29 patients, who had not been prescribed any antidiarrhea medication at the commencing time of nal-IRI. The rest of seven patients were excluded, since they received loperamide for diarrhea symptoms at the start of therapy. The incidence of grade \u22651 diarrhea in patients with UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013), and (+/+) were 27.3%, 21.4%, and 25.0%, respectively (Figure 1). Multivariate analysis did not extract any risk factors, which significantly affected the development of diarrhea possibly induced by nal-IRI/FL\"",
            "Sentence": "UGT1A1 *6 + *28 is not associated with increased risk of Diarrhea when treated with fluorouracil, irinotecan and leucovorin in people with Pancreatic Neoplasms and Neoplasm Metastasis as compared to UGT1A1 *1/*1.",
            "Alleles": "*6 + *28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Diarrhea",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Pancreatic Neoplasms, Other:Metastatic neoplasm",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1452474670",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452474678,
            "Variant/Haplotypes": "UGT1A1*1",
            "Gene": "UGT1A1",
            "Drug(s)": "fluorouracil, irinotecan, leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "\"Grade 3 or 4 leukopenia and neutropenia in the UGT1A1*6 or *28 (+/+) group demonstrated an incidence rate of 50.0%, indicating a higher tendency than those in UGT1A1*6 or *28 (\u2013/\u2013) and (+/\u2013) groups at 7.1% and 12.5%, respectively (p=0.085 for each) (Figure 2C and D). Multiple regression analyses revealed that the UGT1A1*6 or *28 (+/+) genotype, high AST value before the nal-IRI/FL therapy, and pancreatic head cancer were significantly associated with decreased white blood cell count (p=0.009, 0.019, and 0.030, respectively) (Table III), and that of UGT1A1*6 or *28 (+/+) was significantly related to decreased neutrophil count (p=0.017)\"",
            "Sentence": "UGT1A1 *6/*6 + *28/*28 + *6/*28 is associated with increased risk of Neutropenia or Leukopenia when treated with fluorouracil, irinotecan and leucovorin in people with Pancreatic Neoplasms and Neoplasm Metastasis as compared to UGT1A1 *1/*1.",
            "Alleles": "*6/*6 + *28/*28 + *6/*28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Neutropenia, Side Effect:Leukopenia",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Pancreatic Neoplasms, Other:Metastatic neoplasm",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1452474678",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452474678,
            "Variant/Haplotypes": "UGT1A1*6",
            "Gene": "UGT1A1",
            "Drug(s)": "fluorouracil, irinotecan, leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "\"Grade 3 or 4 leukopenia and neutropenia in the UGT1A1*6 or *28 (+/+) group demonstrated an incidence rate of 50.0%, indicating a higher tendency than those in UGT1A1*6 or *28 (\u2013/\u2013) and (+/\u2013) groups at 7.1% and 12.5%, respectively (p=0.085 for each) (Figure 2C and D). Multiple regression analyses revealed that the UGT1A1*6 or *28 (+/+) genotype, high AST value before the nal-IRI/FL therapy, and pancreatic head cancer were significantly associated with decreased white blood cell count (p=0.009, 0.019, and 0.030, respectively) (Table III), and that of UGT1A1*6 or *28 (+/+) was significantly related to decreased neutrophil count (p=0.017)\"",
            "Sentence": "UGT1A1 *6/*6 + *28/*28 + *6/*28 is associated with increased risk of Neutropenia or Leukopenia when treated with fluorouracil, irinotecan and leucovorin in people with Pancreatic Neoplasms and Neoplasm Metastasis as compared to UGT1A1 *1/*1.",
            "Alleles": "*6/*6 + *28/*28 + *6/*28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Neutropenia, Side Effect:Leukopenia",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Pancreatic Neoplasms, Other:Metastatic neoplasm",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1452474678",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452474678,
            "Variant/Haplotypes": "UGT1A1*28",
            "Gene": "UGT1A1",
            "Drug(s)": "fluorouracil, irinotecan, leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "\"Grade 3 or 4 leukopenia and neutropenia in the UGT1A1*6 or *28 (+/+) group demonstrated an incidence rate of 50.0%, indicating a higher tendency than those in UGT1A1*6 or *28 (\u2013/\u2013) and (+/\u2013) groups at 7.1% and 12.5%, respectively (p=0.085 for each) (Figure 2C and D). Multiple regression analyses revealed that the UGT1A1*6 or *28 (+/+) genotype, high AST value before the nal-IRI/FL therapy, and pancreatic head cancer were significantly associated with decreased white blood cell count (p=0.009, 0.019, and 0.030, respectively) (Table III), and that of UGT1A1*6 or *28 (+/+) was significantly related to decreased neutrophil count (p=0.017)\"",
            "Sentence": "UGT1A1 *6/*6 + *28/*28 + *6/*28 is associated with increased risk of Neutropenia or Leukopenia when treated with fluorouracil, irinotecan and leucovorin in people with Pancreatic Neoplasms and Neoplasm Metastasis as compared to UGT1A1 *1/*1.",
            "Alleles": "*6/*6 + *28/*28 + *6/*28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Neutropenia, Side Effect:Leukopenia",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Pancreatic Neoplasms, Other:Metastatic neoplasm",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1452474678",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "or",
            "Gene": "UGT1A1",
            "Drug(s)": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells and neutrophils.",
            "Sentence": "UGT1A1*6 or *28 (+/+) is associated with decreased white blood cell count and neutrophil count when treated with nanoliposomal irinotecan plus 5-fluorouracil and L-leucovorin in patients with metastatic pancreatic cancer.",
            "Alleles": "UGT1A1*6, UGT1A1*28",
            "Specialty Population": "none",
            "Metabolizer types": "homozygous",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "neutropenia, leukopenia",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in patients with",
            "Population Phenotypes or diseases": "Disease:metastatic pancreatic cancer",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013)",
            "Comparison Metabolizer types": "wild-type, heterozygous",
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells (p=0.033) and neutrophils (p=0.043).",
              "Multiple regression analyses revealed that the decreased white blood cell count was significantly associated with the genotype of UGT1A1*6 or *28 (+/+) (p=0.009), high aspartate aminotransferase (AST) value before the therapy (p=0.019), and pancreatic head cancer (p=0.030).",
              "Patients with UGT1A1*6 or *28 (+/+) should be especially concerned about neutropenia and leukopenia during nal-IRI/FL treatment."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*6 or *28 (+/+), *6/*6, *6/*28, *28/*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "(+/+)",
            "Gene": "UGT1A1",
            "Drug(s)": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells and neutrophils.",
            "Sentence": "UGT1A1*6 or *28 (+/+) is associated with decreased white blood cell count and neutrophil count when treated with nanoliposomal irinotecan plus 5-fluorouracil and L-leucovorin in patients with metastatic pancreatic cancer.",
            "Alleles": "UGT1A1*6, UGT1A1*28",
            "Specialty Population": "none",
            "Metabolizer types": "homozygous",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "neutropenia, leukopenia",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in patients with",
            "Population Phenotypes or diseases": "Disease:metastatic pancreatic cancer",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013)",
            "Comparison Metabolizer types": "wild-type, heterozygous",
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells (p=0.033) and neutrophils (p=0.043).",
              "Multiple regression analyses revealed that the decreased white blood cell count was significantly associated with the genotype of UGT1A1*6 or *28 (+/+) (p=0.009), high aspartate aminotransferase (AST) value before the therapy (p=0.019), and pancreatic head cancer (p=0.030).",
              "Patients with UGT1A1*6 or *28 (+/+) should be especially concerned about neutropenia and leukopenia during nal-IRI/FL treatment."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*6 or *28 (+/+), *6/*6, *6/*28, *28/*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "*6/*6",
            "Gene": "UGT1A1",
            "Drug(s)": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells and neutrophils.",
            "Sentence": "UGT1A1*6 or *28 (+/+) is associated with decreased white blood cell count and neutrophil count when treated with nanoliposomal irinotecan plus 5-fluorouracil and L-leucovorin in patients with metastatic pancreatic cancer.",
            "Alleles": "UGT1A1*6, UGT1A1*28",
            "Specialty Population": "none",
            "Metabolizer types": "homozygous",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "neutropenia, leukopenia",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in patients with",
            "Population Phenotypes or diseases": "Disease:metastatic pancreatic cancer",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013)",
            "Comparison Metabolizer types": "wild-type, heterozygous",
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells (p=0.033) and neutrophils (p=0.043).",
              "Multiple regression analyses revealed that the decreased white blood cell count was significantly associated with the genotype of UGT1A1*6 or *28 (+/+) (p=0.009), high aspartate aminotransferase (AST) value before the therapy (p=0.019), and pancreatic head cancer (p=0.030).",
              "Patients with UGT1A1*6 or *28 (+/+) should be especially concerned about neutropenia and leukopenia during nal-IRI/FL treatment."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*6 or *28 (+/+), *6/*6, *6/*28, *28/*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "*6/*28",
            "Gene": "UGT1A1",
            "Drug(s)": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells and neutrophils.",
            "Sentence": "UGT1A1*6 or *28 (+/+) is associated with decreased white blood cell count and neutrophil count when treated with nanoliposomal irinotecan plus 5-fluorouracil and L-leucovorin in patients with metastatic pancreatic cancer.",
            "Alleles": "UGT1A1*6, UGT1A1*28",
            "Specialty Population": "none",
            "Metabolizer types": "homozygous",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "neutropenia, leukopenia",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in patients with",
            "Population Phenotypes or diseases": "Disease:metastatic pancreatic cancer",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013)",
            "Comparison Metabolizer types": "wild-type, heterozygous",
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells (p=0.033) and neutrophils (p=0.043).",
              "Multiple regression analyses revealed that the decreased white blood cell count was significantly associated with the genotype of UGT1A1*6 or *28 (+/+) (p=0.009), high aspartate aminotransferase (AST) value before the therapy (p=0.019), and pancreatic head cancer (p=0.030).",
              "Patients with UGT1A1*6 or *28 (+/+) should be especially concerned about neutropenia and leukopenia during nal-IRI/FL treatment."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*6 or *28 (+/+), *6/*6, *6/*28, *28/*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "*28/*28",
            "Gene": "UGT1A1",
            "Drug(s)": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
            "PMID": 38707740,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells and neutrophils.",
            "Sentence": "UGT1A1*6 or *28 (+/+) is associated with decreased white blood cell count and neutrophil count when treated with nanoliposomal irinotecan plus 5-fluorouracil and L-leucovorin in patients with metastatic pancreatic cancer.",
            "Alleles": "UGT1A1*6, UGT1A1*28",
            "Specialty Population": "none",
            "Metabolizer types": "homozygous",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "neutropenia, leukopenia",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "and",
            "Population types": "in patients with",
            "Population Phenotypes or diseases": "Disease:metastatic pancreatic cancer",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "UGT1A1*6 or *28 (\u2013/\u2013), (+/\u2013)",
            "Comparison Metabolizer types": "wild-type, heterozygous",
            "PMID_norm": "38707740",
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "Patients with UGT1A1*6 or *28 (+/+) exhibited significantly lower nadir counts of white blood cells (p=0.033) and neutrophils (p=0.043).",
              "Multiple regression analyses revealed that the decreased white blood cell count was significantly associated with the genotype of UGT1A1*6 or *28 (+/+) (p=0.009), high aspartate aminotransferase (AST) value before the therapy (p=0.019), and pancreatic head cancer (p=0.030).",
              "Patients with UGT1A1*6 or *28 (+/+) should be especially concerned about neutropenia and leukopenia during nal-IRI/FL treatment."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*6 or *28 (+/+), *6/*6, *6/*28, *28/*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "nanoliposomal irinotecan, 5-fluorouracil, L-leucovorin",
              "drug_id": null,
              "confidence": 0.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.6925658146540324,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.8884872198104858,
            "scores": [
              0.8986640572547913,
              0.8977698683738708,
              0.8690277338027954
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.5,
            "scores": [
              0.5,
              0.5,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 3,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8986640572547913,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452474677,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452474670,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 29.0,
                "prediction": 36.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "diarrhea greater than grade 1 during Nanoliposomal irinotecan +  5-fluorouracil (5-FU) and leucovorin treatment",
                "prediction": "Patients with metastatic pancreatic cancer receiving nal-IRI/FL treatment"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.943",
                "prediction": "= 0.033"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8977698683738708,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452474729,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452474678,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 31.0,
                "prediction": 36.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "predictive factors for leukopenia (multiple regression) during Nanoliposomal irinotecan +  5-fluorouracil (5-FU) and leucovorin treatment",
                "prediction": "Patients with metastatic pancreatic cancer receiving nal-IRI/FL treatment"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.009",
                "prediction": "= 0.043"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8690277338027954,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452474688,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452474678,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 31.0,
                "prediction": 36.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "predictive factors for neutropenia (multiple regression) during Nanoliposomal irinotecan +  5-fluorouracil (5-FU) and leucovorin treatment",
                "prediction": "Patients with high AST value before therapy"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.017",
                "prediction": "= 0.019"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:diarrhea greater tha",
          "None:predictive factors f",
          "None:predictive factors f"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "retrospective",
            "Study Cases": 36.0,
            "Study Controls": null,
            "Characteristics": "Patients with UGT1A1*6 or *28 (+/+) genotype",
            "Characteristics Type": "drug",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.009",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "retrospective",
            "Study Cases": 36.0,
            "Study Controls": null,
            "Characteristics": "Patients with pancreatic head cancer",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.030",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "retrospective",
            "Study Cases": 36.0,
            "Study Controls": null,
            "Characteristics": "Patients with UGT1A1*6 or *28 (+/+) genotype",
            "Characteristics Type": "drug",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.017",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC3387531": {
      "var-pheno": {
        "overall_score": 0.7082352646523052,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.3333333333333333,
            "scores": [
              0.0,
              0.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.29415208101272583,
            "scores": [
              0.8824562430381775,
              0.8824562430381775,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.73713086048762,
            "scores": [
              0.8830347061157227,
              0.8830347061157227,
              0.8906463384628296,
              0.8830347061157227,
              0.8830347061157227,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.8333333333333334,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          }
        },
        "total_samples": 6,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8824562430381775,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8830347061157227,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs3745274",
                "prediction": "CYP2B6"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "T",
                "prediction": "TT, GG"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug Toxicity",
                "prediction": "cutaneous adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8824562430381775,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8830347061157227,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs3745274",
                "prediction": "516G\u2192T"
              },
              "Gene": {
                "ground_truth": "CYP2B6",
                "prediction": "CYP2B6"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "T",
                "prediction": "TT, GG"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug Toxicity",
                "prediction": "cutaneous adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8906463384628296,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-DRB1*01:01",
                "prediction": "HLA-DRB1*01"
              },
              "Gene": {
                "ground_truth": "HLA-DRB1",
                "prediction": "HLA-DRB1"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*01:01",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug Toxicity",
                "prediction": "hepatic adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8830347061157227,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*35:01",
                "prediction": "HLA-B*35"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*35:01",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug Toxicity",
                "prediction": "cutaneous adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.0,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8830347061157227,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-C*04:01",
                "prediction": "HLA-Cw*04"
              },
              "Gene": {
                "ground_truth": "HLA-C",
                "prediction": "HLA-C"
              },
              "Drug(s)": {
                "ground_truth": "nevirapine",
                "prediction": "nevirapine"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*04:01",
                "prediction": null
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug Toxicity",
                "prediction": "cutaneous adverse events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA165955215",
          "PA165951320",
          "hla-c+nevirapine",
          "cyp2b6+nevirapine",
          "cyp2b6+nevirapine"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1185002114,
            "Variant/Haplotypes": "rs3786547",
            "Gene": "CYP2B6",
            "Drug(s)": "nevirapine",
            "PMID": 21505298,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "The frequency of the C allele was greater in those with nevirapine-related cutaneous adverse events as compared to healthy controls. This SNP was in LD with rs2054674 (r2 = 0.982) and rs3745274 (r2 > 0.90). p-value corrected for multiple testing. This SNP was not associated with hepatic adverse events after correcting for multiple comparisons.",
            "Sentence": "Allele C is associated with increased risk of Drug Toxicity when treated with nevirapine in people with HIV Infections.",
            "Alleles": "C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Side Effect:Drug Toxicity",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "21505298",
            "Variant Annotation ID_norm": "1185002114",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs3786547",
              "variant_id": "PA166155411",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "nevirapine",
              "drug_id": "PA450616",
              "confidence": 1.0
            }
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.3005257519086202,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.457886278629303,
            "scores": [
              0.9235373139381409,
              0.9268535375595093,
              0.8969268202781677,
              0.0,
              0.0,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.25,
            "scores": [
              0.5,
              0.5,
              0.5,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              1.0,
              1.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.16666666666666666,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.13333333333333333,
            "scores": [
              0.0,
              0.8,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 6,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9235373139381409,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1185002122,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1185002120,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 175.0,
                "prediction": 276
              },
              "Study Controls": {
                "ground_truth": 587.0,
                "prediction": 587
              },
              "Characteristics": {
                "ground_truth": "Severe cutaneous toxicity - grade III or IV on NIAID Division of AIDS criteria.",
                "prediction": "HIV-infected adults experiencing nevirapine-associated severe cutaneous and/or hepatic adverse events"
              },
              "Characteristics Type": {
                "ground_truth": "Disease",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.13",
                "prediction": "= 0.025"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.66,
                "prediction": 1.66
              },
              "Confidence Interval Start": {
                "ground_truth": 1.29,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": 2.15,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, Asian, Black, White",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9268535375595093,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.8,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1185002101,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1185002099,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 175.0,
                "prediction": 276
              },
              "Study Controls": {
                "ground_truth": 587.0,
                "prediction": 587
              },
              "Characteristics": {
                "ground_truth": "Severe cutaneous toxicity - grade III or IV on NIAID Division of AIDS criteria.",
                "prediction": "HIV-infected adults experiencing nevirapine-associated severe cutaneous adverse events"
              },
              "Characteristics Type": {
                "ground_truth": "Disease",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.019",
                "prediction": "= 0.011"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.76,
                "prediction": 5.44
              },
              "Confidence Interval Start": {
                "ground_truth": 1.36,
                "prediction": 1.49
              },
              "Confidence Interval Stop": {
                "ground_truth": 2.27,
                "prediction": 19.9
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, Asian, Black, White",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8969268202781677,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 1.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1185002116,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1185002114,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": "case/control",
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 175.0,
                "prediction": 276
              },
              "Study Controls": {
                "ground_truth": 587.0,
                "prediction": 587
              },
              "Characteristics": {
                "ground_truth": "Severe cutaneous toxicity - grade III or IV on NIAID Division of AIDS criteria.",
                "prediction": "HIV-infected adults experiencing nevirapine-associated hepatic adverse events"
              },
              "Characteristics Type": {
                "ground_truth": "Disease",
                "prediction": "disease"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.029",
                "prediction": "= 0.0025"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": 1.74,
                "prediction": 3.02
              },
              "Confidence Interval Start": {
                "ground_truth": 1.34,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": 2.25,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Multiple groups, Asian, Black, White",
                "prediction": "Multiple Groups"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "case/control:Severe cutaneous tox",
          "case/control:Severe cutaneous tox",
          "case/control:Severe cutaneous tox"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1185002093,
            "Variant Annotation ID": 1185002091,
            "Study Type": "case/control",
            "Study Cases": 52.0,
            "Study Controls": 173.0,
            "Characteristics": "Severe cutaneous toxicity - grade III or IV on NIAID Division of AIDS criteria.",
            "Characteristics Type": "Disease",
            "Frequency In Cases": 0.192,
            "Allele Of Frequency In Cases": "*35:01",
            "Frequency In Controls": 0.043,
            "Allele Of Frequency In Controls": "*35:01",
            "P Value": "= 0.022",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 5.65,
            "Confidence Interval Start": 2.03,
            "Confidence Interval Stop": 15.71,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1185002091"
          },
          {
            "Study Parameters ID": 1185002085,
            "Variant Annotation ID": 1185002083,
            "Study Type": "case/control",
            "Study Cases": 57.0,
            "Study Controls": 277.0,
            "Characteristics": "Symptomatic grade >= 3 hepatic transaminase elevation (ALT or AST >5x ULN) or acute hepatic failure",
            "Characteristics Type": "Disease",
            "Frequency In Cases": 0.439,
            "Allele Of Frequency In Cases": "*01:01",
            "Frequency In Controls": 0.208,
            "Allele Of Frequency In Controls": "*01:01",
            "P Value": "= 0.0074",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 3.02,
            "Confidence Interval Start": 1.66,
            "Confidence Interval Stop": 5.49,
            "Biogeographical Groups": "Multiple groups, Caucasian and Hispanic/Latino patients",
            "Variant Annotation ID_norm": "1185002083"
          },
          {
            "Study Parameters ID": 1185002079,
            "Variant Annotation ID": 1185002071,
            "Study Type": "case/control",
            "Study Cases": 175.0,
            "Study Controls": 587.0,
            "Characteristics": "Severe cutaneous toxicity - grade III or IV on NIAID Division of AIDS criteria.",
            "Characteristics Type": "Disease",
            "Frequency In Cases": 0.377,
            "Allele Of Frequency In Cases": "*04:01",
            "Frequency In Controls": 0.194,
            "Allele Of Frequency In Controls": "*04:01",
            "P Value": "= 8.7E-6",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 2.51,
            "Confidence Interval Start": 1.73,
            "Confidence Interval Stop": 3.62,
            "Biogeographical Groups": "Multiple groups, Asian, Thai, Black, White",
            "Variant Annotation ID_norm": "1185002071"
          }
        ],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control, retrospective",
            "Study Cases": 276,
            "Study Controls": 587,
            "Characteristics": "HIV-infected adults experiencing nevirapine-associated cutaneous adverse events among Blacks",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 18.9,
            "Confidence Interval Start": 1.53,
            "Confidence Interval Stop": 26.8,
            "Biogeographical Groups": "African America/Afro-Caribbean",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control, retrospective",
            "Study Cases": 276,
            "Study Controls": 587,
            "Characteristics": "HIV-infected adults experiencing nevirapine-associated cutaneous adverse events among Asians",
            "Characteristics Type": "disease",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 18.34,
            "Confidence Interval Start": 5.1,
            "Confidence Interval Stop": 65.99,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC10946077": {
      "var-pheno": {
        "overall_score": 0.09402488988070261,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.12949377298355103,
            "scores": [
              0.9064564108848572,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.12092850889478411,
            "scores": [
              0.8464995622634888,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.14285714285714285,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.12077242987496513,
            "scores": [
              0.8454070091247559,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 7,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.9064564108848572,
              "Is/Is Not associated": 0.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.8464995622634888,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.8454070091247559
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "UGT1A1*6",
                "prediction": "UGT1A1*6"
              },
              "Gene": {
                "ground_truth": "UGT1A1",
                "prediction": "UGT1A1"
              },
              "Drug(s)": {
                "ground_truth": "irinotecan",
                "prediction": "irinotecan"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*6 + *28",
                "prediction": "AA, GA, GG"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Efficacy:Overall survival, Efficacy:Progression-free survival",
                "prediction": "delayed diarrhea, leukopenia, neutropenia"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1",
                "prediction": "none"
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "ugt1a1*6"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1452426860,
            "Variant/Haplotypes": "UGT1A1*1",
            "Gene": "UGT1A1",
            "Drug(s)": "irinotecan",
            "PMID": 38497131,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "\"In this study, we calculated irinotecan dose according to UGT1A1*6 gene polymorphism based on BSA. For patients with GG type, irinotecan was used in full dose. For patients with GA type, irinotecan was used by 20% reduction. For patients with AA type, irinotecan was used by 40% reduction.\" \"Of the 8 patients with UGT1A1*6 AA subtype, 5 had severe toxicity and were subsequently switched to paclitaxel in the following treatment. Three patients received paclitaxel treatment directly.\" \"In the present study, univariable and multivariate analysis revealed no relation between PFS and UGT1A1*6 or UGT1A1*28\"",
            "Sentence": "UGT1A1 *6 + *28 is not associated with decreased likelihood of overall survival or progression-free survival when treated with irinotecan in people with Stomach Neoplasms as compared to UGT1A1 *1.",
            "Alleles": "*6 + *28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Overall survival, Efficacy:Progression-free survival",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stomach Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38497131",
            "Variant Annotation ID_norm": "1452426860",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452426860,
            "Variant/Haplotypes": "UGT1A1*28",
            "Gene": "UGT1A1",
            "Drug(s)": "irinotecan",
            "PMID": 38497131,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "\"In this study, we calculated irinotecan dose according to UGT1A1*6 gene polymorphism based on BSA. For patients with GG type, irinotecan was used in full dose. For patients with GA type, irinotecan was used by 20% reduction. For patients with AA type, irinotecan was used by 40% reduction.\" \"Of the 8 patients with UGT1A1*6 AA subtype, 5 had severe toxicity and were subsequently switched to paclitaxel in the following treatment. Three patients received paclitaxel treatment directly.\" \"In the present study, univariable and multivariate analysis revealed no relation between PFS and UGT1A1*6 or UGT1A1*28\"",
            "Sentence": "UGT1A1 *6 + *28 is not associated with decreased likelihood of overall survival or progression-free survival when treated with irinotecan in people with Stomach Neoplasms as compared to UGT1A1 *1.",
            "Alleles": "*6 + *28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Overall survival, Efficacy:Progression-free survival",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stomach Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38497131",
            "Variant Annotation ID_norm": "1452426860",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452426882,
            "Variant/Haplotypes": "UGT1A1*1",
            "Gene": "UGT1A1",
            "Drug(s)": "irinotecan",
            "PMID": 38497131,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "\"there were no significant differences in diarrhea (p\u2009=\u20090.136), neutropenia (p\u2009=\u20090.991), and leukopenia (p\u2009=\u20090.857) in UGT1A1*28 subgroups.\" \"The frequencies of TA6/TA6, TA6/TA7, TA7/TA7 for UGT1A1*28 and GG, GA, AA genotypes for UGT1A1*6 were 70.9%, 25.5%, 3.6% and 60.9%, 31.8%, 7.3%, respectively (Table 2). Three patients (2.7%) carried double heterozygosity (GA and TA6/TA7). No concurrent homozygous mutations were detected.\"",
            "Sentence": "UGT1A1 *28 is not associated with increased severity of Neutropenia, Leukopenia or Diarrhea when treated with irinotecan in people with Stomach Neoplasms as compared to UGT1A1 *1.",
            "Alleles": "*28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "severity of",
            "Phenotype": "Side Effect:Neutropenia, Side Effect:Leukopenia, Side Effect:Diarrhea",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stomach Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38497131",
            "Variant Annotation ID_norm": "1452426882",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452426882,
            "Variant/Haplotypes": "UGT1A1*28",
            "Gene": "UGT1A1",
            "Drug(s)": "irinotecan",
            "PMID": 38497131,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "\"there were no significant differences in diarrhea (p\u2009=\u20090.136), neutropenia (p\u2009=\u20090.991), and leukopenia (p\u2009=\u20090.857) in UGT1A1*28 subgroups.\" \"The frequencies of TA6/TA6, TA6/TA7, TA7/TA7 for UGT1A1*28 and GG, GA, AA genotypes for UGT1A1*6 were 70.9%, 25.5%, 3.6% and 60.9%, 31.8%, 7.3%, respectively (Table 2). Three patients (2.7%) carried double heterozygosity (GA and TA6/TA7). No concurrent homozygous mutations were detected.\"",
            "Sentence": "UGT1A1 *28 is not associated with increased severity of Neutropenia, Leukopenia or Diarrhea when treated with irinotecan in people with Stomach Neoplasms as compared to UGT1A1 *1.",
            "Alleles": "*28",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "severity of",
            "Phenotype": "Side Effect:Neutropenia, Side Effect:Leukopenia, Side Effect:Diarrhea",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stomach Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38497131",
            "Variant Annotation ID_norm": "1452426882",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*28",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452426961,
            "Variant/Haplotypes": "UGT1A1*1",
            "Gene": "UGT1A1",
            "Drug(s)": "irinotecan",
            "PMID": 38497131,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "\"diarrhea (p\u2009=\u20090.000), neutropenia (p\u2009=\u20090.000), and leukopenia (p\u2009=\u20090.003) were significantly different among UGT1A1*6 subgroups (Table 3). Additionally, grade 3/4 diarrhea, neutropenia, and leukopenia were significantly more common in AA genotype patients compared to GG (2%, 19%, and 24%) or GA (23%, 31%, and 31%) genotype patients, suggesting that that patients with the AA genotype could not tolerate severe toxicity even with reduced doses of irinotecan.diarrhea (p\u2009=\u20090.000), neutropenia (p\u2009=\u20090.000), and leukopenia (p\u2009=\u20090.003) were significantly different among UGT1A1*6 subgroups (Table 3). Additionally, grade 3/4 diarrhea, neutropenia, and leukopenia were significantly more common in AA genotype patients compared to GG (2%, 19%, and 24%) or GA (23%, 31%, and 31%) genotype patients, suggesting that that patients with the AA genotype could not tolerate severe toxicity even with reduced doses of irinotecan.\" \"The frequencies of TA6/TA6, TA6/TA7, TA7/TA7 for UGT1A1*28 and GG, GA, AA genotypes for UGT1A1*6 were 70.9%, 25.5%, 3.6% and 60.9%, 31.8%, 7.3%, respectively (Table 2). Three patients (2.7%) carried double heterozygosity (GA and TA6/TA7). No concurrent homozygous mutations were detected.\"",
            "Sentence": "UGT1A1 *6 is associated with increased severity of Neutropenia, Leukopenia or Diarrhea when treated with irinotecan in people with Stomach Neoplasms as compared to UGT1A1 *1.",
            "Alleles": "*6",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "severity of",
            "Phenotype": "Side Effect:Neutropenia, Side Effect:Leukopenia, Side Effect:Diarrhea",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stomach Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38497131",
            "Variant Annotation ID_norm": "1452426961",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1452426961,
            "Variant/Haplotypes": "UGT1A1*6",
            "Gene": "UGT1A1",
            "Drug(s)": "irinotecan",
            "PMID": 38497131,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "\"diarrhea (p\u2009=\u20090.000), neutropenia (p\u2009=\u20090.000), and leukopenia (p\u2009=\u20090.003) were significantly different among UGT1A1*6 subgroups (Table 3). Additionally, grade 3/4 diarrhea, neutropenia, and leukopenia were significantly more common in AA genotype patients compared to GG (2%, 19%, and 24%) or GA (23%, 31%, and 31%) genotype patients, suggesting that that patients with the AA genotype could not tolerate severe toxicity even with reduced doses of irinotecan.diarrhea (p\u2009=\u20090.000), neutropenia (p\u2009=\u20090.000), and leukopenia (p\u2009=\u20090.003) were significantly different among UGT1A1*6 subgroups (Table 3). Additionally, grade 3/4 diarrhea, neutropenia, and leukopenia were significantly more common in AA genotype patients compared to GG (2%, 19%, and 24%) or GA (23%, 31%, and 31%) genotype patients, suggesting that that patients with the AA genotype could not tolerate severe toxicity even with reduced doses of irinotecan.\" \"The frequencies of TA6/TA6, TA6/TA7, TA7/TA7 for UGT1A1*28 and GG, GA, AA genotypes for UGT1A1*6 were 70.9%, 25.5%, 3.6% and 60.9%, 31.8%, 7.3%, respectively (Table 2). Three patients (2.7%) carried double heterozygosity (GA and TA6/TA7). No concurrent homozygous mutations were detected.\"",
            "Sentence": "UGT1A1 *6 is associated with increased severity of Neutropenia, Leukopenia or Diarrhea when treated with irinotecan in people with Stomach Neoplasms as compared to UGT1A1 *1.",
            "Alleles": "*6",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "severity of",
            "Phenotype": "Side Effect:Neutropenia, Side Effect:Leukopenia, Side Effect:Diarrhea",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stomach Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "38497131",
            "Variant Annotation ID_norm": "1452426961",
            "Variant/Haplotypes_normalized": {
              "normalized": "UGT1A1*1, UGT1A1*6",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "irinotecan",
              "drug_id": "PA450085",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.6717201889128912,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.7714285714285715,
            "scores": [
              0.9,
              0.9,
              0.9,
              0.9,
              0.9,
              0.9,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.7400885479790824,
            "scores": [
              0.8226594924926758,
              0.8505383133888245,
              0.8841285109519958,
              0.8706467151641846,
              0.867308497428894,
              0.885338306427002,
              0.0
            ]
          },
          "Characteristics Type": {
            "mean_score": 0.2857142857142857,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "P Value": {
            "mean_score": 0.5642857142857143,
            "scores": [
              0.95,
              0.5,
              1.0,
              1.0,
              0.5,
              0.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.8571428571428571,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          }
        },
        "total_samples": 7,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.8226594924926758,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.95,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452426880,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452426860,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 110.0,
                "prediction": 107.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "OS for *6",
                "prediction": "Patients with advanced gastric cancer receiving irinotecan treatment based on UGT1A1 genotype"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.703",
                "prediction": "= 0.6821"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.8505383133888245,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452426890,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452426882,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 110.0,
                "prediction": 107.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Leukopenia grade 3-4",
                "prediction": "Patients with advanced gastric cancer receiving irinotecan treatment based on UGT1A1 genotype"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.857",
                "prediction": "= 0.5249"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "HR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.8841285109519958,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452426968,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452426961,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 110.0,
                "prediction": 107.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Leukopenia grade 3-4",
                "prediction": "Patients with UGT1A1*6 genotypes showing different toxicity levels"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.003",
                "prediction": "= 0.003"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.8706467151641846,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452426889,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452426882,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 110.0,
                "prediction": 107.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Neutopenia grade 3-4",
                "prediction": "Patients with UGT1A1*6 genotypes showing different toxicity levels"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.136",
                "prediction": "= 0.136"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.867308497428894,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452426891,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452426882,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 110.0,
                "prediction": 107.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Diarrhea grade 3-4",
                "prediction": "Patients with UGT1A1*6 genotypes showing different toxicity levels"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.136",
                "prediction": "= 0.000"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 5,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.9,
              "Study Controls": 1.0,
              "Characteristics": 0.885338306427002,
              "Characteristics Type": 0.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 1.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1452426980,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1452426961,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "retrospective"
              },
              "Study Cases": {
                "ground_truth": 110.0,
                "prediction": 107.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Neutropenia grade 3-4",
                "prediction": "Patients with UGT1A1*6 genotypes showing different toxicity levels"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "drug"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "< 0.001",
                "prediction": "= 0.000"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Unknown",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:OS for *6",
          "None:Leukopenia grade 3-4",
          "None:Leukopenia grade 3-4",
          "None:Neutopenia grade 3-4",
          "None:Diarrhea grade 3-4",
          "None:Neutropenia grade 3-"
        ],
        "unmatched_ground_truth": [
          {
            "Study Parameters ID": 1452426969,
            "Variant Annotation ID": 1452426961,
            "Study Type": null,
            "Study Cases": 110.0,
            "Study Controls": null,
            "Characteristics": "Diarrhea grade 3-4",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.001",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1452426961"
          }
        ],
        "unmatched_predictions": []
      }
    },
    "PMC12331468": {
      "var-pheno": {
        "overall_score": 0.6888888721664747,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.7685803651809693,
            "scores": [
              1.0,
              1.0,
              0.9164877533912659,
              0.9264140725135803,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.717676830291748,
            "scores": [
              0.8970960378646851,
              0.8970960378646851,
              0.8970960378646851,
              0.8970960378646851,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.6726605772972107,
            "scores": [
              0.8491852283477783,
              0.8374155759811401,
              0.8276481032371521,
              0.8490539789199829,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.7062899947166443,
            "scores": [
              0.9030094742774963,
              0.8724658489227295,
              0.9005528688430786,
              0.855421781539917,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.8,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0
            ]
          }
        },
        "total_samples": 5,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 0.8970960378646851,
              "Phenotype Category": 1.0,
              "Alleles": 0.8491852283477783,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9030094742774963,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs11280056",
                "prediction": "TYMS"
              },
              "Gene": {
                "ground_truth": "TYMS",
                "prediction": "TYMS"
              },
              "Drug(s)": {
                "ground_truth": "FOLFOX, XELOX",
                "prediction": "5-fluorouracil"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "TTA/TTA + TTA/TTAAAGTTA",
                "prediction": "DEL"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Peripheral Nervous System Diseases, Side Effect:Myelosuppression",
                "prediction": "hematological adverse reactions"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 0.8970960378646851,
              "Phenotype Category": 1.0,
              "Alleles": 0.8374155759811401,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.8724658489227295,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs45445694",
                "prediction": "TYMS"
              },
              "Gene": {
                "ground_truth": "TYMS",
                "prediction": "TYMS"
              },
              "Drug(s)": {
                "ground_truth": "FOLFOX, XELOX",
                "prediction": "5-fluorouracil"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3",
                "prediction": "3R"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Hand-foot syndrome, Side Effect:Exanthema, Side Effect:Drug Toxicity",
                "prediction": "skin and subcutaneous tissue disorders"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 0.9164877533912659,
              "Drug(s)": 0.8970960378646851,
              "Phenotype Category": 1.0,
              "Alleles": 0.8276481032371521,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9005528688430786,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs11280056",
                "prediction": "(rs1695)"
              },
              "Gene": {
                "ground_truth": "TYMS",
                "prediction": "GSTP1"
              },
              "Drug(s)": {
                "ground_truth": "FOLFOX, XELOX",
                "prediction": "5-fluorouracil"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "TTA/TTA + TTA/TTAAAGTTA",
                "prediction": "G"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "decreased",
                "prediction": "decreased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Peripheral Nervous System Diseases, Side Effect:Myelosuppression",
                "prediction": "neuropathy, mucositis"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 0.9264140725135803,
              "Drug(s)": 0.8970960378646851,
              "Phenotype Category": 1.0,
              "Alleles": 0.8490539789199829,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.855421781539917,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "rs45445694",
                "prediction": "(rs1801265)"
              },
              "Gene": {
                "ground_truth": "TYMS",
                "prediction": "DPYD"
              },
              "Drug(s)": {
                "ground_truth": "FOLFOX, XELOX",
                "prediction": "5-fluorouracil"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3",
                "prediction": "C"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Hand-foot syndrome, Side Effect:Exanthema, Side Effect:Drug Toxicity",
                "prediction": "neuropathy"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "PA166153648",
          "PA166154249",
          "PA166180936",
          "PA166155331"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1454223701,
            "Variant/Haplotypes": "rs1695",
            "Gene": "GSTP1",
            "Drug(s)": "FOLFOX, XELOX",
            "PMID": 40786508,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "\"The G allele of the GSTP1 rs1695 polymorphism was correlated with a lower risk of hematological and nervous system disorders in treated patients, including a reduced risk of neuropathy. This was observed through the analysis of individual ADR using univariate logistic regression without CTCAE v5.0 grouping ( Supplementary Table 3 , OR = 0.01, p-value = 0.008). However, we observed a higher risk of mucositis in patients carrying this polymorphism ( Supplementary Table 3 , OR = 2.27, p-value = 0.036).\"",
            "Sentence": "Genotype GG is associated with increased likelihood of Mucositis when treated with FOLFOX or XELOX in people with Colorectal Neoplasms as compared to genotypes AA + AG.",
            "Alleles": "GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Mucositis",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Colorectal Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "AA + AG",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40786508",
            "Variant Annotation ID_norm": "1454223701",
            "Variant/Haplotypes_normalized": {
              "normalized": "rs1695",
              "variant_id": "PA166154249",
              "confidence": 1.0
            },
            "Drug(s)_normalized": {
              "normalized": "FOLFOX, XELOX",
              "drug_id": null,
              "confidence": 0.0
            }
          }
        ],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "GSTP1",
            "Gene": "GSTP1",
            "Drug(s)": "5-fluorouracil",
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Protective against neuropathy (OR = 0.147; p = 0.012) but increased mucositis risk (OR = 2.27; p = 0.036)",
            "Sentence": "The G allele of GSTP1 (rs1695) is associated with decreased risk of neuropathy and increased risk of mucositis when treated with 5-fluorouracil in Chilean patients with advanced colorectal cancer.",
            "Alleles": "G",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "neuropathy, mucositis",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in Chilean patients with advanced colorectal cancer",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID": 40786508,
            "Variant Annotation ID_norm": "1",
            "Citations": [
              "The G allele of GSTP1 (rs1695) was protective against neuropathy (OR = 0.147; p = 0.012) but increased mucositis risk (OR = 2.27; p = 0.036).",
              "The G allele of the GSTP1 rs1695 polymorphism was correlated with a lower risk of hematological and nervous system disorders in treated patients, including a reduced risk of neuropathy.",
              "However, we observed a higher risk of mucositis in patients carrying this polymorphism (OR = 2.27, p-value = 0.036)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "GSTP1 (rs1695)",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "fluorouracil",
              "drug_id": "PA128406956",
              "confidence": 0.9230769230769231
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 2,
            "Variant/Haplotypes": "DPYD",
            "Gene": "DPYD",
            "Drug(s)": "5-fluorouracil",
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Linked to higher neuropathy risk (OR = 4.58; p = 0.05)",
            "Sentence": "The C allele of DPYD (rs1801265) is associated with increased risk of neuropathy when treated with 5-fluorouracil in Chilean patients with advanced colorectal cancer.",
            "Alleles": "C",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "neuropathy",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in Chilean patients with advanced colorectal cancer",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID": 40786508,
            "Variant Annotation ID_norm": "2",
            "Citations": [
              "The C allele of DPYD (rs1801265) was linked to a higher neuropathy risk (OR = 4.58; p = 0.05).",
              "Further analysis of ungrouped ADRs indicated a higher risk of neuropathy in patients carrying the C allele of the DPYD rs1801265 polymorphism (codominant model T/C genotype OR = 30.0, p-value = 0.0049, dominant model OR = 4.583, p-value = 0.05).",
              "In this study, we included the DPYD genetic variant rs1801265, which, unlike other DPYD variants, is present in 26% of the world population. The C allele was identified as a risk factor for the development of neuropathies."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "DPYD (rs1801265)",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "fluorouracil",
              "drug_id": "PA128406956",
              "confidence": 0.9230769230769231
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 3,
            "Variant/Haplotypes": "(rs11280056)",
            "Gene": "TYMS",
            "Drug(s)": "5-fluorouracil",
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Conferred protection against hematological adverse reactions (OR = 0.029; p = 0.001)",
            "Sentence": "The TYMS deletion genotype (rs11280056) is associated with decreased risk of hematological adverse reactions when treated with 5-fluorouracil in Chilean patients with advanced colorectal cancer.",
            "Alleles": "DEL",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "hematological adverse reactions",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in Chilean patients with advanced colorectal cancer",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID": 40786508,
            "Variant Annotation ID_norm": "3",
            "Citations": [
              "The TYMS deletion genotype (rs11280056) conferred protection against hematological adverse reactions (OR = 0.029; p = 0.001).",
              "The main therapeutic target of 5-FU is the inhibition of the TS enzyme. Among the key genetic variants, the 6bp deletion in the 3\u2019UTR (rs11280056) was associated with a decreased risk of gastrointestinal and hematological ADRs.",
              "When analyzing the risk of grouped ADR while considering only severe reactions (Grade III-IV), we found that only the TYMS 3\u2019UTR 6bp deletion (rs11280056) was the only polymorphism associated with a lower risk of severe hematological disorders (dominant model OR = 0,098, CI 95% 0.013 \u2013 0.441, p-value =0.005)."
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs11280056",
              "variant_id": "PA166180936",
              "confidence": 0.8
            },
            "Drug(s)_normalized": {
              "normalized": "fluorouracil",
              "drug_id": "PA128406956",
              "confidence": 0.9230769230769231
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 4,
            "Variant/Haplotypes": "(rs45445694)",
            "Gene": "TYMS",
            "Drug(s)": "5-fluorouracil",
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Associated with increased risk of skin and subcutaneous tissue disorders (OR = 6.40; p = 0.029)",
            "Sentence": "The 3R genotype of TYMS 5\u2019UTR (rs45445694) is associated with increased risk of skin and subcutaneous tissue disorders when treated with 5-fluorouracil in Chilean patients with advanced colorectal cancer.",
            "Alleles": "3R",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "skin and subcutaneous tissue disorders",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in Chilean patients with advanced colorectal cancer",
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID": 40786508,
            "Variant Annotation ID_norm": "4",
            "Citations": [
              "\"On the other hand, the 3R genotype of TYMS 5\u2019UTR (rs45445694) is associated as a risk factor for skin and subcutaneous tissue disorders (OR = 6.40; p = 0.029).\"",
              "\"This study provides a foundation for developing pharmacogenetic-based predictive models for adverse reactions associated with 5-FU, including neuropathy, mucositis, and hematological and skin toxicities.\"",
              "\"Identifying biomarkers associated with ADR risk could serve as a valuable tool for predicting, preventing and managing toxicity, ultimately optimizing the safety and efficacy of FP-based chemotherapy.\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "rs45445694",
              "variant_id": "PA166155331",
              "confidence": 0.8
            },
            "Drug(s)_normalized": {
              "normalized": "fluorouracil",
              "drug_id": "PA128406956",
              "confidence": 0.9230769230769231
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "overall_score": 0.6765711741977268,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.8402342796325684,
            "scores": [
              0.8387935161590576,
              0.8466029167175293,
              0.829180121421814,
              0.8466029167175293,
              0.84011310338974,
              0.84011310338974
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.6416666666666667,
            "scores": [
              0.85,
              0.5,
              1.0,
              0.5,
              0.5,
              0.5
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 0.6666666666666666,
            "scores": [
              1.0,
              1.0,
              1.0,
              1.0,
              0.0,
              0.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 6,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8387935161590576,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.85,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454223659,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454223625,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 82.0,
                "prediction": 82.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Skin and subcutaneous tissue disorders (recessive)",
                "prediction": "Chilean patients with advanced colorectal cancer"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.029",
                "prediction": "= 0.027"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8466029167175293,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454223606,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454223600,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 82.0,
                "prediction": 82.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "neuropathy",
                "prediction": "Chilean patients with advanced colorectal cancer"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.05",
                "prediction": "= 0.01"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 2,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.829180121421814,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454223681,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454223701,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 82.0,
                "prediction": 82.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Mucositis",
                "prediction": "Chilean patients with advanced colorectal cancer"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.036",
                "prediction": "= 0.036"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 2.27
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 3,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.8466029167175293,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454223621,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454223640,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 82.0,
                "prediction": 82.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "neuropathy",
                "prediction": "Chilean patients with advanced colorectal cancer"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.02",
                "prediction": "= 0.05"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 4.58
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 4,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.84011310338974,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454223622,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454223640,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 82.0,
                "prediction": 82.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Hematological disorders",
                "prediction": "Chilean patients with advanced colorectal cancer"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.0005",
                "prediction": "= 0.012"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 0.147
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.007
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 0.991
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 5,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 1.0,
              "Study Controls": 1.0,
              "Characteristics": 0.84011310338974,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 1.0,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.5,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 0.0,
              "Confidence Interval Start": 0.0,
              "Confidence Interval Stop": 0.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454223623,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454223652,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "case/control, retrospective"
              },
              "Study Cases": {
                "ground_truth": 82.0,
                "prediction": 82.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Hematological disorders",
                "prediction": "Chilean patients with advanced colorectal cancer"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": null,
                "prediction": null
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.005",
                "prediction": "= 0.001"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "OR"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": 0.029
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": 0.004
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": 0.182
              },
              "Biogeographical Groups": {
                "ground_truth": "Latino",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:Skin and subcutaneou",
          "None:neuropathy",
          "None:Mucositis",
          "None:neuropathy",
          "None:Hematological disord",
          "None:Hematological disord"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "case/control, retrospective",
            "Study Cases": 82.0,
            "Study Controls": null,
            "Characteristics": "Chilean patients with advanced colorectal cancer",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.029",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 6.4,
            "Confidence Interval Start": 1.188,
            "Confidence Interval Stop": 36.705,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC12036300": {
      "var-pheno": {
        "overall_score": 0.21897138075696096,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.16666666666666666,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Gene": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Drug(s)": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 0.16666666666666666,
            "scores": [
              1.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Alleles": {
            "mean_score": 0.3090278108914693,
            "scores": [
              0.9324533939361572,
              0.9217134714126587,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Direction of effect": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.2903907597064972,
            "scores": [
              0.8628723621368408,
              0.8794721961021423,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 0.3333333333333333,
            "scores": [
              1.0,
              1.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 6,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 1.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.9324533939361572,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.8628723621368408,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19*2",
                "prediction": "CYP2C19*2"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "Drug(s)": {
                "ground_truth": "clopidogrel",
                "prediction": "clopidogrel"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy"
              },
              "Alleles": {
                "ground_truth": "*1/*2 + *2/*2 + *2/*17",
                "prediction": "*2"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Not associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": null
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Major Adverse Cardiac Events (MACE)",
                "prediction": "recurrent ischemic events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": null
              }
            },
            "dependency_issues": []
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 0.0,
              "Alleles": 0.9217134714126587,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 0.0,
              "Phenotype": 0.8794721961021423,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 0.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19*1",
                "prediction": "CYP2C19*17"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19"
              },
              "Drug(s)": {
                "ground_truth": "clopidogrel",
                "prediction": "clopidogrel"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*1/*2 + *2/*2 + *2/*17",
                "prediction": "*17"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Not associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": null
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Major Adverse Cardiac Events (MACE)",
                "prediction": "bleeding events"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "cyp2c19*1",
          "cyp2c19*2"
        ],
        "unmatched_ground_truth": [
          {
            "Variant Annotation ID": 1454052100,
            "Variant/Haplotypes": "CYP2C19*17",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40295977,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "\"Among patients who underwent PCI and were treated with a double maintenance dose of clopidogrel, the carrier status of the CYP2C19*2 allele does not appear to be associated with an increased risk of MACE.\" \"Overall, two of the 41 patients who were followed up in the study experienced at least one MACE after PCI. One case was from the CYP2C19*2 allele carrier group and the other was from the non-carrier group. In terms of the distribution of MACE based on CYP2C19*2 status, there was no statistically significant correlation (P\u2009=\u20090.2744).\"",
            "Sentence": "CYP2C19 *1/*2 + *2/*2 + *2/*17 is not associated with increased likelihood of Major Adverse Cardiac Events (MACE) when treated with clopidogrel as compared to CYP2C19 *1/*1.",
            "Alleles": "*1/*2 + *2/*2 + *2/*17",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Major Adverse Cardiac Events (MACE)",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40295977",
            "Variant Annotation ID_norm": "1454052100",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "clopidogrel",
              "drug_id": "PA449053",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1454052160,
            "Variant/Haplotypes": "CYP2C19*1",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40295977,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "\"Our results indicated that carriers of the CYP2C19*17 variant experienced a higher incidence of bleeding events (16.67%) compared to non-carriers (6.9%). Despite this observed difference, it is important to note that the statistical analysis found no significant difference between the two groups (P\u2009=\u20090.567; see Table 7). Similarly, there was no statistically significant difference in bleeding events between CYP2C19*2 carriers and non-carriers (P\u2009=\u20090.0952; see Table 7), although a higher proportion of bleeding events was observed among carriers.\"",
            "Sentence": "CYP2C19 *1/*17 + *17/*17 + *2/*17 is not associated with increased likelihood of Hemorrhage when treated with clopidogrel as compared to CYP2C19 *1/*1.",
            "Alleles": "*1/*17 + *17/*17 + *2/*17",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Hemorrhage",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40295977",
            "Variant Annotation ID_norm": "1454052160",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "clopidogrel",
              "drug_id": "PA449053",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1454052160,
            "Variant/Haplotypes": "CYP2C19*2",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40295977,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "\"Our results indicated that carriers of the CYP2C19*17 variant experienced a higher incidence of bleeding events (16.67%) compared to non-carriers (6.9%). Despite this observed difference, it is important to note that the statistical analysis found no significant difference between the two groups (P\u2009=\u20090.567; see Table 7). Similarly, there was no statistically significant difference in bleeding events between CYP2C19*2 carriers and non-carriers (P\u2009=\u20090.0952; see Table 7), although a higher proportion of bleeding events was observed among carriers.\"",
            "Sentence": "CYP2C19 *1/*17 + *17/*17 + *2/*17 is not associated with increased likelihood of Hemorrhage when treated with clopidogrel as compared to CYP2C19 *1/*1.",
            "Alleles": "*1/*17 + *17/*17 + *2/*17",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Hemorrhage",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40295977",
            "Variant Annotation ID_norm": "1454052160",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "clopidogrel",
              "drug_id": "PA449053",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1454052160,
            "Variant/Haplotypes": "CYP2C19*17",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40295977,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "\"Our results indicated that carriers of the CYP2C19*17 variant experienced a higher incidence of bleeding events (16.67%) compared to non-carriers (6.9%). Despite this observed difference, it is important to note that the statistical analysis found no significant difference between the two groups (P\u2009=\u20090.567; see Table 7). Similarly, there was no statistically significant difference in bleeding events between CYP2C19*2 carriers and non-carriers (P\u2009=\u20090.0952; see Table 7), although a higher proportion of bleeding events was observed among carriers.\"",
            "Sentence": "CYP2C19 *1/*17 + *17/*17 + *2/*17 is not associated with increased likelihood of Hemorrhage when treated with clopidogrel as compared to CYP2C19 *1/*1.",
            "Alleles": "*1/*17 + *17/*17 + *2/*17",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Hemorrhage",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40295977",
            "Variant Annotation ID_norm": "1454052160",
            "Variant/Haplotypes_normalized": {
              "normalized": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "clopidogrel",
              "drug_id": "PA449053",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ],
        "unmatched_predictions": []
      },
      "study-parameters": {
        "overall_score": 0.6913874387741089,
        "field_scores": {
          "Study Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Study Cases": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Study Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Characteristics": {
            "mean_score": 0.9405010044574738,
            "scores": [
              0.938310444355011,
              0.9426915645599365
            ]
          },
          "Characteristics Type": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Frequency In Cases": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Cases": {
            "mean_score": 0.9303105771541595,
            "scores": [
              0.9341182708740234,
              0.9265028834342957
            ]
          },
          "Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Allele Of Frequency In Controls": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "P Value": {
            "mean_score": 0.5,
            "scores": [
              1.0,
              0.0
            ]
          },
          "Ratio Stat Type": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          },
          "Ratio Stat": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Start": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Confidence Interval Stop": {
            "mean_score": 1.0,
            "scores": [
              1.0,
              1.0
            ]
          },
          "Biogeographical Groups": {
            "mean_score": 0.0,
            "scores": [
              0.0,
              0.0
            ]
          }
        },
        "total_samples": 2,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.938310444355011,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 0.9341182708740234,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 1.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454052180,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454052160,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 41.0,
                "prediction": 50.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "Bleeding events, DAPT with a double maintenance dose of clopidogrel 150 mg/day (for at least one month after PCI).",
                "prediction": "Syrian patients with coronary artery disease on dual antiplatelet therapy with a doubled maintenance dose of clopidogrel"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": 0.17,
                "prediction": 0.17
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "*17",
                "prediction": "CYP2C19*17"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.567",
                "prediction": "0.567"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Near Eastern",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          },
          {
            "sample_id": 1,
            "field_scores": {
              "Study Parameters ID": 0.0,
              "Variant Annotation ID": 0.0,
              "Study Type": 0.0,
              "Study Cases": 0.0,
              "Study Controls": 1.0,
              "Characteristics": 0.9426915645599365,
              "Characteristics Type": 1.0,
              "Frequency In Cases": 1.0,
              "Allele Of Frequency In Cases": 0.9265028834342957,
              "Frequency In Controls": 1.0,
              "Allele Of Frequency In Controls": 1.0,
              "P Value": 0.0,
              "Ratio Stat Type": 0.0,
              "Ratio Stat": 1.0,
              "Confidence Interval Start": 1.0,
              "Confidence Interval Stop": 1.0,
              "Biogeographical Groups": 0.0
            },
            "field_values": {
              "Study Parameters ID": {
                "ground_truth": 1454052120,
                "prediction": null
              },
              "Variant Annotation ID": {
                "ground_truth": 1454052100,
                "prediction": null
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort"
              },
              "Study Cases": {
                "ground_truth": 41.0,
                "prediction": 50.0
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Characteristics": {
                "ground_truth": "MACE, DAPT with a double maintenance dose of clopidogrel 150 mg/day (for at least one month after PCI).",
                "prediction": "Syrian patients with coronary artery disease on dual antiplatelet therapy with a doubled maintenance dose of clopidogrel"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort"
              },
              "Frequency In Cases": {
                "ground_truth": 0.08,
                "prediction": 0.08
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "*2",
                "prediction": "CYP2C19*2"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null
              },
              "P Value": {
                "ground_truth": "= 0.2744",
                "prediction": "> 0.9999"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null
              },
              "Biogeographical Groups": {
                "ground_truth": "Near Eastern",
                "prediction": "Unknown"
              }
            },
            "dependency_issues": [],
            "penalty_info": {
              "total_penalty": 0.0,
              "penalized_fields": {},
              "issues_by_field": {}
            }
          }
        ],
        "aligned_variants": [
          "None:Bleeding events, DAP",
          "None:MACE, DAPT with a do"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 50.0,
            "Study Controls": null,
            "Characteristics": "Syrian patients with coronary artery disease on dual antiplatelet therapy with a doubled maintenance dose of clopidogrel",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.0,
            "Allele Of Frequency In Cases": "CYP2C19*3",
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          },
          {
            "Study Parameters ID": null,
            "Variant Annotation ID": null,
            "Study Type": "cohort",
            "Study Cases": 50.0,
            "Study Controls": null,
            "Characteristics": "Syrian patients with coronary artery disease on dual antiplatelet therapy with a doubled maintenance dose of clopidogrel",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.2744",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": null
          }
        ]
      }
    },
    "PMC384715": {
      "var-pheno": {
        "overall_score": 0.8866028338670731,
        "field_scores": {
          "Variant/Haplotypes": {
            "mean_score": 0.0,
            "scores": [
              0.0
            ]
          },
          "Gene": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Drug(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Phenotype Category": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Alleles": {
            "mean_score": 0.8804689645767212,
            "scores": [
              0.8804689645767212
            ]
          },
          "Is/Is Not associated": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Direction of effect": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Phenotype": {
            "mean_score": 0.9092652797698975,
            "scores": [
              0.9092652797698975
            ]
          },
          "When treated with/exposed to/when assayed with": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          },
          "Comparison Allele(s) or Genotype(s)": {
            "mean_score": 1.0,
            "scores": [
              1.0
            ]
          }
        },
        "total_samples": 1,
        "detailed_results": [
          {
            "sample_id": 0,
            "field_scores": {
              "Variant/Haplotypes": 0.0,
              "Gene": 1.0,
              "Drug(s)": 1.0,
              "Phenotype Category": 1.0,
              "Alleles": 0.8804689645767212,
              "Is/Is Not associated": 1.0,
              "Direction of effect": 1.0,
              "Phenotype": 0.9092652797698975,
              "When treated with/exposed to/when assayed with": 1.0,
              "Comparison Allele(s) or Genotype(s)": 1.0
            },
            "field_values": {
              "Variant/Haplotypes": {
                "ground_truth": "HLA-B*57:01",
                "prediction": "HLA-B*5701"
              },
              "Gene": {
                "ground_truth": "HLA-B",
                "prediction": "HLA-B"
              },
              "Drug(s)": {
                "ground_truth": "abacavir",
                "prediction": "abacavir"
              },
              "Phenotype Category": {
                "ground_truth": "Toxicity",
                "prediction": "toxicity"
              },
              "Alleles": {
                "ground_truth": "*57:01",
                "prediction": "HLA-B*5701, Hsp70-Hom M493T"
              },
              "Is/Is Not associated": {
                "ground_truth": "Associated with",
                "prediction": "Associated with"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": "increased"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Drug Hypersensitivity",
                "prediction": "abacavir hypersensitivity"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": null,
                "prediction": null
              }
            },
            "dependency_issues": []
          }
        ],
        "aligned_variants": [
          "hla-b+abacavir"
        ],
        "unmatched_ground_truth": [],
        "unmatched_predictions": [
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "Hsp70-Hom",
            "Gene": "HLA-B",
            "Drug(s)": "abacavir",
            "PMID": 15024131,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Presence of HLA-B*5701 strongly predicts abacavir hypersensitivity; odds ratio 960; P < 0.00001.",
            "Sentence": "HLA-B*5701 is associated with increased likelihood of abacavir hypersensitivity when treated with abacavir in people with HIV.",
            "Alleles": "HLA-B*5701, Hsp70-Hom M493T",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "abacavir hypersensitivity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "HIV",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "\"We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.\"",
              "\"HLA-B*5701 was present in 94.4% of hypersensitive cases compared with 1.7% of controls (odds ratio, 960; P < 0.00001).\"",
              "\"However, in combination with HLA-B*5701, the Hsp70-Hom M493T allele was strongly associated with abacavir hypersensitivity (17 of 18 individuals vs. 1 of 230 individuals, OR = 3,893, P_c < 0.00001).\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*5701, Hsp70-Hom M493T",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "abacavir",
              "drug_id": "PA448004",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          },
          {
            "Variant Annotation ID": 1,
            "Variant/Haplotypes": "M493T",
            "Gene": "HLA-B",
            "Drug(s)": "abacavir",
            "PMID": 15024131,
            "Phenotype Category": "toxicity",
            "Significance": "yes",
            "Notes": "Presence of HLA-B*5701 strongly predicts abacavir hypersensitivity; odds ratio 960; P < 0.00001.",
            "Sentence": "HLA-B*5701 is associated with increased likelihood of abacavir hypersensitivity when treated with abacavir in people with HIV.",
            "Alleles": "HLA-B*5701, Hsp70-Hom M493T",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "abacavir hypersensitivity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "HIV",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": null,
            "Variant Annotation ID_norm": null,
            "Citations": [
              "\"We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC.\"",
              "\"HLA-B*5701 was present in 94.4% of hypersensitive cases compared with 1.7% of controls (odds ratio, 960; P < 0.00001).\"",
              "\"However, in combination with HLA-B*5701, the Hsp70-Hom M493T allele was strongly associated with abacavir hypersensitivity (17 of 18 individuals vs. 1 of 230 individuals, OR = 3,893, P_c < 0.00001).\""
            ],
            "Variant/Haplotypes_normalized": {
              "normalized": "HLA-B*5701, Hsp70-Hom M493T",
              "variant_id": null,
              "confidence": 0.0
            },
            "Drug(s)_normalized": {
              "normalized": "abacavir",
              "drug_id": "PA448004",
              "confidence": 1.0
            },
            "_expanded_from_multi_variant": true
          }
        ]
      },
      "study-parameters": {
        "error": "Empty predictions list",
        "overall_score": 0.0,
        "total_samples": 0
      }
    }
  }
}